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Thesis Summary 
This thesis explores the effects of dietary probiotic administration in anxiety-like behaviour and 
cognitive functioning.  Desbonnet et al (2008) reported degradation of serotonin in the frontal 
cortex following dietary probiotic administration implicating cognition and anxiety-like behaviour.  
Therefore, the effects of direct serotonin manipulation on behaviour were examined in parallel to 
probiotic treatment. 
Identification of a task reliant on both frontal lobe and serotonergic functioning lead to the use of 
the probabilistic reversal learning task.  Probiotic treatment did not produce effects on this task.  
Exploration of the effect of probiotic treatment on a watermaze reversal learning paradigm, known 
to be reliant on frontal lobe and hippocampal functioning indicated improvements with probiotic 
treatment.  Further examination of this improvement in memory was explored in a novel object 
discrimination task and found to be significantly improved following probiotic treatment.  These 
results produce clear indication the probiotic treatment improves aspects of learning and memory. 
The effects of dietary probiotics on anxiety-like behaviour were also explored.  The results from the 
behavioural data indicated that these tests did not assess the same facet of emotional behaviour 
therefore conclusions could not be drawn on the effects of probiotic on anxiety-like behaviour. 
Examinations of the effects of probiotics at a cellular level were conducted through the use of H1 
nuclear magnetic resonance spectroscopy.  Results from this illustrate distinct alterations in the 
metabolite profile following probiotic treatment.  The finding from this study provide a new rational 
for the further exploration of the effects of probiotic treatment on behaviour and cognition. 
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General Introduction 
1.1. Summary 
The introduction of this thesis discusses the bacterial composition of the human gastrointestinal 
tract and correlations between microbiotal perturbations and psychiatric illness.  The correlations 
are discussed in the context of the brain-gut axis and current evidence on the potential routes of 
action between the two presented.  The effects of manipulations to the bacterial profile of the gut 
using probiotics and the consequences in central nervous system are explored, thus explaining the 
rationale for the current thesis. 
1.2. The Human Gastrointestinal Tract 
The human intestinal microflora consists of a diverse range of microbial species (Howarth & Wang, 
2013).  The colonisation of the intestine begins postnatally when vaginal delivery exposes the infant 
to a diverse range of bacteria giving the initial microbial profile a maternal signature (Cryan & Dinan, 
2012; Palmer et al., 2007).  Resident or commensual bacteria colonise the gut and a relatively stable 
composition is established at about 2 years of age (Palmer et al, 2007). A fully developed adult 
human intestine contains nearly 100 trillion bacteria (Gill et al, 2006) with over 1000 bacterial 
species and approximately 7000 strains (Ley et al, 2006).  This number of bacterial cells is equal to 
10-100 times more eukaryotic cells than in the human body (Gill et al, 2006).  This diverse ecosystem 
has been referred to as the forgotten organ (O’Hara & Shanahan, 2006) as it is fundamental in the 
development of adaptive immune system responses (Hooper & Macpherson, 2010; Bäckhed et al, 
2005), endocrine system function (Sudo et al, 2004), intestinal barrier homeostasis (Husebye et al, 
2001), as well as for the appropriate structural development of the smooth muscle layers required 
for gastrointestinal tract motility (Berg, 1996; Stappenbeck et al, 2002).  
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Although established in early life the composition of the gut microbiota can be influenced over the 
course of a lifetime, causes of perturbations of the microflora include diet, infection, stress and 
exposure to medications, such as antibiotics (Koenigsknecht & Young, 2013; O’Mahony et al, 2009; 
Scribano & Prantera, 2013; Wu et al, 2011).  Perturbation in the natural balance of the gut 
microbiota has been associated with numerous illnesses including irritable bowel syndrome (Dai et 
al, 2013), inflammatory bowel disease and obesity (Mondot et al, 2013).  Despite exposure to 
environmental factors over the course of a lifetime, the intestinal microbiome tends to defer to its 
initial composition, which was established in infancy (Forsythe et al, 2010).  This indicates that while 
environmental factors influence the indigenous populations of gut microbiota during a lifetime, the 
preferential state is that which was established in infancy.  Furthermore, the composition of the 
human microbiota can be categorised into one of 3 main categories, partially determined by 
genetics (Gulati et al, 2012) but strongly associated with long-term diets (Wu et al, 2011).  Three 
main bacterial enterotypes have been identified, with each characterized by the predominance of a 
single microbial genus: Bacteriodes, Prevotella and Ruminococcus.  Bacteroides are strongly 
associated with a diet high in animal fats and proteins as common in western culture. Prevotella is 
predominantly associated with carbohydrate-based diets common in agrarian societies (Wu et al, 
2011) while Ruminococcus  are largely found in the intestinal tract of cows and sheep where their 
diet is primarily plant based (Devillard et al, 2004).  Acute changes in the diet of healthy volunteers 
from high in carbohydrates to high in fats and vice versa, has not been shown to produce any 
distinct changes in bacterial enterotypes (Wu et al, 2011).  However, the complexity and stability of 
other microbial genus predominant in the human gastrointestinal tract (which include 
bifidobacterium and lactobacilis) are considered ‘transient’ (Bercik et al, 2012).  Increases in their 
populations are associated with the ingestion of certain foods and have been shown to be sensitive 
to environmental factors, including exposure to antibiotics (Bercik et al, 2012).  The presence of 
these bacterial strains has been associated with inhibition of listerial infections in vivo. This is largely 
due to competition between these indigenous bacteria with pathogens for nutrients and receptors 
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and the production of antimicrobial proteins (Kopp-Hoolihan 2001; Sekirov et al, 2010).  The 
prevention of pathogenic microbial colonisation is only one of the beneficial functions of lactobacilli 
and bifidobacterium.  Other functions include the protection of the intestinal barrier defence 
system, metabolism of carcinogenic substances and lowering of potentially neurotoxic components 
(Holzapfel et al, 1998). It is the beneficial effects of these bacteria on the host when ingested in 
adequate amounts, that classifies them as ‘probiotics’ (Dinan & Quigley, 2011). 
Studies examining the prevalence of gastrointestinal dysfunction, such as irritable bowel syndrome 
(IBS) and inflammatory bowel disease (IBD), have found a high comorbidity with psychiatric 
disorders. Indeed, approximately 30% of patients with major depressive disorder (MDD) are 
reported to have IBS (Logan & Katzman, 2005).  The incidence of depression in sufferers of Crohn’s 
disease, a type of IBD, both preceding and following diagnosis, is shown to be greater than chance, 
with relapse correlated with depressive episodes (Logan & Katzman, 2005).  Reduced populations of 
lactobacilli are evident in suffers of Crohn’s disease and other forms of IBD (Ott et al, 2004).  Of 
course, the incidence of depression in these patients may not be surprising given the nature of the 
symptoms.  However, emotional disturbances can have physical effects on microbial compositions. 
For example, stress has been shown to reduce lactobacillis populations (Lutgendorff et al, 2008).  It 
is the existence of this comorbidity of depressive symptoms and gastrointestinal disorders that have 
lead to the proposition that probiotic treatment may ameliorate depressive symptoms.  Empirical 
evidence from clinical trials is limited in this area - as the first hypothesis to suggest that probiotics 
may be an adjuvant therapy to depression was suggested by Logan & Katzman in 2004.  Much of the 
empirical evidence to date has focused on the preclinical arena.  
A double-blind placebo controlled trial using one hundred and twenty-four healthy 
volunteers found that after 3 weeks of consuming a lactobacillus and bifidobacterium containing 
yogurt , the participants who originally scored in the bottom third on mood and cognition tests were 
significantly improved compared with controls (Benton et al, 2007).  A more recent clinical study 
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again using strains of lactobacillus and bifidobacteriumin a double-blind placebo-controlled trial, and 
found that 30 days of consumption had beneficial psychological effects on healthy volunteers as 
measured by the Hopkins Symptom Checklist, the Hospital Anxiety and Depression Scale and Coping 
Checklist (Messaoudi et al, 2011).  Chronic fatigue syndrome is frequently associated with anxiety 
and gastrointestinal irregularity, including lower levels of bifidobacterium and small intestine 
bacterial overgrowth (Logan et al, 2003).  Treatment with a strain of lactobacillus was shown to 
increase intestinal bifidobacterium and lactobacillus populations after 2 months in chronic fatigue 
syndrome sufferers, as well as reducing anxiety as measured by the Beck Depression and Anxiety 
Inventories (Rao et al, 2009). 
  The evidence for the mutual interaction of the gut and brain in psychiatric disorders at a 
clinical level is limited.  However, recent years have seen a vast increase in the number of studies 
examining this interaction at a pre-clinical level, these studies will be considered in the next section. 
1.3. The Brain-Gut Axis 
Much of the evidence for the existence of a gut-brain axis stems from studies on stress and 
microbiota.  One of the initial studies focused on the development of hypothalamic-pituitary-adrenal 
(HPA) axis reactivity in mice raised in a germ-free (GF) environment.  This original study by Sudo et al 
(2004) demonstrated that postnatal exposure to microbes at an early developmental stage is 
required for the development of a functional HPA axis response to stress.  The exaggerated HPA 
response in GF mice, as indicated by higher concentrations of plasma adrenocorticotrophic hormone 
(ACTH) and corticosterone and lower levels of brain derived neurotrophic factor (BDNF), a key 
neurotrophin in neuronal growth and survival, in the cortex and hippocampus, was shown to be 
partly corrected following reconstitution of faeces of control animals at an early stage (Sudo et al, 
2004).  However, later stage reconstitution did produce these results.  Decreased NMDA (2A) 
receptor expression was also found in the hippocampus and cortex in GF mice compared with 
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controls (Sudo et al, 2004).  This landmark study prompted further research into the effects of 
microbiota on CNS function. 
Several studies have used maternal separation as a model of stress (Gareau et al, 2007; O’Mahony 
2009).  These have confirmed that alteration to HPA activity in response to stress directly affects 
microbiota of the gut. Furthermore this effect is more pronounced during neonatal development.  A 
study by O’Mahoney (2009) demonstrated that maternal separation for three hours per day from 
postnatal day (PND) two, to PND twelve, caused perturbations in the gut microbiota and elevated 
HPA-axis function in adulthood.  This study further revealed that maternal stress also increased 
systemic immune responses, increased anxiety and visceral hypersensitivity.  Rhesus monkeys have 
been shown to have a substantial decrease in lactobacilli populations following three days of 
maternal separation; this then returned to normal levels by day seven (Bailey & Coe, 1999).  
Probiotic treatment was found to normalise the perturbation in corticosterone following maternal 
separation in rats providing evidence for the bidirectional nature of the relationship between the 
HPA axis and gut microflora (Gareau et al, 2007).  Further to this, results from a study by Desbonnet 
et al (2010) indicated that the behavioural, neurochemical and immune system alterations caused by 
maternal stress could be normalised by the probiotic Bifidobacterium Infanis.  Maternal stress has 
also been shown to negatively affect intestinal permeability (Garcia-Rodenas et al, 2006). The 
primary impact of increased intestinal permeability is directly on the enteric nervous system (ENS), 
as this allows for greater intestinal microbiotal translocation, which in turn, may affect immune and 
neuronal cells of the ENS (Soderholm & Perdue, 2001).  It has also been shown that this ‘leakiness’ 
results in increased circulating levels of immunomodulatory bacterial cell wall components such as 
lipopolysaccharide (Soderholm & Perdue, 2001).The effects of stress on the composition of gut 
microbiota are not limited to the postnatal period.  Chronic stress in adulthood has been shown to 
alter the relative abundance of Clostridium in the caecum of adult mice following chronic 
psychosocial stress (Bailey et al, 2011).  Furthermore, alterations were also found in immune system 
function.  Chronic stress increased levels of interleukin-6 (IL-6) and chemokine CCL2, indicative of 
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immune system activation (Bailey et al, 2011). These studies indicate that effects of stress have 
consequences beyond the HPA axis, affecting microbiotal composition of the gut, integrity of 
intestinal barrier allowing this altered microbiota of the gut to impact upon the ENS.  Furthermore, 
correlations have been found between alterations in gut microbiota and immune system activation 
(Ashraf & Shah, 2014).  Given the results from the studies considered previously, it is evident that a 
complex and mutually interactive relationship exists between the gut microflora and the HPA axis.   
A developing area of research has focused on the effects of microbiotal pathogens on stress circuitry 
(Goehler et al, 2005; Lyte et al, 2006).  Evidence from this field has shown that changes to the gut 
microbiota via infection with food-born pathogens, have direct effects on peripheral and central 
nervous system activation (Goehler et al, 2005; Lyte et al, 2006).  Examination of c-fos levels in the 
vagal sensory nerve following infection with C. rodentium and Campylobacter jejuni indicated that 
there was significant activation of vagal sensory nerves, independent of immune activation (Goehler 
et al, 2005; Lyte et al, 2006).  C-fos levels were also found to be significantly higher in several brain 
regions including the central amygdala (CEA), hypothalamic paraventricular nucleus (PVN) and the 
medial prefrontal cortex (mPFC) (Gaykema et al, 2004; Goehler et al, 2005). These areas are typically 
associated with vagal nerve stimulation (Naritoku et al, 1995).  Infection with E. Coli. has been shown 
to produce similar activation of the PVN in GF mice (Sudo et al, 2004).  Vagotomy studies have 
confirmed that the vagus nerve is a mediator in CNS activation found following infection with 
Salmonella Typhimurium in the rat (Wang et al, 2002).  However, contrasting evidence has shown 
that vagotomy prior to infection with Trichuris muris did not prevent the increase in anxiety levels 
associated with infection in control animals (Bercik et al, 2010), indicating that other pathways, 
independent of the vagus nerve enable the CNS response to microbiotal infection and this may 
dependent upon the specific microbiotal agent.  This research provides clear evidence for bottom-up 
signalling where microbiota agents have direct impact on peripheral and central nervous system 
function.  Considered with the evidence from maternal separation studies, it is clear that 
interactions between the gut microflora and CNS are bidirectional and utilise multiple pathways 
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including the HPA axis, vagus nerve and immune system.  The behavioural effects of infection with 
food-born pathogens have indicated that anxiety and depressive symptoms are impacted by gut 
microbiota.  Subclinical infection with C. Jejuni was found to increase anxiety-like behaviour in the 
elevated plus maze (EPM) in the absence of immune system activation (Lyte et al, 1998).  Similar 
results have been reported showing that infection with the same pathogen increases anxiety-like 
behaviour in the hole-board test with activation of the brain regions associated with anxiety-like 
behaviour: the paraventricular (PVN), basolateral amygdala (BLA), anterior cingulate, medial 
prefrontal cortex (mPFC) and bed nucleus of the striaterminalis (BST).  Furthermore, c-fos expression 
in the BST predicted the degree of anxiety-like behaviour (Goehler et al, 2008).  C.Rodentium also 
increased anxiety-like behaviour in this test in the absence of immune system activation, indicating 
that behavioural changes are unlikely to be a result of inflammation-related stress.  Further to this, 
analysis of c-fos expression in vagal sensory neurons indicated that the behavioural impact of 
infection is mediated by vagal sensory neurons (Lyte et al, 2006).  
Exposure to antibiotics has been shown to increase exploratory behaviour and reduce anxiety-like 
behaviour in step-down and light-dark preference tests when given in combination with an 
antifungal agent over a seven day period (Bercik et al, 2010). Furthermore, after a 2 week washout 
period, normalisation of intestinal microbiota was accompanied with normalisation of behaviour.  
Treatment with the antibiotic and antifungal agent did not have any behavioural impact in GF mice, 
thus providing evidence for the conclusion that the anxiolytic properties of antibiotics are mediated 
by alterations in gut microflora (Bercik et al, 2010). 
Irrespective of the route of signalling between the gut to the brain, more and more evidence is 
indicating a distinct alteration in CNS functioning following alteration of the gut microbiota.  
Hippocampal serotonergic concentrations, and its metabolite 5-hydroxyindolacetic acid (5-HIAA), 
were found to be elevated in mice raised in a germ-free environment in comparison with 
conventional colonised control mice (Clarke et al, 2013).  Striatal 5-HT metabolism was found to be 
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elevated in GF mice (Diaz-Heijtz et al, 2011).  Furthermore, plasma tryptophan levels in male GF mice 
were found to be significantly higher than that of control mice (Diaz-Heijtz et al, 2011).  Post-
weaning colonisation of GF mice attenuated the behavioural aberrations in GF mice, but 
neurochemical function remained altered despite the fact that plasma tryptophan levels returned to 
baseline (Clarke et al, 2012).  This provides further support for the theory that there is a critical 
window in postnatal development, during which, gut microbiotia composition plays in important 
role in the development of other systems such as central serotonergic signalling, BDNF expression 
and HPA axis activity.  Another study that examined the effects of commensual bacteria 
compositions on neurochemistry found increased hippocampal BDNF mRNA levels and hippocampal 
5-HT1a receptor expression, and decreased NMDA 2b receptor mRNA expression in the amygdala 
(Neufeld et al, 2011a).  The effects on BNDF levels found in this study is in contrast to reports by 
Sudo et al, 2004.  In the study by Neufeld et al, 2011a, the alteration to hippocampal BDNF levels 
was only found in male GF mice where female mice demonstrated quantitative but not a significant 
increase, indicating that sex may play an important role in BDNF expression. From a behavioural 
perspective, several studies have reported significantly lower levels of anxiety-like behaviour in a 
range of tests, namely EPM, open field test (OFT), and a light/dark test where anxious behaviour is 
thought to result in reduced exploration in illuminated area of the maze (Diaz-Heijtz et al, 2011; 
Neufeld et al, 2011; Clarke et al, 2012).  Reconstitution of the gut microbiota in early life was shown 
to normalise behaviour in the EPM and some aspects of behaviour in the light/dark test (Diaz-Heijtz 
et al, 2011; Clarke et al, 2012).  However, reconstitution in later life did not attenuate the aberrant 
behaviour in the EPM (Neufeld et al, 2011).  Again this is further evidence that interactions in gut-
brain signalling during postnatal development are key in CNS development.  
Given the abundance of evidence for a gut-brain axis involving several possible signalling systems, 
including the immune, neurochemical, endocrine and vagal systems, current research has focused 
on the effects of probiotic administration on these faculties and CNS function.   
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1.4. Probiotics and the Brain-Gut Axis 
Probiotic administration can ameliorate some of the physiological effects of stress.  Several strains of 
Lactobacillus improve the integrity of the intestinal mucosal barrier preventing translocation of 
bacteria in stressed animals (Zareie et al, 2006).  It is important to note that this study also showed 
treatment with probiotics in control animals did not significantly alter intestinal barrier integrity 
(Zareie et al, 2006).  The effects of probiotic treatment on the HPA axis and immune function were 
the focus of a recent study by Ait-Belgnaoui et al (2012).  Lactobacillus farciminis prevented hyper-
permeability of the intestinal mucosal barrier as indicated by lower lipopolysaccharide translocation.  
Other findings from this study demonstrated that probiotic treatment prevents the HPA axis 
response to acute stress in rats.  Plasma ACTH and corticotesterone were lower in probiotic treated 
stressed rats.  Hypothalamic CRF expression was also lower.  Neuroinflammation was also lower in 
these rats with reduced proinflammatory cytokine mRNA levels in the PVN compared with stressed 
vehicle treated rats (Ait-Belgnaoui et al 2012).  Treatment with Bifidobacterium infantis produced 
similar results in GF mice, where restraint-stress induced increased plasma levels of ACTH and 
corticotesterone in control animals and no significant increase was found in probiotic treated control 
animals (Sudo et al, 2004).  C-fos activation in the PVN was also induced 6 hours after inoculation 
with B. Infantis, before any changes in peripheral cytokine had been established.  This result 
indicates that signalling pathways from the gut to the brain following treatment with B. Infantis are 
independent of immune system modulation.   Conversely, other studies have shown significant 
suppression of proinflammatory cytokine release following B. Infantis administration (Desbonnet et 
al, 2008).  As previously discussed, alterations in HPA axis functioning caused by maternal stress in 
mice, evidenced by increased corticotesterone levels, have been attenuated with the administration 
of Lactobacillis strains (Gareau et al, 2007).  The use of probiotics in the maternal separation model 
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of stress has demonstrated the normalisation effects of B. Infantis on peripheral anti-inflammatory 
cytokine (IL-10) levels (Desbonnet et al, 2010). 
1.5. Probiotic and Behaviour 
Given the volume of evidence presented for an effect of probiotic administration on central and 
peripheral immune system activation, HPA axis functioning and intestinal wall integrity (Ait-
Belgnaoui et al, 2012; Desbonnet et al, 2008; Gareau et al, 2007; Sudo et al, 2004; Zareie et al, 2006) 
combined with the results from GF, stress and infection studies, there has been a shift in focus on 
the potential effects of probiotics on neurochemical levels.   A study by Desbonnet et al (2008) 
demonstrated that B. Infantis administration over a 14 day period significantly reduced the 
concentration of 5-HIAA, a metabolite of serotonin, in the frontal lobe and reduced 
dihydroxyphenylacetic acid (DOPAC) levels in the amygdaloid cortex.  Peripheral neurochemical 
concentrations were also significantly affected, with higher plasma tryptophan levels found in the 
probiotic treated group (Desbonnet et al, 2008).  The forced swim test (FST) was used to examine 
the behavioural implications of these changes in neurotransmitter level, a test routinely used to 
assess the efficacy of antidepressant agents (Cryan et al, 2005).  Results indicated that the changes 
in frontal lobe serotonergic functioning or amygdaloid cortex dopaminergic functioning did not 
translate to behavioural changes in this test.  Similar results were reported in maternal separation 
stress studies with B. Infantis shown to normalise basal noradrenaline concentrations (Desbonnet et 
al, 2010).  However, this study did not report the alterations in serotonergic or dopaminergic 
functioning previously found.  Equally peripheral tryptophan levels were also unaffected by 
treatment.  Results from the forced swim test in this study indicated that chronic treatment with B. 
Infantis normalised the behaviour of the maternally separated animals.  Combined, these results 
indicate that induced stress may diminish the potential for probiotic treatment to affect specific 
neurochemical functioning i.e. serotonergic and dopaminergic functioning, but may optimise the 
potential for probiotics to affect noradrenergic functioning.  Other effects of probiotics on CNS 
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functioning include alterations in GABA receptor expression (B 1b and Aα2) (Bravo et al, 2011).  
GABAA receptors are the pharmacological targets for anti-anxiety medication, benzodiazepines.  
mRNA levels of GABAB 1b, following ingestion of Lactobacillus, were found to be lower in the cingulate 
and prelimbic cortices and elevated in the amygdala, locus coeruleus and dentate gyrus.  GABAA α2 
were also lower in the cingluate and prelimbic cortices as well as the infralimbic cortex and 
amygdala whilst elevated in the dentate gyrus (Bravo et al, 2011).  Behaviours relevant to GABAergic 
activity were assessed to establish whether these alterations could significantly alter behaviour.  
Tests relevant to an anxiety and depression were assessed as GABAergic activity is associated with 
psychiatric disturbances.  Results from the EPM and FST showed that changes induced in GABA 
receptor expression by Lactobacillus can be detected at a behavioural level with healthy animals 
showing less anxiety and depression-like behaviour in these tests (Bravo et al, 2011).  It is evident 
that the neurochemical effects of probiotic administration is not only region dependent but that 
baseline functioning determined by stress levels influences these effects.   
It is clear that probiotics can alter concentrations of various neurochemicals throughout the brain.  
However, studies have indicated that probiotics can directly influence neurotransmitter activity.  
Strains of Lactobacillus and Bifidobacterium, derived from human intestines, produce GABA from 
monosodium glutamate under in vivo conditions (Barrett et al, 2012).  Various microbial species 
have been shown to secrete neurochemicals given the optimum conditions (Lyte, 2011).  Serotonin 
can be produced from candida, streptococcus, escherichia, enterococcus, dopamine from bacillus 
and serratia and norepinephrine from esherichia, bacillis and saccharomyces (Lyte, 2011). 
Further examination into the potential for probiotics to produce neuroactive compounds has 
highlighted an alternative route of action that may account for their action on the brain.  Described 
by Lyte (2011) as a microbial endocrinology- based theory, it is hypothesised that the mechanism by 
which probiotics exert their effects on the brain is due the activation of receptors on immune and 
neuronal cells both intestinally and extra-intestinally by neurochemicals secreted by probiotic 
General Introduction Chapter 1 
 
12 
 
bacteria. Furthermore, it is the common recognition of these neurochemical products by both 
prokaryotic and eukaryotic cells that provides the foundation for gut-brain axis communication. 
 
1.6. Thesis rationale 
The purpose of the current thesis is two-fold.  Firstly, given the evidence presented by Desbonnet et 
al (2008) it is clear the probiotic treatment causes alterations in frontal lobe serotonergic 
functioning, but failed to identify a behavioural manifestation of the changes.  Therefore, Chapter 2 
aims to identify a task that is reliant on frontal lobe functioning.  Further examination of the effects 
of direct serotonergic manipulation on this task is explored in Chapter 3, before examining the 
impact of probiotic administration in Chapter 4.  The effects of probiotics in a task known to be 
dependent on the frontal cortex and hippocampus, namely a watermaze reversal learning paradigm, 
will be explored in Chapter 4.  Identification of brain areas that show improvements following 
probiotic treatment are explored through object recognition tasks that rely differentially on 
contributions of the hippocampus and subregions of the frontal cortex (Chapter 5).  Secondly, 
several studies have implied that the behaviour effects of probiotic treatment are indicative of an 
anxiolytic property and proposed the use of probiotics as an adjuvant therapy for comorbid anxiety 
and depression (Logan & Katzman 2004).  Therefore, this thesis also aims to examine the effects of 
probiotic treatment on anxiety-like behaviour.  As previously mentioned alterations in frontal lobe 
serotonergic functioning have been found following probiotic treatment (Desbonnet et al, 2008).  As 
this neurochemical effect is similar to that produced by serotonin selective reuptake inhibitors 
(SSRI), citalopram treatment on anxiety-like behaviour was also examined in Chapter 3.  The impact 
of probiotics on anxiety-like behaviour was then explored in Chapter 4.  In order to establish where 
potential affects could be attributed to improved serotonergic transmission this task was also 
conducted with citalopram.   
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Nuclear magnetic resonance is a powerful assessment tool that detects fluctuations in the 
metabolite profile.  This profile is indicative of downstream genomic, transcriptomic and proteomic 
functioning and provides insight into cellular processes in the context of health and disease 
(Trushina and Mielke, 2013).  Therefore, in Chapter 6 NMR was used to examine the effects of 
probiotic treatment on intracellular metabolism to determine whether any behavioural changes can 
be attributed to alterations in intracellular metabolism pathways. 
The results from each task using the various manipulations from each chapter are discussed 
collectively in the general discussion. 
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Medial prefrontal cortex lesions impair performance in probabilistic reversal 
learning. 
2.1. Summary 
The studies presented in the current chapter used a probabilistic reversal learning (PRL) paradigm 
designed by Bari et al (2010).  The aim of the initial study was to establish the pattern of 
performance in this task.  The PRL task was conducted using two different stimulus reward 
contingencies to assess performance at two different levels of difficulty.   Results from this study 
indicated that task difficulty affects the number of reversals achieved.  Performance in the easier 
version of the task displayed a distinct learning pattern however, performance in the more difficult 
of the two tasks declined across sessions.  This task was also conducted with medial prefrontal 
(mPFC) lesions.    Results showed that the mPFC is implicated in probabilistic reversal learning, with 
the lesioned group completing fewer reversals, exhibiting reduced sensitivity to positive 
reinforcement across the sessions and reduced sensitivity to positive reinforcement in the reversal 
phase of the first session.  Sensitivity to negative reinforcement was unaffected by the lesion 
therefore mPFC is integral to processing of positive feedback dissociated from negative feedback 
processing. 
 
2.2. Introduction 
Reversal learning is one example of cognitive flexibility in which subjects are required to adjust 
behaviour to changes in the stimulus-reward contingency.  This requires the ability to desist in 
current responding to a stimulus and switch responding to a previously non-rewarded stimulus.  
Deficits in reversal learning and the inability to moderate responding based on reward outcome is 
often seen clinically in patients with Parkinson’s disease, schizophrenia and bipolar disorder, as well 
as in developmental disorders such as autism and Tourette’s syndrome (Verte et al, 2005).   
mPFC lesions in probabilistic reversal learning Chapter 2 
 
15 
 
Lesion studies have highlighted a fundamental role for the orbitofrontal cortex (OFC) in reversal 
learning, with lesioned rats demonstrating perseverative errors once the stimulus-reward 
contingency has been reversed (Chudasama et al, 2001; Kim & Ragozzion, 2005; McAlonan & Brown, 
2003; Rygula et al, 2010).  Interestingly, monkeys with lateral prefrontal cortex (lPFC) lesions (Rygula 
et al, 2010), or rats with medial PFC (mPFC) lesions (Chudasama et al, 2001; Ragozzino & Kim, 2003) 
do not show reversal learning deficits.  In contrast, lesions to striatal regions impair reversal but only 
following by impaired responding to negative feedback whilst unaffecting sensitivity to positive 
reinforcement (Clarke et al, 2008).  This suggests a role for striatal input to the OFC in reinforcement 
learning.  Studies have shown differential contributions of the ventrolateral PFC and OFC in reversal 
performance, with lesions to the former resulting in the ability to maintain reversal abilities with 
familiar but not novel stimuli, while lesions to the latter impair reversal abilities regardless of 
whether the stimuli are familiar or novel (McAlonan & Brown, 2003). Reversal learning tasks are 
therefore useful indicators of OFC damage, dissociating medial, ventrolateral and dorsolateral 
prefrontal damage (Ghods-Sharifi et al, 2008; McAlonan & Brown, 2003; Rygula et al, 2010).  
Reversal learning incorporates several different stages of information processing, which may further 
differentiate the role of specific brain regions in cognitive flexibility. Thus negative feedback 
indicates that the previous response is incorrect and that an unexpected violation of the rule has 
occurred.  As a consequence an adaption in goal-directed behaviour is required in the next trial 
(Holroyd & Coles, 2002).  Negative feedback can also be used to test a new hypothesis once 
behaviour has been adapted; this is referred to as effective negative feedback (Walton et al, 2004).  
Several studies have indicated that the medial prefrontal cortex (mPFC) plays a fundamental role in 
negative feedback processing (Holroyd & Coles, 2002).  In humans, source identification of negative 
scalp potentials following negative feedback indicated localisation on or near the anterior cingulate 
cortex (ACC) (Holroyd & Coles, 2002; Nieuwenhuis et al, 2004; Yeung & Botvinick, 2004).  Imaging 
studies using fMRI have produced similar results indicating that the mPFC/ACC are activated 
following negative feedback (Holroyd et al, 2004, Mars et al, 2005).  Selective excitotoxic lesions and 
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temporary pharmacological inactivation of the ACC in rodents impairs performance in reversal 
learning without increasing preservative responding to previously rewarded responses (Newman & 
McGaughy, 2011; Ng et al, 2007; Ragozzino & Rozman, 2007).  This suggests that the ACC has a 
distinct role in processing negative feedback and in error detection unrelated to inhibition of 
behaviour.  
 Lesions to ventro-lateral prefrontal areas in non-human primates only impaired reversal learning 
once novel stimuli were used whereas lesions to the OFC impaired reversal learning irrespective of 
whether the stimuli were novel or familiar (Rygula et al, 2010).  This indicates that the outcome of 
the current study could rely on the choice of experimental procedure.  Post-surgery performance in 
reversal learning in this study was dependent on pre-surgery experience most likely due to the 
development of learned sets or rules that can be implemented to guide responding therefore 
enabling response choice to be less dependent on accurate feedback processing (Browning et al, 
2007; Wilson and Gaffan, 2008).  Other studies on the ventrolateral prefrontal cortex have found 
that this area is more active following negative feedback compared with positive feedback (Monchi 
et al, 2001).  ERP studies have indicated a role for the right superior fronal gyrus in the processing of 
positive feedback compared with negative feedback (Nieuwenhuis et al, 2005), indicating that 
subregions within the lateral prefrontal cortex can be sensitive to both positive and negative 
feedback (Zanolie et al, 2008).  The finding from these studies suggest that the lateral PFC interacts 
with the mPFC/ACC in monitoring and evaluating reinforcement (Gehring & Knight, 2000). 
Accurate performance in reversal learning tasks has been taken to involve both the implementation 
of learned rules and inhibition of current responding, as well as error detection and evaluation of 
feedback. This reflects an interaction between the orbitofronal cortex and ACC/mPFC regions.  
However, activation of these regions have been found to be negatively correlated with increased 
activation of the ACC and decreased activation of the OFC associated with reversal when it is 
individual goal-driven decision making whereas an opposing activation pattern is found when the 
response is experimenter guided (Walton et al, 2004).  These results suggest that the OFC and 
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ACC/mPFC play dissociable roles in reversal learning.   When independent decision making processes 
are required to detect errors and evaluate feedback, mPFC/ACC functions are employed whilst the 
OFC is fundamental for rule-learning. 
 
Classical reversal-learning paradigms use stimulus-reward contingencies which present the subject 
with 100% rewarded correct responses.  Probabilistic reversal learning requires the subject to 
choose between two responses both of which have a probability of reward however at contrasting 
contingencies.  This task requires the ability to decipher the new contingency and choose responses 
accordingly.  This is achieved by integrating feedback over a number of trials (Cools et al, 2002). OFC 
lesions impair reversal learning using this 100% stimulus –reward contingency where rule learning is 
paramount. However, little research has focused on the systems responsible for effective reversal 
learning when accurate feedback processing is required to direct subsequent response.  The 
increased difficulty of the probabilistic reversal learning hypothetically should employ mPFC 
resources to direct responding as no discrete rules exist. 
The current study presents two versions of the automated PRL task developed by Bari et al (2010).  
The initial study, a pilot of the this task, used a stimulus-reward contingency set to 80% reward on 
correct responses and 20% reward on incorrect responses (referred to as PRL80).  In order to assess 
whether task difficulty affects sensitivity to positive and negative reinforcement in normal rats the 
stimulus reward contingency was subsequently changed to 60% reward on correct responses and 
40% reward on incorrect responses (referred to as PRL60).  This may provide another level at which 
to assess the effect of pharmacological interventions in future experiments.  The purpose of this 
experiment is to determine whether the task can be performed by normal animals across a range of 
difficulties. The second part of the study examines the performance of animals with mPFC 
excitotoxic lesions.  The rationale behind this is that in probabilistic reversal learning attention to 
positive and negative reinforcement is required to optimise performance whereas discrete rule –
learning is not.  Evidence from previous lesion studies has indicated that feedback processing is 
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reliant on mPFC functioning (Gehring & Knight, 2000).  It is expected mPFC lesioned rats will show a 
deficit in reversal but not acquisition of the PRL task. 
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2.3. Method and Procedure 
Subjects 
Experiment 1:  Thirty-two male adult Lister hooded rats (Harlan, UK) weighing 280-350g were used 
in this experiment. They were housed in pairs in a 12h:12h light dark cycle, the holding room was 
maintained at 55% ± 10 humidity and a temperature of 19-23 oC and were all tested during the 12 
hour light cycle.  The rats were 3 months old when being tested and were thoroughly habituated to 
handling before the study began. The rats were food restricted to 85% of free feeding body weight 
and had free access to water.  The experiment was performed in accordance with Home Office 
under Animals Scientific Procedures Act 1986. 
 
Experiment 2: Twenty-two male adult Lister hooded rats (Harlan, UK) weighing 280-380g were used 
in this experiment.  These animals were 6 months old when testing began.  They were housed under 
the same conditions as animals in Experiment 1. 
 
Experiment 2: Surgical Procedure 
Twenty-two rats were divided into 2 cohorts; medial prefrontal lesion (n=11) and surgical controls 
(n=11).  The animals were anesthetized and maintained with isoflurane gas during the surgical 
procedure. Once anaesthetized, the rats were placed in a stereotaxic frame (David Kopf instruments, 
Tujunga, CA, USA) at flat skull position (-3.3 mm).  A longitudinal incision was made along the scalp 
and the skull exposed. The scalp was retracted using haemostats and a dental drill used to remove 
the skull at the point of the lesion.  Ibotonic acid (63 mM) (Sigma-Aldrich, UK) was infused bilaterally 
using a 1µl Hamilton syringe (Reno, NV, USA) that was mounted on an injection pump (KD Scientific, 
Holliston, MA, USA).  Ibotonic acid was administered to each injection site at an infusion rate of 
0.1µl/min with the needle left in situ for 10 minutes.  The coordinates and volume of ibotonic acid 
used at each injection site are as follows: AP +0.7 mm from bregma, ML ±0.7 mm and DV -4.5 mm 
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from skull surface at bregma, 0.5 µl; AP +3.7 mm from bregma, ML ±0.7 mm and DV -4.0 mm from 
skull surface at bregma, 0.5 µl, (Paxinos & Watson, 2008).  
After surgery, the scalp was sutured and the rats were placed in a temperature controlled recovery 
box.  They received a 5ml glucose saline subcutaneous (s.c.) injection and 1.0mg/kg s.c. injection of 
Meloxicam, an analgesic agent.  Rats were given 2 weeks to recover before food restriction or 
behavioural testing. 
 
 
Apparatus 
The rats were trained in four five-hole operant chambers (30.5 x 24 x 21 cm, Med Associates, St 
Albans, VT, USA). The chambers had five apertures on one side adjacent to the food magazine.  The 
house light, (100mA), had been removed from the operant box and placed at the top of the right 
wall of the external box to increase the saliency of the aperture lights.  The external chamber was 
fitted with a fan which remained on throughout the experiment.  Food reinforcement (savoury 
pellets, 45mg; Test Diet, Richmond, IN, USA) was delivered to a food magazine.  A photo-beam was 
located across the mouth of each of the apertures and food magazine to detect nosepoke responses. 
MED-PC IV was used to custom write a program that controlled the chamber conditions.  Data was 
recorded by a RM personal computer connected to the chambers via an interface using MEDPC-IV 
software (Med Associates, St Albans, VT, USA). 
 
Training Procedure 
The rats were given 3 daily sessions lasting 20 minutes to habituate to the test environment. During 
these sessions they received free reward pellets on a random schedule of inter-trial intervals (15, 30, 
4 and 60 seconds).  After the habituation sessions the rats commenced nosepoke training.  
Nosepoke training involved one 30 minute session per day.  One side only (right or left), was trained 
per day.  One hole per trial, immediately to the right or left of the centre hole, was illuminated for 30 
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seconds, during this time a nosepoke response to the illuminated aperture was rewarded with a 
single food pellet.  The aperture lights turned off once a response was detected.  No response 
resulted in a five second timeout during which the house-light was turned off.  Nosepoke responses 
to a non-illuminated hole were not followed by food but had no other consequences.  Retrieval of 
the food pellet from the magazine signalled the next trial. Once the rats had demonstrated their 
ability to nosepoke by completing 150 trials per session in two successive sessions of right and two 
sessions of left nosepoke training, task training commenced.   
Task training involved random presentation of either right or left illuminated apertures for 30 
seconds, again no response during this time resulted in the five second timeout. In addition, 
responding in a non-illuminated aperture resulted in a five second timeout.  Allocation of rewards on 
the next trial was determined by the rewarding schedule and is uninfluenced by the preceding trial.  
Correct responding resulted in a single food pellet reward.  Once individual performance had 
reached a criterion of 90% accuracy and had remained there for at least three consecutive sessions 
performance was deemed stable and the rats moved on to the PRL task.  After 12 days of training 
any rats that had still not met the criteria were excluded at this stage.  In Experiment 2 one rat was 
excluded from the surgical control group. In addition, rats displaying a side bias as identified by 
greater than 5% of errors on either right or left side where excluded from the study as this stage.  
 
Test 
The PRL task presented the subjects with two illuminated apertures simultaneously.  The reward 
contingency was that a response in one aperture was rewarded on 80% of occassions and the other, 
ON 20% of occassions.   Initial allocation of ‘correct’ hole was random.  After 8 consecutive 
responses in the ‘correct’ aperture, as indicated by the 80% reward rate, the stimulus-reward 
contingency was reversed so that responding in the other (previously rewarded on 20% of occasions) 
aperture then became the ‘correct’ response.  An inappropriate response in the ‘correct’ hole was 
classed as as error and thus unrewarded and was followed by a two and a half second timeout.  
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Again, the stimulus was presented for 30 seconds, during which if there was no response a five 
second timeout was issued.  During the PRL task, however, responding in a non-illuminated aperture 
no longer warranted a timeout.  Animals had one session per day and given 40 minutes to complete 
200 trials. In Experiment 1, this stimulus-reward contingency of 80% reward for correct responses 
and 20% rewards for incorrect responses was presented for 3 sessions.  This is referred to as PRL80.  
Following this task difficulty was increased to 60% reward on the correct response and 40% reward 
on incorrect response, this contingency was presented for 3 days.  This is referred to as PRL60. 
 In Experiment 2, the rats were presented with 80% reward for correct responses and 20% reward 
for incorrect responses for 8 sessions. 
 
Statistical analysis 
Performance on the task was analysed by phase on the first test session, the acquisition phase 
comprised of the trials before the first reversal, the reversal phase comprised of any trials after the 
acquisition phase but prior to any further reversals should they be completed.  The results from any 
animal that failed to complete reversals of the discrimination had their data analysed as acquisition 
phase and therefore did not contribute to the reversal phase data. 
The data analysed from all the test session was the number of reversals completed, reward (win-
stay) and negative feedback (lose-shift) sensitivity.  Response to positive and negative feedback was 
analysed by evaluating responding on a trial after having received a reward or punishment in the 
previous trial.  Win-stay performance was the likelihood of repeating the same behaviour having 
been rewarded on a pervious trial (positive feedback), lose-shift performance was the likelihood of 
discontinuing the behaviour following a punishment on the previous trial (negative feedback).  
When calculating the probabilities the number of omissions and responses in non-illuminated 
apertures were not included. i.e. win-stay probability is calculated by dividing total number of 
rewarded responses in the same hole as the previous trial by the total number of reward responses 
and lose-shift probability is calculated by dividing the total number of shifts in response following 
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punished responses divided by the total number of punished responses.  Repeated measure ANOVA 
was carried out on all the measures.  Win-stay and lose-shift probability were also analysed by 
phase, acquisition and reversal on the first test day.  Analysis was also carried out of the 
perseverative errors.  These were calculated at the percentage of trials where an incorrect 
response was recorded following reward for the same response.  The number of trials to 
reach the criterion was also recorded, i.e. the number of trials in the acquisition phase of 
each session. 
Where repeated measure ANOVA gave a significant interaction, analysis of the simple effects were 
examined by pairwise comparisons.  The results are expressed as mean ± 1 standard error.  The 
threshold for significance was p<0.05.  Where data was non-spherical given the output from 
Malchly’s Test of Shericity  ,the Greenhouse-Geisser adjustment was used to give a corrected 
F ratio.  Where interactions were significant pairwise comparisons were used to examine 
the simple effects of this interaction.  All statistical analysis was carried out using SPSS version 
20.0. 
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2.4. Results 
2.4.1. Histology  
 
Bregma + 4.7      Bregma + 4.2 
 
 
 
 
 
 
Bregma +3.7      Bregma +3.2 
 
 
 
 
Bregma +2.7 
 
 
Figure 1. shows the minimum (black shading) and maximum (grey shading) prefrontal lesions in 
coronal sections..  Distance from Bregma given with each section (mm) (Paxinos and Watson, 1997). 
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Lesions to the medial prefrontal cortex resulted in substantial damage to the prelimbic (PrL) and 
intralimbic (IL) cortices.  Moderate damage was sustained to the medial orbital frontal cortex on 2 of 
the 11 lesioned animals.  Of these no lesions resulted in complete bilateral damage to the mOFC.  2 
rats sustained damage to the cingulate cortex, which was limited area 1.  
 
2.4.2. Experiment 1: PRL Pilot 
Conditional probabilities were analysed by phase on the first day of each task (Figure 2).  Repeated 
measures ANOVA showed that the win-stay probability did not significantly differ been the tasks 
(F(1,30)=0.099, p=NS). However, there was a significant main effect of phase with win-stay 
probability significantly lower during the reversal phase compared with acquisition phase across 
both tasks (F(1,22)=20.44, p<0.001). During the acquisition phase responses were guided by positive 
reinforcement, however, this was not the case during the reversal phase.  There was no significant 
task by phase interaction (F(1,22)=0.241, p=NS).  Lose shift probability did not significantly alter 
between tasks (F(1,30)=0.054, p=NS).  However, there was a significant main effect of phase with 
lose-shift probability higher in the reversal phase of both tasks (F(1,22)=23.377, p<0.001). During the 
acquisition phase responding was completely unguided by negative reinforcement however, in the 
reversal phase sensitivity to negative reinforcement increased.  The was no significant task by phase 
interaction (F(1,22)=0.329, p=NS).   
One animal failed to acquire the task and so was excluded from the data completely. 9 animals did 
not complete any reversals in the first session therefore data from these animals did not contribute 
towards reversal phase data.  Any animals which did not complete any reversals in a session had all 
their data from that session analysed as acquisition data, hence the variation in degrees of freedom 
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in the results.
 
Figure 2.  Conditional probability analysed by phase (acquisition and reversal) on initial session of 
both tasks (PRL80 and PRL60) (WS: win-stay probability; LS: lose-shift probability). 
 
Inspection of Figure 3 suggests that the mean number of reversals completed was reduced when 
task difficulty was increased from PRL80 to PRL60.  Repeated measures ANOVA showed that there is 
a significant main effect of task (PRL80 v PRL60) on number of reversals with the PRL60 task having a 
lower number of completed reversals (F(1,30)=10.611, p<0.001). There was no main effect of session 
(F(2,60)=0.126, p=NS), however there was a significant session by group interaction (F(2,60)=3.673, 
p<0.05).  Analysis of the simple effects of this interaction show that session 1 (PRL80) and session 4 
(PRL60) were not significantly different (F(1,30)=0.225, p=NS) neither were session 2 (PRL80) and 
session 5 (PRL60) (F(1,30)=3.107, p=NS).  However, the third session of each task showed significant 
differences (F(1,30)=11.897, p<0.01). 
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Figure 3.  Mean reversal completed over 7 sessions on PRL80 task and 3 sessions on PRL60 task. 
 
Figure 4 shows conditional probabilities over the sessions.  Repeated measure ANOVA indicated that 
there was no significant main effect of task on win-stay probability (F(1,30)=2.898, p=NS).  There was 
also no significant main effect of session (F(2,60)=1.35, p=NS).  However, there was a significant task 
by session interaction (F(2,60)=3.422, p<0.05).  Analysis of the simple effects of this interaction 
showed that  there is no significant difference between the tasks on the first session of each 
(F(1,30)=1.29, p=NS) or the second session of each (F(1,30)=1.817, p=NS), however performance on 
the third session of the PRL60 task was significantly lower (F(1,30)=7.852, p<0.01).   
Repeated measures ANOVA indicated that there was no significant main effect of task on lose-shift 
probability (F(1,30)=0.199, p=NS).  There was also no significant main effect of session 
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(F(2,60)=2.565, p=NS) or task by session interaction (F(2,60)=0.005, p=NS).  
 
Figure 4.  Mean win-stay and lose-shift probabilities of PRL80 and PRL60 tasks. 
 
2.4.3. Experiment 2:  The effects of mPFC lesions on the PRL task  
The PRL task was conducted with mPFC lesioned rats using the PRL80 stimulus reward contingency.  
Figure 5 shows analysis of the conditional probability by phase (acquisition and reversal) during the 
initial session.  Statistical analysis found no significant main effect of group on win-stay probability 
(F(1,11)=3.217, p=NS).  However there was a significant main effect of phase (F(1,11)=8.065, p<0.05) 
and significant phase by group interaction (F(1,11)=12.001, p<0.01).  Pairwise comparisons showed 
that the mPFC lesioned group were significantly impaired on win-stay probability during the reversal 
phase (F(1,11)=10.097, p<0.01).  Analysis of lose-shift probability shows no significant main effect of 
group (F(1,11)=0.081, p=NS), no significant main effect of phase (F(1,11)=2.344, p=NS) or phase by 
group interaction (F(1,11)=0.0, p=NS). 
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Figure 5.  Conditional probabilities of sham surgery and mPFC lesioned groups during acquisition and 
reversal phases in reversal session 1.  
 
Inspection of Figure 6 indicates that lesions to the mPFC impaired reversal.  This is confirmed by 
repeated measure ANOVA, which revealed a significantly higher of number of reversals in the sham 
group compared with the mPFC lesion group (F(1,15)=7.038, p<0.05).  There was also a significant 
main effect of session (F(7,105)=2.266, p<0.05) however there was no significant session by group 
interaction (F(7,105)=1.904, p=NS).    
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Figure 6.  Mean number of reversal completed by sham surgery and mPFC lesioned groups over 8 
sessions. 
Inspection of Figure 7 that shows the mean win-stay probability values across training sessions were 
impaired across training sessions. Repeated measure ANOVA showed a significant main effect group 
(F(1,15)=53524, p<0.05) and a significant main effect of session (F(7,105)=2.59, p<0.05)  However, 
there was no significant session by group interaction (F(7,105)=0.252, p=NS). 
 
Figure 7.  Win-stay probability of sham surgery and mPFC lesioned group over 8 sessions. 
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Lose-shift probability was also examined across the sessions (Figure 8) however repeated measures 
ANOVA indicated no significant difference between the groups (F(1,15)=0.026. p=NS).  There was 
also no significant main effect of session (F(7,105)=105, p=NS) or session by group interaction 
(F(7,105)=0.678, p=NS). 
 
Figure 8.  Lose-shift probability of sham surgery and mPFC lesioned group over 8 sessions. 
 
Analysis of the perseverative errors indicated that there was a significant main effect of session 
(F(1,13)=27.138, p<0.001).  However, there was no main effect of group (F(1,13)=0.057, p=NS) or 
session by group interaction (F(1,13)=0.33, p=NS) (figure 9). 
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Figure 9. Perseverative errors of lesion and sham groups. 
Repeated measures ANOVA of trials to criterion (figure 10) indicated that were was no significant 
main effect of group (F(1,11)=3.773, p=NS), session (F(1,11)=2.296, p=NS) or session by group 
interaction (F(1,11)=2.749, p=NS). 
 
Figure 10.  Trials to criterion of sham surgery and mPFC lesioned groups. 
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2.5. Discussion  
The purpose of the first experiment was to pilot an automated version of the probabilistic reversal 
learning task to establish the pattern of performance on this task in rats.  As predicted performance 
was influenced by task difficulty.  Furthermore, performance in the tasks was found to be 
differentially affected by session.  The number of reversals increased in the PRL80 task over the 
sessions while performance in the PRL60 task decreased.  As the PRL80 task was run first, improved 
performance over the session was expected.  The opposing pattern found in the PRL60 task implies 
that performance is not stable at this task difficulty.  Analysis of conditional probabilities by phase 
showed that both win-stay and lose-shift probabilities was significantly affected.  During the 
acquisition phase win-stay probability was higher than in the reversal phase in both tasks, the 
opposing pattern was found in lose-shift probability.  This suggests that during initial rule learning 
there is greater sensitivity to positive reinforcement while during reversal of this rule there is greater 
sensitivity to errors, irrespective of task difficulty.  Sensitivity to positive reinforcement was found to 
be significantly reduced in the more difficult task.  This was illustrated by lower win-stay probability 
in the PRL60 task.  This was not found with negative feedback sensitivity (lose-shift), which suggests 
that task difficulty reduces the animals’ sensitivity to positive reinforcement while sensitivity to 
negative reinforcement remains stable.   
Analysis of the perseverative errors in experiment indicated a learning effect across the session 
where there was a significant reduction in perseveration however this was not differentially affected 
by lesion.  Results from this experiment showed that lesions of the mPFC significantly reduced the 
number of reversals completed relative to sham surgery animals.   Previous studies using reversal 
learning with a 100% reward rate for correct responses found that lesions of the orbiofrontal cortex 
but not the mPFC impaired performance (Chudasama et al, 2001; Ragozzino & Kim, 2003).  This 
suggested that it is the probabilistic nature of this task which engages the mPFC during reversal 
learning.  
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 As attention is shifting between right or left nosepoke to ‘correct’ and ‘incorrect’ responding (not 
always the same in this probabilistic task), the task information could be processed as an extra-
dimensional shift.  Spatial discrimination between right and left is then replaced with a choice of 
response based on reward likelihood and could therefore be considered motivational.  Extra-
dimensional shifts have been found to be selectively sensitive to lesions of the IL and PL cortex 
(Birrell and Brown, 2000; Ng et al, 2007).  The rats with mPFC lesions were less sensitive to positive 
reinforcement during the reversal phase however lose-shift probability was unaffected.  This was 
found in the conditional probabilities across the sessions. The anterior cingulate cortex (ACC) has 
been associated with the processing of negative feedback (Holroyd & Coles, 2002; Nieuwenhuis et 
al, 2004; Yeung & Botvinick, 2004).  The dissociable effect of mPFC lesions on negative and positive 
feedback sensitivity imply that these are neurally dissociable.  There was substantial sparing of the 
ACC in mPFC lesions which may explain why negative feedback sensitivity was unaffected by the 
lesion.  
Human studies have found greater activation in areas of the frontal cortex following positive 
feedback compared with negative feedback (Nieuwenhuis et al, 2004).  It has been reported that 
prelimbic (Prl) and infralimbic (IL) regions of the mPFC are activated by positive reinforcement with 
25% of neurons exhibiting prominent excitation during rewarded, but not unrewarded lever presses 
for food (Burgos-Robles et al, 2013).  Lesions to the PrL cortex have been shown to impair goal-
directed behaviour by impairing sensitivity to goal value after training (Killcross & Coutureau, 2003).  
This study also found that lesions to the IL cortex caused habitual responding after devaluation 
implying that sensitivity to reward is impaired following lesions to this area.  This result is consistent 
with the current study that showed reduced sensitivity to reward.  
This chapter provides evidence that efficient reversal learning on the PRL task requires a functionally 
intact medial prefrontal cortex. Furthermore, the results from the current study indicate that the 
impact of positive reinforcement on reversal learning is modulated by the mPFC.   
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Effects of citalopram administration on anxiety-like behaviour and probabilistic 
reversal learning. 
3.1. Summary  
The aim of the current set of experiments aims to test the acute effects of a serotonin selective 
reuptake inhibitor (SSRI) on anxiety-like behaviour, and the cognitive aspects examined by 
probabilistic reversal learning.  The rational for this was to determine whether direct manipulation 
of serotonin would produce a similar pattern of behaviour as indirect manipulation though the 
administration of probiotics in Chapter 4. 
3.2. Introduction 
Serotonin selective reuptake inhibitors (SSRIs) are one of the most common family of drugs used in 
the treatment of depression and anxiety-related disorders, including generalised anxiety , social 
anxiety, panic disorder and obsessive-compulsive disorder (Bespalov et al, 2010; Golden, 2004; 
Zohar & Westenbery, 2000).  SSRIs work by blocking the serotonin (5-hydroxytryptamine; 5-HT) 
transporter protein (5-HTT) located on the presynaptic membrane, this increases extracellular levels 
of 5-HT in the synaptic cleft by preventing reuptake into the presynaptic nerve terminal.  Studies 
using microdialysis and high performance liquid chromatography (HPLC) indicate that SSRI treatment 
affects extracellular 5-HT levels in several brain regions (Fuller, 1994).  Chronic exposure to SSRIs 
increase baseline 5-HT levels in comparison with acute treatment, shown only to transiently increase 
extra cellular 5-HT (Kreiss & Lucki, 1995).  The differential effects of treatment type suggest that 5-
HT reuptake inhibition per se is not responsible for the therapeutic effects of SSRIs administration, 
but rather adaptive neuronal responses over prolonged and repeated exposure are required before 
maximised therapeutic effects can be seen.   Various studies investigating the adaptive change in 
neurochemical function have found that chronic treatment results in desensitisation of the 5-HT1a 
receptor (Ceglia et al, 2004; Chaput et al, 1986; Goodwin et al, 1985; Invernizzi et al, 1994, 1996; 
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Kreiss & Lucki, 1995).  This receptor is found presynapically in the raphe nuclei and autoregulates 
serotonin release, stimulating serotonergic projections to other brain areas such as the stiatum and 
prefrontal cortex via a negative feedback mechanism (Kreiss & Lucki, 1994, 1995).  Desensitisation of 
this receptor through increased extracelluar serotonin results in increased raphe firing rates to other 
brain areas.   Acute treatment with SSRIs activate the auto-inhibitory properties of 5-HT1a 
autoreceptors reducing raphe nuclei firing (Blier, 2001).  Hence anxiolytic effects of SSRI 
administration are not seen in acute treatment (in some behavioural measures of anxiety, discussed 
later), often anxiety symptoms in clinical populations  are more pronounced during initial treatment 
(Birkett et al, 2011; Gorman et al, 1987; Ravinder et al, 2011).  This has been supported in studies 
showing that co-administration of SSRIs and 5-HT1a receptor antagonist enhances the behavioural 
effects of SSRIs in both humans and animals (Muraki et al, 2008; Portella et al¸ 2011; Romero et al, 
1996).  However, administration of 5-HT1a receptor antagonists alone produce no anxiolytic effect 
(Muraki et al, 2008).  As the effects of probiotic treatment on serotonin function in the raphe nuclei 
has not been examined, theoretically the increase in 5-HT function in the frontal lobe reported by 
Desbonnet et al (2010) may inhibit 5-HT transmission in the raphe nuclei, via negative feedback, 
similar to acute SSRI administration. 
The initial behavioural test used in the preclinical study of anxiety was the open field test (OFT) 
designed by Calvin Hall (1934).  Since then other tests have been developed to assess the 
therapeutic  value of anxiolytic agents including the elevated plus maze (EPM) which is now the first 
choice for screening anxiolytic drugs (Ramos, 2008).  Both of these tests rely on an unconditioned 
avoidance of threatening situations, an approach avoidance conflict is established where the animal 
is conflicted between exploring new areas whilst having an innate tendency to avoid potentially 
dangerous areas (Ramos, 2008).  These tests have been used to assess the anxiolytic properties of 
benzodiazepines, SSRIs and tricyclic antidepressants (Oh et al, 2009; Prut & Belzung, 2003; 
Vendruscolo et al, 2003; Vorhees et al, 2011).  Pharmacological studies have shown incoherency 
between these two tests, the benzodiazepine, chlordiazepoxide produced anxiolytic effects on the 
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EPM but not that OFT (Vendruscolo et al, 2003).  Similarly, in genetic studies, in spontaneously 
hyperactive rats (SHRs), an animal model of anxiety, this same drug produced anxiolytic effects in 
the OFT but not the EPM (Vendruscolo et al, 2003). This demonstrates that anxiety, as with other 
emotional disorders, is a multi-faceted condition and that any one test may only be sensitive to one 
aspect of this complex behaviour.  In a study using Flinders Sensitive Line (FSL) rats, a genetic model 
of depression, chronic dosing over 14 days of 10 mg/kg of citalopram reduced anxiety in the OFT and 
EPM without affecting locomotor activity (Kokras et al, 2011).   Acute dosing with SSRIs has routinely 
been shown to produce anxiogenic effects in animals. The SSRI fluoxetine in acute doses increased 
anxiety in the EPM (Ravinder et al, 2011).  Conversely, studies have found dose dependant effects of 
SSRI administration with acute and chronic doses producing an anxiolytic effect whilst sub-chronic 
doses having no anxiolytic effect in an elevated T-maze (Pinheiro et al, 2008).  High acute doses of 
citalopram (10, 30 & 100mg/kg) have also been found to reduce conditioned fear-stress induced 
behaviour (Muraki et al, 2008).  These findings suggest that behavioural measures of anxiety, 
potency of SSRI (citalopram v escitalopram) and dose may produce contrasting results. 
In clinical populations, anxiety disorders and depression are commonly accompanied by cognitive 
inflexibility (Dickstein et al, 2009).  The functional implications of this are an inability to alter 
behaviour in response to changes in stimulus-reward contingencies.  Several studies have shown 
that depressed patients demonstrate an attention bias towards negative stimuli (Gotlib et al, 2004; 
Siegle et al, 2001), have increased sensitivity to negative feedback (Murphy et al, 2003) and have 
reduced sensitivity to positive stimuli (Roiser et al, 2009).  An accurate way of measuring responses 
to positive and negative stimuli is to use the probabilistic reversal learning paradigm.  In this task, 
mice with a 5-HTT knockout mutation demonstrated reduced negative feedback sensitivity (NFS) 
compared with wild types.  Furthermore, administration of escitalopram (a clinical prescribed 
antidepressant derived from the potent s-enaniomer of citalopram) resulted in reduced NFS, 
increased reward sensitivity and increased number of reversals (Ineichen et al, 2012).  Similar results 
were found in normal rats with a high (10mg/kg) acute dose of citalopram; increasing the number of 
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reversals and decreasing NFS. However, a low (1 mg/kg) acute dose produced the opposite effect on 
both measures (Bari et al, 2010).  In the latter study, chronic dosing increased reversals and 
responsiveness to positive reinforcement. 
 Selective 5-HT depletion in the frontal cortex has also been shown to result in an inability to shift 
responding (Clarke et al, 2005, 2007).  Global 5-HT depletion resulted in reduced reversals and 
reward sensitivity (Bari et al, 2010).  In human studies, depletion of tryptophan, the biochemical 
precursor to 5-HT increased NFS. However, it did not affect reward sensitivity (Robinson et al, 2012).  
This supports previous findings that 5-HT is important in processing affective stimuli (Gotlib et al, 
2004; Roiser et al, 2010; Siegle et al, 2001).   The neurochemical mechanisms which underpin 
cognitive flexibility have been the focus of studies examining the role of 5-HT transmission in 
inhibitory processes.  A study by Brown et al (2012) examined the contribution of inhibitory 
processes and anxiety in flexibility of responding.  Given previous findings that SSRI administration 
facilitates learning in tasks which contain an anxiety producing component (Hashimoto et al, 2007; 
Montezhino et al, 2010) it was proposed that SSRI administration at doses which reduce anxiety 
improve cognitive flexibility by reducing anxiety when a previously rewarded response is no longer 
reinforced; allowing for more rapid switching in response patterns.  Using the EPM as the standard 
test for anxiety, the results indicated that administration of escitalopram did not reduce anxiety at 
doses which also improved flexibility in responding.  A second theory on the mechanism by which 5-
HT manipulation affects response switching was based on findings that administration of SSRIs 
facilitate inhibitory processes.  The theory proposed that SSRIs affect cognitive flexibility by 
inhibiting learned or naturally biased prepotent reponses, i.e. SSRIs facilitate inhibition of a response 
which previously was rewarded (learned prepotent response) or SSRIs facilitate inhibition of a 
naturally biased response, e.g. entering closed arms of EPM more than open arms.  Results from this 
study indicated that escitalopram facilitates inhibition of naturally biased prepotent responses 
(tested using an elevated conflict test) and inhibition of learned prepotent responses (tested using 
serial reversal). 
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The purpose of the current study was to produce a behavioural profile of acute citalopram 
administration on anxiety-like behaviour and reversal learning.  The combination of these 
experiments aims to provide insight into how these behaviours interact with each other.  Acute 
dosing of SSRIs have previous shown to increase anxiety in normal animals and animal models of 
anxiety (FSL & SHR)  and so it is expected that anxiety-like behaviour will be increased in these tests.  
As the reversal learning paradigm used here is based on that by Bari et al (2010) it is expected that 
acute citalopram dosing will facilitate performance on this task, by increasing NFS.  This behavioural 
profile can then be used to compare the effects of probiotic treatment on reversal learning and 
anxiety-like behaviour. 
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3.3. Methods and Procedure 
Subjects 
Experiment 1 and 2; Open field test and elevated plus maze: Thirty-two male adult Lister hooded rats 
(Harlan, UK) weighing 400-550g were used in this experiment.  There were housed in pairs in a 
12h:12h light dark cycle, the holding room was maintained at 55% ±10 humidity and a temperature 
of 19-23oC.  There were all tested during the 12 hour light cycle.  These animals were 7 months old 
when being tested.  All animals were thoroughly habituated to handling before the study began.  
The experiment was performed in accordance with Home Office under Animals Scientific Procedures 
Act (1986). 
The same animals were used for the OFT and EPM.  There was one week given between finishing 
one study and the beginning of the next. For these tests the rats were divided into 3 groups, 1mg/kg 
citalopram, 10mg/kg citalopram and vehicle.  The EPM was the first of the two tests to be run.  The 
groups were then rotated so that the group which received 1mg/kg citalopram i.p. in the EPM (n=11) 
then received vehicle I.p. injection in the OFT, the group which received vehicle i.p. injection in the 
EPM (n=10) received 10mg/kg citalopram i.p. in the OFT and the group which received 10mg/kg 
citalopram i.p in the EPM (n=11) then received 1mg/kg citalopram i.p. in the OFT. 
Experiment 3; PRL 5 mg/kg citalopram:  Thirty-two male adult Lister hooded rats (Harlan, UK) 
weighing 270-350g were used in this experiment.  These animals were 4 months old when testing 
began.  
Experiment 4; PRL 10mg/kg citalopram: Twenty-four male adult Lister hooded rats (Harlan, 
UK)weighing 250-320g were used in this experiment.  These animals were 4 months old when 
tested. 
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All animals were thoroughly habituated to handling before the study began. The animals were food 
restricted to 85% of free feeding body weight and had free access to water.  The experiment was 
performed in accordance with Home Office under Animals Scientific Procedures Act 1986. 
Citalopram Administration 
The Citalopram treated groups were injected i.p with 1mg/kg, 5mg/kg or 10mg/kg of Citalopram 
Hydrobromide (Tocris, Bristol, UK).  Citalopram was dissolved in 0.9% injectable saline to a 
concentration of 1mg/ml and administered 30mins prior to testing.  Vehicle treated animals were 
injected with 0.9% injectable saline at a volume of 1ml/kg administered 30mins prior to testing.  The 
animals were injected in a separate room and were returned to their holding room for 30 minutes 
before testing. 
Apparatus and Procedure 
Experiment 1: Open Field Test 
The open field test arena was a 1m x 1m box with walls 40cm high. The activity of the animals was 
recorded using wide lens camera attached to a RM PC and analysed using EthoVision, an automated 
behavioural tracking system (Noldus Information Technology, Netherlands). All animals were naive 
to the room prior to testing.  The room was illuminated using 60 watt lighting.  All items in the room 
remained in place over the two days of testing.  Animals were carried in groups of four in a blacked 
out carrying box into the room.  The first animal was placed into the centre of the area whilst the 
experimenter remained out of sight.  After the 10 minute testing periods the animal was removed 
from the arena and placed back into the carrying box.   The arena was thoroughly cleaned before the 
next animal was introduced.  The data was analysed according to zones, the edge of the arena was 
20 cm from the wall, where these intersected were the corners, the 60cm x 60cm area in the centre 
was the middle.  Measure taken during the test session the length of time spent in each zone, the 
velocity of movement, maximum distance moved and the frequency of entrances to each area.  The 
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data given for the corners consists of all the data recorded for each of the four corners; this is the 
same with the data given for the edges.  Each animal had two ten minute sessions in the OFT, this 
was run on two consecutive days. 
Experiment 2: Elevated Plus Maze 
The elevated plus maze consists of two intersecting platforms in the shape of a plus sign measuring 
110cm x 10cm raised 70cm off the floor.  Two opposing arms of the maze have 40cm black Perspex 
walls whilst the other two opposing arms are open.  This allows for a 10cm x 10cm intersection to 
allow the animal to move freely between the arms of the maze.  The activity of the animals was 
recorded using a camera attached to a RM PC and analysed using EthoVision, an automated 
behavioural tracking system (Noldus Information Technology, Netherlands).  All animals were naive 
to the room prior to testing.  Animals were carried in groups of four in a blacked out carrying box 
into the room.  The first animal was placed into intersection facing an open arm.  The animal was left 
to explore for 5 minutes before being returned to the carrying box.  Once the animal had completed 
the test the maze was wiped down with alcohol wipes before the next animal was introduced.  The 
data recorded during the session were the length of time spent in each zone, the velocity of 
movement, latency to enter each zone, maximum distance moved and the frequency of entrances to 
each area.  The data recorded for both open arms was complied to give one data point, this was the 
same for the closed arms.   
Experiment 3 and 4: PRL with 5 mg/kg and 10 mg/kg Citalopram 
The apparatus and procedure used in this experiment ere identical to that described in Chapter 
section 2.3.  The rats had one session per day and were given 3 days to acquire the task.  They were 
counterbalanced on average number of reversals over days completed on the first three days and 
assigned to one of two group, drug or vehicle.  These groups then had a further 3 days of the test 
phase.  Injections were administered 30 minutes before behavioural testing.  
Effects of citalopram on anxiety and PRL Chapter 3 
 
43 
 
Statistical analysis 
For the EPM and the OFT the duration, total distance moved and the frequency of entrances into 
each area were all analysed as a percentage of duration, total distance moved and frequency of 
entrances into all areas.  Maximum distance moved at any one time was calculated and analysed as 
a percentage of maximum distance moved in all areas.  For the EPM, a one-way ANOVA was carried 
out on each of the following measures; duration, frequency of entrances, total distance moved, 
maximum distance moved (maximum distance move without stopping in at any one time), and 
velocity. As the OFT was conducted over two days a repeated measures ANOVA was carried out on 
each of the measures.  The between subjects factor was dose (1mg/kg, 10mg/kg and vehicle).  The 
results are expressed as mean ± 1 standard error.  The threshold for significance was p<0.05.  Where 
data was non-spherical given the output from Malchly’s Test of Shericity  ,the Greenhouse-Geisser 
adjustment was used to give a corrected F ratio.  Where interactions were significant pairwise 
comparisons were used to examine the simple effects of this interaction.  Tukey’s post hoc analysis 
was carried out to examine the differences between groups.  All statistical analysis was carried out 
using SPSS version 20.0. 
Performance in the PRL task was analysed by phase, the acquisition phase was comprised of the 
trials before the first reversal, the reversal phase comprised of any trials after the acquisition phase 
but prior to any further reversals should they be completed.  The results of any animals that failed to 
complete any reversals had their data analysed as acquisition phase and therefore did not contribute 
to the reversal phase data. 
The data analysed from the test phase was the number of reversals completed, reward (win-stay) 
and negative feedback (lose-shift) sensitivity.  Response to positive and negative feedback was 
analysed by evaluating responding on a trial after having received a reward or punishment in the 
previous trial.  Win-stay performance was the likelihood of repeating the same behaviour having 
been rewarded on a pervious trial, (positive feedback), lose-shift performance was the likelihood of 
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discontinuing the behaviour following a punishment on the previous trial, (negative feedback).   
Analysis was also carried out of the perseverative errors.  These were calculated at the percentage of 
trials where an incorrect response was recorded following reward for the same response.  The 
number of trials to reach the criterion was also recorded, i.e. the number of trials in the acquisition 
phase of each session. 
When calculating the probabilities, omissions and responses in non-illuminated apertures were not 
included. That is win-stay probability is calculated by dividing total number of rewarded responses in 
the same hole as the previous trial by the total number of reward responses and lose-shift 
probability is calculated by dividing the total number of shifts in response following punished 
responses divided by the total number of punished responses. 
Repeated measure ANOVA was carried out on all the measures.  Win-stay and lose-shift probability 
were also analysed by phase, acquisition and reversal on the first test day. Where repeated measure 
ANOVA gave a significant difference pairwise comparisons were carried out.  All statistical analysis 
was carried out using SPSS version 20.0. 
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3.4. Results 
3.4.1. Open Field test 
Repeated measure ANOVA were carried out for each of the measures examining each area of the 
maze separately.  Post hoc analysis was also conducted to examine the difference between the 
groups in each area. 
Frequency 
Frequency of entrances into all area of the arena are displayed in Figure 1. Frequency of entrances at 
the corners of the areas showed that there was no main effect of dose (F(2,29)=0.377, p=NS).  Post 
hoc analysis showed there was no significant difference between any of the groups (Table 1). There 
was a significant main effect of day (F(1,29)=144.666, p<0.001).  However, there was no significant 
day by dose interaction (F(2,29)=2.989, p=NS).  A table of the raw scores in provided (Table 2).  
Statistical analysis of the raw scores are also showed a significant main effect of day (F(2,29)=20.717, 
p<0.001), no significant main effect of group (F(2,29)=0.645, p=NS) or day by dose interaction 
(F(1,29)=1.369, p=NS). 
There was also no main effect of dose on frequency at the edges of the maze (F(2,29)=1.563, p=NS) 
or main effect of day (F(1,29)=0.08, p=NS).  This was confirmed by Post hoc analysis (Table 1). There 
was also no day by dose interaction (F(2,29)=0.836, p=NS).   Analysis of the raw scores also indicated 
no significant main effect of day (F(1,29)=146.72, p=NS), no significant main effect of dose 
(F(2,29)=1.414, p=NS) or day by dose interaction(F(2,29)=1.998, p=NS) 
Results from the middle portion of the arena showed that there was no main effect of dose 
(F(2,29)=0.166, p=NS).  Post hoc analysis of this measure is displayed in Table 1.  There was a 
significant main effect of day (F(1,29)=158.693, p<0.001) and day by dose interaction (F(2,29)=4.229, 
p<0.05).  Analysis of the simple effects of this interaction showed that each group, 10 mg/kg 
(F(1,29)=28.373, p<0.001), 1 mg/kg (F(1,29)=53.47, p<0.001) and vehicle (F(1,29)=82.755, p<0.001) 
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differed significantly across the two sessions.  Pairwise comparisons of the groups on each day are 
displayed in table 3.  A similar pattern of results was observed when raw scores were analysed.  
There was no significant main effect of dose (F(2,29)=2.983, p=NS).  However there was a significant 
main effects of day (F(1,29)=313.847, p<0.001) and day by dose interaction (F(2,29)=3.994, p<0.05). 
 
Figure 1. Frequency of entrances into the areas of the maze as a percentage of frequency of 
entrances into all areas of the maze.  
Table 1.  Post hoc analysis of frequency into each area of the arena. 
Area Dose (1) Dose (2) F value p value 
Corner 10 mg/kg 1 mg/kg 0.377 0.715 
10 mg/kg Vehicle 0.617 
1 mg/kg  Vehicle 0.393 
Edge 10 mg/kg 1 mg/kg 1.563 0.507 
10 mg/kg Vehicle 0.28 
1 mg/kg  Vehicle 0.09  
Middle 10 mg/kg 1 mg/kg 0.166 0.803 
10 mg/kg Vehicle 0.745 
1 mg/kg  Vehicle 0.57 
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 Table2. Raw scores of frequency of entrances 
Area Day Dose Frequency 
Corner 1 1mg/kg 28.18 
10mg/kg 25.36 
Vehicle 26.70 
2 1mg/kg 18.10 
10mg/kg 18.75 
Vehicle 22.40 
Edge 1 1mg/kg 87.67 
10mg/kg 39.64 
Vehicle 44.90 
2 1mg/kg 38.91 
10mg/kg 20.38 
Vehicle 24.40 
Middle 1 1mg/kg 19.45 
10mg/kg 14 
Vehicle 19.40 
2 1mg/kg 3.10 
10mg/kg 1.88 
Vehicle 2.00 
 
Table 3. Pairwise comparison of middle area frequency 
Day Dose (1) Dose (2) P value 
1 10mg/kg 1mg/kg 0.212 
Vehicle 0.07 
1mg/kg Vehicle 0.531 
2 10mg/kg 1mg/kg 0.537 
Vehicle 0.071 
1mg/kg Vehicle 0.216 
 
Duration 
Duration of time spent in each area of the arena is displayed in Figure 2.  The duration of time spent 
in the corner of the arena was not found to be significantly affected by dose (F(2,29)=0.444, p=NS).  
Post hoc analysis showed there was no significant different between any of the groups (Table 4).  
There was a significant main effect of day (F(1,29)=111.675, p<0.001).  However, there was no 
significant day by dose interaction (F(2,29)=1.042, p=NS). Raw scores are provided in table 5.  
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Analysis of the raw scores also showed a significant main effect of day (F(1,29)=104.434, p<0.01), no 
main effect of dose (F(2,29)=3.281, p=NS) or day by dose interaction (F(2,29)=1.179, p=NS) 
There was no main effect of dose found on duration at the edges of the maze (F(2,29)=0.32, p=NS).  
Post hoc analysis showed no significant difference between any of the groups (Table 4).  There was a 
significant main effect of day (F(1,29)=57.809, p<0.001) however, no significant day by dose 
interaction (F(2,29)=0.061, p=NS).  Analysis of raw scores show a significant main effect of day 
(F(1,29)=28.255, p<0.001), however there was also no main effect of dose (F(2,29)=0.66, p=NS) or 
day by dose interaction (F(2,29)=1.281, p=NS) 
Analysis of the duration in the middle of the arena showed there was no significant main effect of 
dose (F(2,29)=0.098, p=NS).  Post hoc analysis also showed no difference between any of the groups 
(Table 4).  There was an significant main effect of day (F(1,29)=139.175, p<0.001) and day by dose 
interaction (F(2,29)=6.425, p<0.01).  Pairwise comparisons of this interaction showed that each 
group, 10 mg/kg (F(1,29)=21.389, p<0.001), 1 mg/kg (F(1,29)=40.814, p<0.001) and vehicle 
(F(1,29)=86.559, p<0.001) significantly differed across the two days.  Pairwise comparisons of doses 
on each day is displayed on table 6.  Analysis of the raw scores also showed a significant main effect 
of day (F(1,29)=221.695, p<0.001) and day by dose interaction (F(2,29)=4.083, p<0.05) and no main 
effect of group (F(2,29)=1.092, p=NS). 
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Figure 2. Percentage of time spent in each area of the maze as a percentage for total duration of the 
session. 
 
 
Table 4. Post hoc analysis of duration in each area of the arena. 
Area Dose (1) Dose (2) F value p 
value 
Corner 10 mg/kg 1 mg/kg 0.444 0.831 
10 mg/kg Vehicle 0.93 
1 mg/kg  Vehicle 0.626 
Edge 10 mg/kg 1 mg/kg 0.32 0.593 
10 mg/kg Vehicle 0.804 
1 mg/kg  Vehicle 0.443 
Middle 10 mg/kg 1 mg/kg 0.098 0.839 
10 mg/kg Vehicle 0.811 
1 mg/kg  Vehicle 0.662 
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Table 5. Raw scores of duration 
Area Day Dose Duration 
Corner 1 1mg/kg 79.44 
10mg/kg 93.55 
Vehicle 83.15 
2 1mg/kg 179.48 
10mg/kg 201.9 
Vehicle 189.54 
Edge 1 1mg/kg 163.73 
10mg/kg 156.69 
Vehicle 152.88 
2 1mg/kg 107.86 
10mg/kg 91.48 
Vehicle 108.04 
Middle 1 1mg/kg 56.84 
10mg/kg 49.65 
Vehicle 63.84 
2 1mg/kg 12.66 
10mg/kg 6.625 
Vehicle 2.24 
 
Table 6. Pairwise comparison of middle area duration 
Day Dose (1) Dose (2) P value 
1 10mg/kg 1mg/kg 0.429 
Vehicle 0.131 
1mg/kg Vehicle 0.448 
2 10mg/kg 1mg/kg 0.672 
Vehicle 0.064 
1mg/kg Vehicle 0.143 
 
Total Distance 
The total distance travelled in the areas of the maze is illustrated in Figure 3.  Repeated measure 
ANOVA indicated that there was no significant main effect of dose on distance travelled in the 
corners (F(2,29)=0.242, p=NS).  Post hoc analysis also showed no significant between any of the 
groups (Table 7).  There was a significant main effect of day (F(1,29)=127.203, p<0.001) however, 
there was no significant day by dose interaction (F(2,29)=1.272, p=NS).  Raw scores are provided in 
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table 8.  Analysis of the raw scores also show a significant main effect of day (F(1,29)=52.937, 
p<0.05), no main effect of dose (F(2,29)=0.542, p=NS) or day by dose interaction (F(2,29)=3.099, 
p=NS). 
There was also no significant main effect of dose on distance travelled at the edges of the arena 
(F(2,29)=0.043, p=NS).  The post hoc analysis for dose is displayed in Table 7.  There was a significant 
main effect of day (F(1,29)=18.532, p<0.001), however no significant day by does interaction 
(F(2,29)=1.528, p=NS).  Again, analysis of raw scores show a significant main effect of day 
(F(1,29)=66.733, p<0.001), no main effect of dose (F(2,29)=2.331, p=NS) or day by dose interaction 
(F(2,29)=0.594, p=NS). 
There was no significant main effect of dose on the total distance travelled in the middle of the 
arena (F(2,29)=0.498, p=NS).  Post hoc analysis showed no significant difference between the groups 
(Table 7).  There was a significant main effect of day (F(1,29)=156.885, p<0.001) and day by dose 
interaction (F(2,29)=6.88, p<0.01).  Analysis of the simple effects of this interaction showed that 
each group, 10 mg/kg (F(1,29)=30.65, p<0.001), 1 mg/kg (F(1,29)=36.64, p=<0.001)  and vehicle  
(F(1,29)=99.538, p<0.001) differed significantly across the two days.  Pairwise comparisons of the 
doses on each day are displayed in table 9.  Analysis of the raw scores also showed a significant main 
effect of day (F(1,19)=195.828, p<0.001) and day by dose interaction (F(2,29)=4.824, p<0..05) and no 
main effect of dose (F(2,29)=0.831, p=NS). 
Effects of citalopram on anxiety and PRL Chapter 3 
 
52 
 
 
Figure 3.  Total distance in each area as a percentage of total distance moved in all areas. 
 
 
Table 7. Post hoc analysis of total distance travelled in each area of the arena. 
Area Dose (1) Dose (2) F value p 
value 
Corner 10 mg/kg 1 mg/kg 0.242 0.832 
10 mg/kg Vehicle 0.811 
1 mg/kg  Vehicle 0.999 
Edge 10 mg/kg 1 mg/kg 0.043 0.954 
10 mg/kg Vehicle 0.983 
1 mg/kg  Vehicle 0.993 
Middle 10 mg/kg 1 mg/kg 0.498 0.638 
10 mg/kg Vehicle 0.705 
1 mg/kg  Vehicle 0.996 
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Table 8. Raw scores of total distance 
Area Day Dose Total 
Distance 
Corner 1 1mg/kg 181.67 
10mg/kg 150.65 
Vehicle 161.42 
2 1mg/kg 228.73 
10mg/kg 242.86 
Vehicle 267.43 
Edge 1 1mg/kg 430.08 
10mg/kg 381.88 
Vehicle 431.29 
2 1mg/kg 250.90 
10mg/kg 216.55 
Vehicle 298.11 
Middle 1 1mg/kg 625.7 
10mg/kg 630.44 
Vehicle 872.75 
2 1mg/kg 148.98 
10mg/kg 88.13 
Vehicle 46.59 
 
Table 9. Pairwise comparison of middle area total distance 
Day Dose (1) Dose (2) P value 
1 10mg/kg 1mg/kg 0.608 
Vehicle 0.161 
1mg/kg Vehicle 0.062 
2 10mg/kg 1mg/kg 0.339 
Vehicle 0.011* 
1mg/kg Vehicle 0.088 
(* = p<0.05) 
 
Maximum Distance 
The maximum distance travelled in each area of the arena is displayed in Figure 4.  Repeated 
measure ANOVA showed that there was no significant main effect of dose on maximum distance 
travelled in the corners of the arena (F(2,29)=0.086, p=NS).  Post hoc analysis also shows no 
significant difference between any of the groups (Table 10).  There was also no significant main 
effect of day (F(1,29)=1.487, p=NS) or day by group interaction (F(2,29)=1.028, p=NS).  Raw scores 
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are provided in table 11.  Statistical analysis of the raw scores also showed no main effect of day 
(F(1,29)=1.917, p=NS) or dose (F(2,29)=0.135, p=NS) and no significant day by dose interaction 
(F(2,29)=0.282, p=NS). 
Analysis of maximum distance at the edges of the maze also showed no significant main effect of 
dose (F(2,29)=0.656, p=NS).  Post hoc analysis also showed no significant difference between the 
groups (Table 10).  There was also no significant main effect of day (F(1,19)=0.369, p=NS), or day by 
dose interaction (F(2,290=0.477, p=NS).  Analysis of raw scores indicated no significant main effect 
of day (F(1,29)=0.494, p=NS) or dose (F(2,29)=0.994, p=NS) day by dose interaction (F(2,29)=0.574, 
p=NS). 
There was no significant main effect of dose found on maximum distance travelled in the middle of 
the maze (F(2,29)=2.223, p=NS).  Post hoc analysis showed no significant difference between any of 
the groups (Table 10).  There was also no main effect of day (F(1,29)=0.804, p=NS) or day by dose 
interaction (F(2,29)=1.363, p=NS).  Analysis of the raw scores indicated that there was no main effect 
of day (F(1,29)=1.729, p=NS) or day by dose interaction (F(2,29)=2.298, p=NS), however there was a 
significant main effect of dose (F(2,29)=3.418, p<0.05).  Post hoc analysis showed that there was a 
significant difference between 10mg/kg group and vehicle (p<0.05) but not between any other 
groups. 
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Figure 4.  Maximum distance travelled in each area as a percentage of maximum distance travelled 
in all areas. 
 
 
 
Table 10. Post hoc analysis of maximum distance travelled in each area of the arena. 
Area Dose (1) Dose (2) F value p value 
Corner 10 mg/kg 1 mg/kg 0.086 0.792 
10 mg/kg Vehicle 0.692 
1 mg/kg  Vehicle 0.89 
Edge 10 mg/kg 1 mg/kg 0.656 0.264 
10 mg/kg Vehicle 0.661 
1 mg/kg  Vehicle 0.51 
Middle 10 mg/kg 1 mg/kg 2.223 0.143 
10 mg/kg Vehicle 0.059 
1 mg/kg  Vehicle 0.556 
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Table 11. Raw scores of maximum distance 
Area Day Dose Maximum 
Distance 
Corner 1 1mg/kg 8.13 
10mg/kg 6.98 
Vehicle 7.29 
2 1mg/kg 7.83 
10mg/kg 10.46 
Vehicle 8.34 
Edge 1 1mg/kg 9.48 
10mg/kg 9.40 
Vehicle 9.51 
2 1mg/kg 8.89 
10mg/kg 12.03 
Vehicle 10.23 
Middle 1 1mg/kg 10.73 
10mg/kg 10.30 
Vehicle 10.10 
2 1mg/kg 7.42 
10mg/kg 13.44 
Vehicle 5.60 
 
Velocity 
The velocity moved in each area of the maze is displayed in Figure 5.  Repeated measure ANOVA 
showed there was no significant main effect of dose on velocity in the corners of the maze 
(F(2,29)=0.912, p=NS).  Post hoc analysis showed no significant differences between any of the 
groups (Table 12).  The was a significant main effect of day (F(1,29)=62.084, p<0.001) and a 
significant day by dose interaction (F(2,29)=4.392, p<0.05).  Analysis of the simple effects of this 
interaction showed that all groups, 10 mg/kg (F(1,29)=5.075, p<0.05), 1 mg/mg (F(1,29)=27.53, 
p<0.001) and vehicle (F(1,29)=36.927, p<0.001) significantly differed across the days.  Pairwise 
comparisons of the doses on each day are displayed in figure 14.  Raw scores are provided in table 
13. Analysis of the raw scores shows that there was a significant main effect of day (F(1,19)=66.74, 
p<0.001) and day by dose interaction (F(2,29)=2.445, p<0.05) but no main effect if dose 
(F(2,29)=2.553, p=NS) . 
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Velocity at the edges of the arena was not significantly affected by dose (F(2,29)=2.03, p=NS).  Post 
hoc analysis also showed no significant difference between the groups (Table 12).  There was no 
main effect of day (F(1,29)=0.285, p=NS) or day by group interaction (F(2,29)=0.43, p=NS).  Analysis 
of the raw scores also showed no main effect of day (F(1,29)=0.224, p=NS) or dose (F(2,29)=2.287, 
p=NS) or day by group interaction (F(2,29)=0.409, p=NS). 
Velocity in the middle of the arena was not significantly affected by dose (F(2,29)=0.437, p=NS).  Post 
hoc analysis showed no significant difference between any of the groups (Table 12).  There was also 
no significant main effect of day (F(1,29)=2.089, p=NS) or day by dose interaction (F(2,29)=0.037, 
p=NS).  Analysis of the raw scores also showed no significant main effect of day (F(1,29)=1.211, 
p=NS), or dose (F(2,29)=2.429, p=NS) or day by dose interaction. 
 
Figure 5.  Average velocity in each area. 
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Table 12. Post hoc analysis of velocity in each area of the arena. 
Area Dose (1) Dose (2) F value p value 
Corner 10 mg/kg 1 mg/kg 0.912 0.188 
10 mg/kg Vehicle 0.48 
1 mg/kg  Vehicle 0.553 
Edge 10 mg/kg 1 mg/kg 2.03 0.23 
10 mg/kg Vehicle 0.056 
1 mg/kg  Vehicle 0.431 
Middle 10 mg/kg 1 mg/kg 0.437 0.411 
10 mg/kg Vehicle 0.986 
1 mg/kg  Vehicle 0.455 
 
Table 13. Raw scores of velocity 
Area Day Dose Velocity 
Corner 1 1mg/kg 10.72 
10mg/kg 8.88 
Vehicle 10.65 
2 1mg/kg 7.23 
10mg/kg 6.84 
Vehicle 6.80 
Edge 1 1mg/kg 11.42 
10mg/kg 11.04 
Vehicle 12.62 
2 1mg/kg 12.83 
10mg/kg 10.48 
Vehicle 13.01 
Middle 1 1mg/kg 11.98 
10mg/kg 13.38 
Vehicle 13.59 
2 1mg/kg 14.92 
10mg/kg 24.77 
Vehicle 17.32 
 
Table 14. Pairwise comparison of corner area velocity 
Day Dose (1) Dose (2) P value 
1 10mg/kg 1mg/kg 0.026* 
Vehicle 0.037* 
1mg/kg Vehicle 0.925 
2 10mg/kg 1mg/kg 0.995 
Vehicle 0.379 
1mg/kg Vehicle 0.376 
(* = p<0.05) 
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The results from the OFT indicated that neither dose of citalopram treatment significantly affected 
any of the behavioural measures compared with vehicle on either day.  Analysis of the raw data did 
not find any contrasting results. 
 
3.4.2. Experiment 2: Elevated Plus Maze 
One-way ANOVA was carried out on the measures recorded in the elevated plus maze (Figure 6). 
Velocity in each area of the maze is displayed in Figure 7.  Statistical analysis showed no significant 
differences between the groups in the closed arms on frequency (F(2,31)=1.4, p=NS), or velocity 
(F(2,31)=0.304, p=NS) in the closed arms of the maze.  However, there was a significant difference 
between the groups on duration (F(2,31)=4.737, p<0.05) and total distance (F(2,31)=6.239, p<0.01) 
and  maximum distance (F(2,31)=3.36, p<0.05).  Post hoc analysis of the differences between each 
group is displayed in Table 15. 
 
Table 15. Post hoc analysis of all measures in the closed arms of the maze. 
Measure Dose (1) Dose (2) F value p value 
Frequency 10 mg/kg 1 mg/kg 1.4 0.493 
10 mg/kg Vehicle 0.466 
Vehicle 1 mg/kg 1 
Duration 10 mg/kg 1 mg/kg 4.737 0.025 * 
10 mg/kg Vehicle 0.063 
Vehicle 1 mg/kg 1 
Total 
Distance 
10 mg/kg 1 mg/kg 6.239 0.009 * 
10 mg/kg Vehicle 0.026 * 
Vehicle 1 mg/kg 1 
Maximum 
Distance 
10 mg/kg 1 mg/kg 3.36 0.711 
10 mg/kg Vehicle 0.044 * 
Vehicle 1 mg/kg 0.59 
Velocity 10 mg/kg 1 mg/kg 0.304 1 
10 mg/kg Vehicle 1 
Vehicle 1 mg/kg 1 
(* = p<0.05) 
One-way ANOVA from the open arms of the maze showed that there was no significant differences 
between the groups on maximum distance (F(2,31)=1.829, p=NS) or velocity (F(2,31)=1.542, p=NS).  
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However, there were significant difference found in frequency (F(2,31)=4.544, p<0.05), duration 
(F(2,31)=3.698, p<0.05) and total distance (F(2,31)=4.694, p<0.05).  Post hoc analysis of the 
differences between each group are displayed in Table 16. 
 
Table 16.  Post hoc analysis of all measures in the open arms of the maze 
Measure Dose (1) Dose (2) F value p value 
Frequency 10 mg/kg 1 mg/kg 4.544 0.019 * 
10 mg/kg Vehicle 0.173 
Vehicle 1 mg/kg 0.946 
Duration 10 mg/kg 1 mg/kg 3.698 0.033 * 
10 mg/kg Vehicle 0.632 
Vehicle 1 mg/kg 0.457 
Total 
Distance 
10 mg/kg 1 mg/kg 4.694 0.015 * 
10 mg/kg Vehicle 0.204 
Vehicle 1 mg/kg 0.747 
Maximum 
Distance 
10 mg/kg 1 mg/kg 1.829 0.683 
10 mg/kg Vehicle 0.211 
Vehicle 1 mg/kg 1 
Velocity 10 mg/kg 1 mg/kg 0.381 1 
10 mg/kg Vehicle 1 
Vehicle 1 mg/kg 1 
 (* = p<0.05) 
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Figure 6.  Frequency of entrances, maximum distance, total distance and duration in closed and 
open arms of the maze. 
 
 
Figure 7. Mean velocity in the closed and open arms of the maze. 
 
 
The results from the EPM indicated that the two doses of citalopram induced opposing effects on 
the duration of time spent and total distance travelled in the closed arms of the maze with the 
higher dose increasing both of these compared with the lower dose.  The frequency, duration and 
total distance travelled in the open arms was also found to be significantly lower in the 10 mg/kg 
dose compared with 5 mg/kg.  The total distance and maximum distance moved by the 10 mg/kg  
treated group in the closed arms was also found to be higher in  the closed arms.  These results 
indicate a distinct dissociation of behaviour in this task dependant on dose with the 10 mg/kg group 
displaying more anxiety-like behaviour than the 1 mg/kg group. 
 
  
0 
1 
2 
3 
4 
5 
6 
7 
8 
Closed Velocity Open Velocity 
V
e
lo
ci
ty
 c
m
/s
 
Error bars = +/- SEM 
1 mg/kg Citalopram 
10 mg/kg citalopram 
Vehicle 
Effects of citalopram on anxiety and PRL Chapter 3 
 
62 
 
3.4.3. Experiment 3: PRL with 5 mg/kg Citalopram 
Conditional probabilities were analysed by phase, acquisition and reversal on the first session of the 
test phase (Figure 8).  Repeated measure ANOVA indicated that there was no main effect of group 
on win-stay probability (F(1,23)=1.8, p=NS) or phase by group interaction (F(1,23)=0.041, p=NS).   
There was however, as significant main effect of phase with win-stay probability found to be higher 
in the acquisition phase (F(1,23)=16.183, p<0.05).  Analysis of lose-shift probability also shows no 
significant main effect of group (F(1,23)=2.369, p=NS) or phase by group interaction (F(1,23)=0.001, 
p=NS).  There was also no main effect of phase (F(1,233)=0.848, p=NS). 
 
Figure 8.  Conditional probability during the acquisition and reversal phase in the 5 mg/kg 
Citalopram and vehicle treated groups. 
Repeated measures ANOVA on the number of reversals completed indicated the there was no 
significant main effect of group (F(1,26)=0.745, p=NS) (Figure 9).  The was also no main effect of 
session (F(2,52)=2.637, p=NS), phase by group interaction (F(1,26)=1.991, p=NS) or session by phase 
by group interaction (F(2,52)=1.377, p=NS).  However,there was a significant main effect of phase 
(F(1,26)=21.891, p<0.001) and session by group interaction (F(2,52)=3.317, p<0.05).  Analysis of the 
simple effects of this interaction revealed that there was a significant difference between the groups 
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on the first session of test phase (F(1,26)=4.446, p<0.05), with no significant differences between the 
groups on any of the other sessions.  The F and p values for these are displayed in Table 17. 
   
Figure 9.  Mean number of reversals competed in the baseline and test phase in the vehicle and 5 
mg/kg Citalopram treated groups. 
 Table 17.  Pairwise comparisons of reversals across sessions in 5 mg/kg and vehicle treated groups. 
Phase Session F value p value 
Baseline 1 1.55 0.224 
2 0.317 0.578 
3 0.037 0.849 
Test 4 4.446 0.045* 
5 1.098 0.304 
6 0.047 0.831 
(* = p<0.05) 
Repeated measure ANOVA conducted on win-stay probability indicated that there was no main 
effect of group (F(1,26)=0.009, p=NS) or session (F(2,52)=3.059, p=NS) (Figure 10).  However, there 
was a main effect of phase (F(1,26)=6.046, p<0.05).  There was no significant phase by group 
interaction (F(1,26)=1.974, p=NS), session by group interaction (F(2,52)=0.323, p=NS), phase by 
session interaction (F(2,52)=1.895, p=NS) or phase by session by group interaction (F(2,52)=0.93, 
p=NS). 
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Figure 10. Win-stay probability in the baseline and test phase in 5 mg/kg Citalopram and vehicle 
treated groups. 
Repeated measures ANOVA of the lose-shift performance indicated that there was no main effect of 
group (F(1,26)=1.494, p=NS), phase (F(1,26)=3.187, p=NS) or session (F(1,26)=1.313, p=NS) (Figure 
11).  There was also no significant phase by group interaction (F(1,26)=0.817, p=NS), session by 
group interaction (F(2,52)=2.053, p=NS) phase by session interaction (F(2,52)=1.89, p=NS) or phase 
by session by group interaction (F(2,52)=0.273, p=NS). 
 
Figure 11. Lose-shift probability in baseline and test phase in 5 mg/kg Citalopram and vehicle treated 
groups. 
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Repeated measures ANOVA was also carried out on perseverative errors (Figure 12).  Results 
showed there was no significant main effect of group (F(1,25)=0.601, p=NS) or session by group 
interaction (F(1,25)=1.151, p=NS).  However, there was a significant reduction in perseverative 
errors across the sessions (F(1,25)= 4.401, p<0.05). 
 
Figure 12.  Perseverative errors in test phase of the 5mg/kg citalopram and vehicle treated groups. 
Analysis of the number of trials to reach criterion of the first reversal indicated that there was no 
main effects group (F(1,26)=1.479, p=NS) or session (F(1,26)=0.51, p=NS).  However, there was a 
significant session by group interaction (F(1,26)=10.089, p<0.05) (Figure 13).  Pairwise comparison of 
this interaction indicated that there was significant difference between the groups on the first test 
session (F(1,26)=6.331, p<0.05) only. 
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Figure 13.  Trials to criterion in test phase of 5mg/kg citalopram and vehicle treated groups. 
3.4.4. Experiment 4: PRL with 10mg/kg Citalopram 
Analysis of conditional probabilities by phase on the first test session indicated that there was no 
significant main effect of group on win-stay probability (F(1,18)=0.12, p=NS) (Figure 14).  There was 
also no main effect of phase (F(1,18)=1.011, p=NS) or phase by group interaction (F(1,18)=0.787, 
p=NS).  Analysis of lose-shift probability also showed no significant main effect of group 
(F(1,18)=0.279, p=NS) or phase by group interaction (F(1,18)=0.004, p=NS).  However there was a 
significant main effect of phase (F(1,18)=9.994, p<0.01). 
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Figure 14.  Conditional probability during the acquisition and reversal phase in the 10 mg/kg 
Citalopram and vehicle treated groups. 
Figure 15 shows the mean number of reversal completed over sessions.  Repeated measures ANOVA 
showed there was no significant main effect of group (F(1,18)=2.57, p=NS), phase (F(1,18)=3.276, 
p=NS) or session (F(2,36)=0.11, p=NS).  There was also no significant main phase by group interaction 
(F(1,18)=0.634, p=NS), session by group interaction (F(2,36)=0.525, p=NS), phase by session 
interaction (F(2,36)=0.502, p=NS) or phase by session by group interaction (F(2,36)=0.502, p=NS). 
 
Figure 15.  Mean number of reversals competed in the baseline and test phase in the vehicle and 10 
mg/kg Citalopram treated groups. 
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Win-stay probability across the sessions is displayed in Figure 16.  Repeated measures ANOVA 
showed that there was no significant main effect of group (F(1,18)=2.367, p=NS) or session 
(F(2,36)=1.631, p=NS).  However, there was a significant main effect of phase (F(1,18)=5.446, 
p<0.05).   There was no significant phase by group interaction (F(1,18)=2.179, p=NS), session by 
group interaction (F(2,36)=1.597, p=NS) or session by phase by group interaction (F(2,36)=0.712, 
p=NS).  However, there was a significant phase by session interaction (F(2,36)=4.184, p<0.05).  
Analysis of the simple effects of this interaction showed that the first (F(1,26)=0.034, p=NS) and 
second (F(1,26)=0.746, p=NS) session of each phase were not significantly different however, the 
third sessions of each were significantly different (F(1,26)=5.121, p<0.05). 
 
Figure 16. Win-stay probability in the baseline and test phase in 10 mg/kg Citalopram and vehicle 
treated groups. 
Lose-shift probability is displayed in Figure 17.  Repeated measure ANOVA show there was no 
significant main effect of group (F(1,18)=0.001, p=NS).  There was also no main effect of phase 
(F(1,18)=2.953, p=NS) or session (F(2,36)=.334, p=NS).  There was no significant phase by group 
interaction (F(1,18)=3.692, p=NS), session by group interaction (F(2,36)=2.03, p=NS) or phase by 
session by group interaction (F(2,36)=0.445, p=NS).  However, there was a significant phase by 
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session interaction (F(2,36)=12.57, p<0.001).  Analysis of the simple effect s of this interaction 
showed that session one of each phase was not significantly different (F(1,18)=0.071 , p=NS) 
however the second (F(1,18)=7.537, p<0.05) and third session (F(1,18)=37.829, p<0.001) were 
significantly different between phases. 
 
Figure 17. Lose-shift probability in baseline and test phase in 5 mg/kg Citalopram and vehicle treated 
groups. 
Analysis of the perseverative errors indicated that there was no significant main effect of group 
(F(1,18)=1.357, p=NS) or session (F(1,18)=0.631, p=NS), there was also no significant session by 
group interaction (F(1,18)=0.038, p=NS) (Figure 18). 
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Figure 18.  Perseverative errors of 10mg/kg and vehicle treated groups. 
Repeated measures ANOVA of the trials to criterion indicated there was no significant main effects 
of group (F(1,18)=0.687, p=NS) or session (F(,18)=0.006, p=NS).  There is also no significant session 
by group interaction (F(1,18)=0.164, p=NS) (Figure 19). 
 
Figure 19.  Trials to criterion of 10mg/kg citalopram and vehicle treated group. 
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The results from this experiment indicate that 5 mg/kg citalopram increased the number of reversal 
in the first session of the test phase.  However this was not found with the higher dose of 10 mg/kg.  
There was no effect of either drug dose on sensitivity to either positive or negative reinforcement 
across the sessions.  Analysis of the effect of the drug doses on feedback sensitivity during 
acquisition and reversal also showed that citalopram did not affect these two variables.  
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3.5. Discussion 
The lower dose of 5 mg/kg Citalopram was found to increase the number of reversals on the first day 
of the test sessions.  This result is consistent with studies that manipulate endogenous 5-HT levels 
through either the use of SSRI treatment or depletion of 5-HT levels (Bari et al, 2010; Clarke et al, 
2005, 2007; Ineichen et al, 2012). 
The present study followed a similar protocol to that used by Bari et al (2010). In the study by Bari et 
al (2010) an acute dose of 5 mg/kg citalopram was not found to significantly increase the number of 
reversals but 10 mg/kg citalopram produced a significant increase.  In contrast, in the current study 5 
mg/kg increased the number of reversals achieved on the initial test session while no effect with 
found with the 10 mg/kg treated group.  The differential response in reversal learning between the 
two drug doses may be attributable to 5-HT receptor activity.  The serotonergic projections from 
raphe nuclei extend to the frontal cortex, previous implicated in reversal learning (Chudasama & 
Robbins, 2003; Dias et al, 1996; Iversen & Miskin, 1970; Schoenbaum et al, 2002).  Activation of the 
5-HT1a autoreceptors by citalopram in the raphe nuclei reduces serotonergic signalling to the frontal 
cortex. However, repeated exposure desensitises the receptor.  The lower dose of citalopram used 
in the present study may not have sufficiently activated 5-HT1a receptors in the raphe nuclei whilst 
still increasing extracellular 5-HT levels in the frontal cortex. Therefore the drug may not have 
inhibited projections to the frontal cortex.  However the higher dose may have activated this 
receptor with desensitisation occurring over the test sessions.  The differences found in this study 
compared with Bari et al (2010) may be attributed to any number of variables that can affect 
serotonergic receptor expression in the dorsal raphe nuclei, including rearing conditions (Gardner et 
al, 2009) and prior exposure to antidepressant drugs (Limón-Morales et al, 2014).  Dorsal raphe 
nuclei 5-HT1a receptor function is affected, via a negative feedback mechanism, by 5-HT function in 
other areas (Almada et al, 2009; Kreiss & Lucki,1994).  Juvenile stress attenuates dorsal hippocampal 
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5-HT1a receptor function in adult rats suggesting another factor that may have produced differences 
between these two studies (Matsuzaki et al, 2011). 
No effect of win-stay or lose-shift probability was seen with either drug dose in the current study.  
This impies that responsiveness to feedback is not modulated by the serontergic system. Increased 
number of reversals exhibited by the 5 mg/kg treated group may be attributed to improved function 
in other subregions of the frontal cortex.  The ability to reverse learned stimulus-response patterns 
though inhibition of responding and rule implementation is well established to be reliant on the 
orbitofrontal cortex (OFC) (Rudebeck et al, 2013).  The administration route of citalopram in this 
study increases global extracellular 5-HT therefore it may have facilitated function of the OFC in 
inhibition of responding and enhanced rule-learning.  This improvement in performance may have 
been due to the rats deciphering a pattern of behaviour which optimises the number of rewards.  
This trend was also exhibited by the 10mg/kg treated group however it did not reach statistical 
significance 
The study by Bari et al (2010) indicated that SSRI administration alters sensitivity to positive 
reinforcement however the specific mechanism by which 5-HT affects value-based decision making 
is unclear (Nakamura, 2013).  Given the evidence for the effect of other variables on 5-HT1a receptor 
function, previously discussed, it is important to consider differences in the prior experience of the 
animals were comparing results between studies. 
In the EPM there was a significant difference between the lower dose of 1 mg/kg and the higher 
dose of 10 mg/kg in several measures of anxiety-like behaviour.  The rats treated with the 1 mg/kg 
dose of citalopram had a higher number of entries, duration and total distance moved in the open 
arms and lower duration and total distance moved in the closed arms compared with the 10 mg/kg 
treated group .  These results indicate that although neither dose significantly alters behaviour 
compared with vehicle both doses produce contrasting effects on anxiety-like behaviour with the 
lower dose inducing a reduction and the higher dose causing increases.  This result parallels findings 
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by Mombereau et al (2010) where higher acute doses of citalopram produced a significantly higher 
anxiogenic effects on an elevated zero maze (EZM) (an elevated circular maze comprising of two 
enclosed quadrants and two open quadrants) compared with a lower dose.  The SSRI fluoxetine 
when administered at the same dose, 10 mg/kg, was also found to produce an anxiogenic effect 
(Ravinder et al, 2011). 
The results from the OFT study however, found no main effect on dose on any of the measures.  This 
test implies a lack of coherency with the EPM.  This has been previously reported in pharmacological 
and genetic studies (Vendruscolo et al, 2003) and supports opinion that construct differences mean 
each test assesses only one facet of an animals’ emotional profile.  
 Another area of concern regarding the use of a battery of tests to assess anxiety in animals is that 
sequential testing increases familiarly with testing therefore reducing anxiety.  This may in part 
explain why no drug effect with found in the OFT, which was the second test to be administered.  
Furthermore, results from the OFT, which was run for two days found a main effect of day 
suggesting that anxiety-like behaviour changed over the two days.  On some of these measures drug 
dose produced an interaction by day implying that adaption to environment is differentially affected 
by drug dose.  For example, the 1 mg/kg dose showed lower frequency of entries into the corners 
and edges of the maze and higher frequency of entries into the middle on the first day compared 
with the 10 mg/kg group, although this was not significant this pattern was reversed on the second 
day.  This suggests that although the drug is not significantly impacting anxiety-like behaviour in this 
test, adaption to novel environments may be differentially affected by different doses of citalopram. 
The results from the current study indicate that serotonergic transmission is implicated in reversal 
learning and in acute doses may induce anxiety-like behaviour.   The lack of coherency between the 
two behavioural tests used in this study to assess anxiety levels highlight the problems in the use of 
behavioural testing to examine emotional disorders and indicate the need for  caution when 
interpreting and comparing behavioural results across studies. 
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Effects of the dietary probiotics, bifidobacterium bifidum (CUL20), 
bifidobacterium lactis (CUL34) and lactobacillus acidophilus (CUL21 & CUL60)  
on anxiety-like behaviour, locomotor activity, reversal learning and 
probabilistic reversal learning. 
4.1. Summary 
The current study examined the effect of chronic probiotic treatment on anxiety levels using the 
open field test (OTF), an elevated plus maze (EPM) and a locomotor activity (LMA) test to assay the 
effects of the probiotics on general activity.  Cognitive flexibility was assessed using a probabilistic 
reversal learning task and a watermaze reversal learning paradigm.  The results from these 
experiments indicated that there was no effect of probiotics on anxiety-like behaviour in the EPM.  
However, in the OFT the probiotic treatment reduced exploration, suggesting a possible anxogenic 
effect on performance.  However, results of the LMA test showed a reduction in activity levels  
across successive sessions which may account for the reduced exploration rates of the probiotic 
group in the second day of testing in the OFT.  Results from the PRL task indicated that there was no 
difference between the groups on several measures of performance including sensitivity to reward 
and non-reward.  However, eight of the thirty-two animals tested failed to pass the training phase of 
this task indicating the age of the animals may have reduced the power to detect a probiotic 
treatment effect on reversal learning.  In contrast, probiotic treatment improved spatial 
discrimination learning in the watermaze. 
4.2. Introduction 
Depression has been cited as being the fourth leading cause of disability worldwide accounting for 
4.4% of total disability adjusted life years (DALYs) and almost 12% of all total years lived with non-
fatal disability world-wide (Ustun et al, 2004).  Depression is co-morbid with anxiety disorders 
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(Braam et al, 2014).  These psychiatric conditions are often accompanied by gastro-intestinal (GI) 
disorders with the onset of GI disturbances associated with stressful life events (Lutgendorff et al, 
2008).  Studies have found that over 50% of patients with irritable bowel syndrome (IBS) also had 
mood disorders (Lutgendorff et al, 2008).  The symptomatic presentation of mood disorders was 
also found to be exacerbated during periods of increased gastrointestinal disturbance (Graff et al, 
2009; Whitehead et al, 2002).   
One of the common pharmaceutical interventions for IBS is antidepressants (Neufeld & Foster, 
2009).  This treatment for IBS gives a clear indication that the link between GI disturbances and 
mood disorders is believed to be a top-down process with CNS functioning negatively impacting 
intestinal constituents to cause GI disturbances.  This has also been demonstrated in preclinical trials 
where early-life stress in rodents induced alterations of the bacterial profile of the gut (O’Mahony et 
al, 2009).  Indeed, there exists an abundance of evidence to suggest a top-down component in gut-
brain communication (Bailey & Coe, 1999; Garcia-Rodenas et al, 2006). However, the focus of recent 
research clearly indicates bi-directional communication between the gut and the brain with 
composition of the GI tract shown to impact CNS functioning (Bercik et al, 2010; Gaykema et al, 
2004; Goehler et al, 2005; Lyte et al, 2006; Sudo et al, 2004; Wang et al, 2002). 
Logan and Katzman (2004) were first to suggest a bidirectional pathway between the gut and the 
brain and that probiotics could utilize the bottom-up communication pathway and be used as an 
adjuvant therapy in the treatment of depression.   Probiotic administration has been shown to alter 
functioning in numerous systems beyond the gut including the immune system, neuroendocrine 
system (Ait-Belgnaoui et al 2012; Desbonnet et al, 2008, 2010; Gareau et al, 2007; Sudo et al, 2004) 
neurotransmitter metabolism and production (Barrett et al, 2012; Desbonnet et al, 2010; Roshchina, 
2010) and enterological integrity (Ait-Belgnaoui et al 2012; Zareie et al, 2006). 
Two common strains of probiotics are Lactobacillus and Bifidobacterium.  A probiotic formulation 
containing a species of each of these two bacteria had anxiolytic-like activity in rats using a 
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defensive-burying task (Messaoudi et al, 2011).  Administration of Lactobacillus rhamnosus reduced 
anxiety-like behaviour in the elevated plus-maze (EPM) and forced swim test (FST) (Bravo et al, 
2011).  Early life stress in animal models has been shown to significantly alter the indigenous 
populations of bifidobacterium and lactobacillus (Bailey & Coe, 1999; Bailey et al, 2011).  One such 
early life stressor is maternal separation.  The effects of maternal separation on intestinal 
functioning include perturbations in the bacterial profile of the gut (Gareau et al, 2006, 2007) and 
aberrant behavioural in tests of anxiety and depression (Berman et al, 2014; Desbonnet et al, 2010; 
Diehl et al, 2014).  The maternal separation preparation is therefore commonly used as a model of 
comorbid GI disturbances and depression.  Interventions with probiotics resulted in increased 
preservative behaviour in the FST, characteristic of antidepressant effects (Desbonnet et al, 2010).  
Other studies have reported anxiolytic effects of probiotics in a passive avoidance step-down test (a 
behavioural test often used in animal models to assess anxiety levels) (Bercik et al, 2011).  Tests 
examining the behavioural effects of probiotic on healthy animals have produced conflicting results, 
with bifidobacterium producing no beneficial effects in the FST despite causing immune and 
neurochemical changes (Desbonnet et al, 2008).  When examining the behavioural effects of 
probiotics in animals following subclinical infection with pathenogenic bacteria, Trichuris muris 
anxiety-like behaviour in the light/dark preference test was ameliorated following treatment with 
bifidobacterium.  In animal models of depression, where water avoidance stress is applied, probiotic 
pre-treatment was found to attenuate the physiological stress responses (Ait-Belgnaoui et al, 2013). 
Similarly, in rats with post-myocardial infarction depression probiotic treatment, starting at the on-
set of reperfusion, reduces anxiety and depression-like behaviour in the FST, social interaction test 
and passive avoidance step-down test (Arseneault-Bréard et al, 2012; Gilbert et al, 2012). 
In summary, there is a growing body of emerging evidence in the preclinical arena supporting the 
use of probiotics in the treatment of anxiety and depression.  However, the demonstration of 
therapeutic efficacy has been confined to models of compromised gastrointestinal systems or 
neurochemical functioning.  Furthermore, probiotic interventions have generally been acute, 
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typically two weeks.  Thus the long-term effects of probiotic treatment on anxiety and depression-
like behaviours have not been fully explored. 
The aim of the present study was to examine the effect of chronic exposure to a probiotic 
formulation, bifidobacterium bifidum, bifidobacterium lactis and lactobacillius acidophilus on 
anxiety-like behaviour using the EPM and open-field test (OFT).  A potential behavioural confound 
when examining anxiety-like behaviour following an intervention in these tasks is a change in 
baseline activity levels.  In order to fully understand the impact of probiotic treatment on anxiety 
levels a locomotor activity test (LMA) was also carried out.  Although the behavioural effects of 
chronic treatment with probiotic has never been explored, previous results suggest an anxiolytic-
effect and therefore it was anticipated that probiotics would reduce anxiety measures in rats. The 
alterations in neurochemical functioning exhibited in animals treated with probiotics suggest that 
anxiety-like behaviours maybe not be the only component of behaviour affected. 
Desbonnet et al, (2008) reported that probiotic treatment in rats reduced serotonergic degradation 
in the frontal cortex using high performance liquid chromatography (HPLC).  In CHAPTER 2 
experiment 2 (it was reported that lesions of the medial prefrontal cortex (mPFC) disrupted 
probabilistic reversal learning (PRL).   Furthermore, probabilistic reversal learning was also sensitive 
to a serotonergic agonist, which enhanced performance (Bari et al, 2010; den Ouden et al, 2013; see 
CHAPTER 3 experiment 3).    Based on these findings it was hypothesised that probiotic treatment 
would have a similar effect on PRL learning to a serotonergic agonist, via a putative effect on 5-HT 
activity in the frontal cortex. 
Other areas of the frontal cortex have also been implicated in reversal learning, specifically the 
orbitofronal cortex (OFC) (Chudasama & Robbins, 2003; Izquierdo et al, 2004; Schoenbaum et al, 
2002).  Examination of the role of the OFC in reversal learning indicated that it is fundamental for 
rule-implementation and inhibition of responding while areas of the mPFC is responsible for error 
detection and evaluation of feedback (Gehring & Knight, 2000; Walton et al, 2004; Zanolie et al, 
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2008).  As the PRL task assess flexibility of responding as well as sensitivity to reward and on-reward 
it may identify which subregions of the frontal cortex are affected by probiotic treatment.  
Serotonergic activity has also been implicated in reversal learning involving spatial discriminations 
(Brown et al, 2012; Boulougouris & Robbins, 2010).  In order to examine the extent to which 
probiotic administration affected reversal learning involving a spatial discrimination, a watermaze 
reversal learning paradigm was employed (Russig et al, 2003).  Earlier studies where SSRIs were used 
to alter serotonergic functioning indicated that serotonin transmission facilitates the inhibitory 
processes required to shift responding from a learned choice pattern in spatial reversal learning 
(Brown et al, 2012).  Furthermore, specific 5-HT receptors have been implicated in spatial reversal 
learning.  Systemically administered SB 242084, a 5-HT2C receptor agonist, has been found to 
improve spatial reversal learning (Boulougouris et al, 2008).  Further examination of the 
neuroanatomical specificity of this 5-HT2C agonist indicated that the OFC is the locus of action for 
this drug.  This was differentiated from the mPFC where targeted infusion of SB 242084 showed no 
improvement (Boulougouris & Robbins, 2010).  Given the results from the study by Desbonnet et al 
(2008) it was expected that the reduction in metabolism of 5-HT in the frontal cortex would have 
similar effects on spatial reversal learning as that found by Brown et al (2012) when SSRIs were 
administered.   
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4.3. Method and Procedure 
Subjects 
The same cohort of rats were used for the OFT, EPM, LMA test, PRL task and the watermaze reversal 
task.  Fifty were used in the OFT and EPM, forty-five were used in the LMA test, thirty-two for the 
PRL task and watermaze reversal task. The numbers of animals used in the latter experiments was 
dictated by time constraints and the resources available at the time of testing.  Rats’ weights ranged 
from 423g to 556g. All animals were given free access to water.  During the OFT, EPM, LMA test and 
the watermaze reversal task, the rats were fed 30g of food per day.  During the PRL the food was 
titrated to reduce body weight to 85% of free feeding body weight.  The rats were housed in pairs in 
a holding room with a 12h light-dark cycle with lights on at 7am.  Testing occurred during lights on 
hours.  The temperature of the room was maintained at 19-23oC and humidity at 55% ±10.  During 
the OFT, EPM, LMA test and watermaze reversal task, rats were 15 months old.  Testing on the PRL 
task was conducted when the rats were 24 months old.  Ideally all four experiments would have 
been conducted when the rats were the same age, however, due to technical problems with the 
equipment for the PRL task this experiment could not be conducted earlier. 
Feeding Procedure 
All rats had their food placed into their cages in glass dishes.  The probiotic treated group had their 
food dusted with the probiotic powder from capsules.  The probiotic capsule (Obsidian Research, 
U.K., Port Talbot) contained four strains of bacteria, Lactobacillis acidophilus CUL60, Lactobacillis 
acidophilus CUL21, Bifidobacterium bifidum CUL20 and Bifidobacterium lactis CUL34.  This probiotic 
formulation is a product sold by Cultech Ltd. (Wales, UK), a sponsor of the current research.  
Bifidobacterium and Lactobacillus strains have been previously used in studies examining the impact 
of probiotics on CNS functioning (Bravo et al, 2011; Desbonnet et al, 2009).  A dose rate of 1 x 108 cfu 
(colony forming unit)/capsule per rat was used. In the current study, the probiotic was directly 
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added to a fixed volume of food daily.  The probiotic capsules were stored in a refrigerator at 7oC 
and food was prepared with fresh probiotic powder daily.  Rats in the probiotic condition received 
this diet from weaning and throughout the study.  Prior to weaning the mother received the same 
probiotic dose in her food during the gestation and post-natal period. The probiotic treated group 
and the control group were kept in separate rooms to avoid cross contamination. 
 
Apparatus  
The apparatus for the OFT, EPM, and PRL task were identical to those described in chapter 3. 
Experiment 3: Locomotor activity test 
Locomotor activity was recorded using 8 boxes (32x53cm), there had two photobeams running 
across the shortest edges, one 10cm from the edge and one 20 cm for the edge.  Photobeams ran 2 
cm from the bottom of the cages.  Activity was recorded by a Noldus Information technology 
photobeam system and analysed with an Acorn PC.  The floors of the boxes were a wire grid as was 
the top of the boxes.  These were placed in 2 rows of 4 boxes in a holding rack.  Both groups of 
animals were run simultaneously, with one row being used for the citalopram treated animals and 
the other used for the control treated animals.  The room was illuminated with standard 70w 
florescent tube lighting.  This remained on during the experiment.  All of the animals were naive to 
the room prior to testing.   All boxes were cleaned thoroughly before being used again to avoid smell 
of pervious animal affecting behaviour.  All testing occurred between 1pm and 5 pm to avoid any 
diurnal variation.  Each group was tested at the same time every day for 3 consecutive days.  During 
the one hour testing the rats were allowed to freely explore the box, the activity was recorded in 6 
sets of 10 minutes before being returned to their home cages.  The number of overall ‘breaks’, 
number of times a beam was broken, ‘runs’, number of times one beam then the other was broken, 
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and ‘consecutive breaks’, number of times one beam was broken in succession, were recorded. The 
data was analysed across ‘bins’ and ‘days’.  
Experiment 5: Watermaze reversal learning paradigm 
The watermaze was constructed from, a white circular pool with a diameter of 2m.  The pool had a 
total depth of 62cm and was raised on a platform 75cm off the floor in the middle of the room 
(3.5mx3m).  The pool was filled with water (23-25oC) to a depth of 20cm. 0.5l of opacifer E308 
(Roehm and Haas, U.K., Ltd., Dewsbury) was added to the water to make it opaque.  The water was 
changed for every session.  A circular ceiling was suspended 1m above the top of the pool. A video 
camera with wide-angled lens was placed in the centre of the suspended ceiling.  The camera was 
connected to a video monitor and fed input into a RM PC running Windows XP.  The data was 
analysed using WaterMaze software (Actimetrics, Inc., U.K., Edinburgh).  The room was illuminated 
by 8, 45 watt, lights with a diameter of 20cm in the circular ceiling.  Four 60 watt spot-lights in each 
of the four corners illuminated the rest of the room.  These lights were 1.2m off the floor and angled 
upwards. 
A circular platform with a diameter of 10cm was placed into the water.  The height of the platform 
was 18cm and was located  2cm below the surface of the water.  A beacon could be attached to the 
edge of the platform.  The beacon was black and white stripped plastic rod of 2 cm in diameter 
which rose 10cm above the surface of the platform when attached. 
On the walls of the room were three large distinct shapes made from various colours of card.  These 
were all visible from the surface level of the water.  At the edges of the circular ceiling two large 
objects were hung, one was a black rectangular basket (70cm x 40cm x 40 cm) and the second was a 
spherical white lampshade approximately 30cm in diameter.  These were hung so that they came to 
60cm above the top of the pool and approximately 20cm outside the pool.  These were hung at east 
and west positions. 
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Procedure 
The procedure for the OFT, EPM, LMA test and PRL task are identical to that described in chapter 3.  
In the PRL task, of the thirty-two who underwent 12 days of nose-poke training, twenty-four rats 
met the criteria to continue on the task, the other 8 were excluded from the study.  The criteria 
required to progress to the PRL task was 90% accuracy in nosepoke training (where only one 
aperture was illumined per trial).  The PRL task was conducted for 5 consecutive days. 
The watermaze reversal task had three stages; pretraining, acquisition and reversal.  The pretraining 
stage lasted one session and had 4 trials.  The rats were carried into the room, 4 at a time, in a light-
tight box.  Each rat was carried to the watermaze and released from one of the four start locations 
(N, S, E, W). The order of the start locations was random and each rat was released from all of the 
start locations during the session, facing the pool wall.  The platform was located in one of the four 
platform positions (NE, SE, SW, NW), the order of these was random and only changed after each rat 
in the group had one trial at that location. The order of platform locations was the same for each 
group of four rats.  The platforms in each location were positioned in the middle of the quadrant 
20cm from the edge of the pool.  The platform had a beacon attached to allow for the rats to learn 
to swim and locate the submerged platform in opaque water.  Each trial lasted 60 seconds and rats 
were left on the platform for 20 seconds.  If after 60 seconds if the rat failed to locate the platform, 
the experimenter guided the animal to it, where they remained for 20 seconds.  After this interval, 
the rat was removed from the maze, towel-dried and return to a light-tight box.  Each of the four 
rats in the group completed the first trial before moving on to the second trial therefore the inter-
trial interval was approximately 4 minutes. 
All rats were required to locate and climb on to the platform by the fourth trial before moving on to 
the acquisition phase.  During this phase, platform locations (either SE or NW quadrants) were 
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counter-balanced between the groups. The beacon was removed from the platform for the duration 
of the experiment.  Each trial lasted a maximum of 60 seconds and animals were confined to the 
platform for 20 seconds. If the platform was not located, the rat was guided to the platform by the 
experimenter and left there for 20 seconds.  Rats were trained on acquisition of the platform 
location for 6 sessions.  On the 6th day a 5th probe trial was introduced.  During the probe trial the 
platform was removed from the pool and the rats swam for 60 seconds.  The reversal phase 
commenced on the 7th session.  During these sessions the platform location for all the trials was 
switched to the quadrant opposite that used for acquisition.  The procedure for this phase was 
identical to that used in the acquisition phase, except that a 5th probe trial was completed at the end 
of each session to track acquisition of the new spatial bias. 
 
Statistical analysis 
Statistical analysis of the data from the OFT, EPM and PRL task were identical to that described in 
Chapter 3, section 3.3.  In the watermaze reversal task the following measures were recorded for all 
of the first four trials in the acquisition and reversal phases; time taken to reach the platform, 
percentage of time spent in the correct quadrant, percentage of time spent within 10cm of the edge 
of the platform (zone time) and velocity of swimming were recorded.  For the probe trials where the 
platform was removed the number of platform crossings was also recorded.  Averages were 
calculated for each measure over the 4 trials of the acquisition and reversal phases to produce one 
data point for each phase.  A repeated measures ANOVA was conducted on each of the measures.  
Repeated measures ANOVA was conducted on each of the measures recorded in the LMA test, 
breaks, runs and consecutive breaks.  Where significant interactions occurred pairwise comparisons 
were carried out to examine the differences between the groups. 
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The results are expressed as mean ± 1 standard error.  The threshold for significance was p<0.05.  
Where data was non-spherical given the output from Malchly’s Test of Shericity  ,the Greenhouse-
Geisser adjustment was used to give a corrected F ratio.  Where interactions were significant 
pairwise comparisons were used to examine the simple effects of this interaction.  All statistical 
analysis was carried out using SPSS version 20.0. 
 
4.4. Results  
4.4.1. Experiment 1: Open Field Test 
Frequency  
Figure 1 shows the frequency of entrances to the areas of the maze over two days.  Statistical 
analysis indicated a significant main effect of group on frequency of entrances into the corners of 
the maze (F(1,48)=8.871, p<0.05). However, there was no significant main effect of day 
(F(1,48)=0.088, p=NS) or group by day interaction (F(1,48)=0.518, p>0.05).  A table of raw scores is 
provided (Table 1).  Analysis of the raw scores showed there was a significant main effect of group 
(F(1,48)=0.839, p<0.05), no significant main effect of day (F(1,48)=0.248, p=NS) or or day by group 
interaction (F(1,48)=0.184, p=NS). 
Frequency of entrances to the edges of the maze was not significantly different between groups 
(F(1,48)=0.136, p=NS).  There was also no significant main effect of day (F(1,48)=1.910, p=NS) or 
group by day interaction (F(1,48)=0.078, p=NS).  Analysis of the raw scores showed there the was no 
significant main effect of group (F(1,48)=4.135, p=NS), day (F(1,48)=0.006, p=NS), day by dose 
interaction (F(1,48)=0.052, p=NS). 
There was a significant main effect of group on frequency of entrances to the middle of the maze 
(F(1,48)=10.268, p<0.01).  There was no significant main effect of day (F(1,48)=0.702, p=NS) nor 
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group by day interaction (F(1,48)=0.795, p=NS).  Analysis of the raw scores also showed a significant 
main effect of group (F(1,48)=7.731, p<0.05), no main effect of day (F(1,48)=0.511, p=NS) or day by 
group interaction (F(1,48)=0.152, p=NS). 
 
Figure 1. Frequency of entrances into the areas of the maze as a percentage of frequency of 
entrances into all areas of the maze. 
 
Table 1. Raw scores of frequency. 
Area Day  Control Probiotic 
Corner 1 9.24 8.80 
2 9.76 8.92 
Edge 1 14.30 12.63 
2 14.87 12.49 
Middle 1 21.65 16.42 
2 21.19 14.38 
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Duration 
Duration of time spent in each area of the maze is displayed in Figure 2.  There was a significant 
main effect of group on duration of time spent in the corners of the maze (F(1,48)=11.213, p<0.05).  
There was a also a significant day by group interaction on duration of time spent in the corners of 
the maze (F(1,48)=4.531, p<0.05). Analysis of the simple effects of this interaction showed that there 
was no difference between the group on the first day (F(1,48)=2.449, p=NS). However, the probiotic 
group had a significantly higher duration on the second day (F(1,48)=17.179, p<0.001).  No 
significant main effect of day was found (F(1,48)=1.176, p=NS).  Raw score are provided in table 2.  
Analysis of raw scores also showed a significant main effect of group (F(1,48)=5.455, p<0.05) and no 
main effect of day (F(1,48)=2.23, p=NS) however there was also no day by group interaction 
(F(1,48)=3.549, p=NS). 
 
There was also a significant main effect of group on duration of time spent at the edges of the maze 
(F(1,48)=5.548, p<0.05).  There was no significant main effect of day (F(1,48)=0.245, p=NS) or group 
by day interaction (F(1,48)=3.802, p=NS).  Analysis of the raw scores also showed a significant main 
effect of group (F(1,48)=4.399, p<0.05), no main effect of day (F(1,48)=0.174, p=NS) or day by dose 
ineraction (F(1,48)=4.405, p=NS). 
 
There was a significant main effect of group on duration in the middle of the maze (F(1,48)=18.414, 
p<0.001).  There was however, no significant main effect of day (F(1,48)=2.518, p=NS)  or group by 
day interaction (F(1,48)=1.015, p=NS).  This was also found with analysis for the raw scores.  There 
was a significant main effect  of group (F(1,48)=17.784, p<0.001), no main effect of day 
(F(1,48)=2.697, p=NS) or day by group interaction (F(1,48)=1.002, p=NS). 
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Figure 2. Percentage of time spent in each area of the maze as a percentage of the duration of the 
session. 
 
Table 2. Raw scores of duration. 
Area Day  Control Probiotic 
Corner 1 71.08 82.35 
2 67.27 99 
Edge 1 60.69 56.34 
2 62.5 49.83 
Middle 1 72.73 47.53 
2 70.12 31.48 
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Total Distance 
Total distance travelled in each area of the maze in displayed in Figure 3.  Repeated measures 
ANOVA indicated a significant main effect of group on total distance moved in the corners of the 
maze, (F(1,48)=8.354, p<0.01).  Analysis of the simple effects of this interaction showed that there 
was no significant difference between the groups on the first day (F(1,48)=0.108, p=NS). However, 
the probiotic group showed significantly higher total distance travelled on the second day 
(F(1,48)=8.392, p<0.01).  There was also a significant main effect of day (F(1,48)=9.512, p<0.01) and 
a day by group interaction (F(1,48)=5.272, p<0.05).  Raw scores are provided in table 3.  Statistical 
analysis of the raw scores also showed a significant main effect of day (F(1,28)=19.081, p<0.001) 
however there was no main effect of group (F(1,48)=2.443, p=NS) or day by group interaction 
(F(1,48)=2.792, p=NS). 
There was no significant main effect of group found on the total distance moved at the edges of the 
maze (F(1,48)=3.432, p=NS).  There was also no significant main effect of day (F(1,48)=0.018, p=NS) 
or group by day interaction (F(1,48)=2.907, p=NS).  Analysis of the raw scores also showed a similar 
pattern.  No main effect of group (F(1,48)=0.003, p=NS) or day (F(1,18)=7.267, p=NS)  was found or 
day by group interaction (F(1,48)=0.527, p=NS). 
There was a significant main effect of group found on total distance travelled in the middle of the 
maze (F(1,48)=21.997, p<0.001).  There was also a significant main effect of day (F(1,48)=8.625, 
p<0.05). However, there was no significant day by group interaction (F(1,48)=2.072, p=NS).  Analysis 
of raw scores showed a significant main effect of group (F(1,48)-18.385, p<0.001) however there was 
no main effect of day (F(1,48)=0.678, p=NS) or day by dose interaction (F(1,47)=1.272, p=NS). 
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Figure 3.  Total distance in each area as a percentage of total distance moved in all areas. 
 
Table 3.  Raw scores of total distance 
Area Day  Control Probiotic 
Corner 1 203.44 198.45 
2 260.23 302.71 
Edge 1 554.14 594.80 
2 713.35 693.95 
Middle 1 1075.56 721.38 
2 1117.11 546.71 
 
 
Maximum Distance 
The average maximum distance moved is the maximum distance travelled at any one time and is 
displayed in Figure 4.  There is no significant main effect of group on the maximum distance moved 
in in the corners of the maze (F(1,48)=0.235, p=NS).  There was also no significant main effect of day 
(F(1,48)=3.851, p=NS) or group by day interaction (F(1,48)=1.578,p=NS).  Raw scores are displayed in 
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table 4.  Analysis of the raw scores also showed no significant main effect of group (F(1,48)=0.039, 
p=NS) or day (F(1,48)=0.835, p=NS) or day by dose interaction (F(1,48)=3.956, p=NS). 
A significant main effect of group was also found in the maximum distance moved at the edges of 
the maze (F(1,48)=11.91, p<0.01).  However, there was no significant main effect of day 
(F(1,48)=2.512, p=NS)  or group by day interaction (F(1,48)=0.077, p=NS).  Analysis of the raw scores 
showed a significant main effect of group (F(1,48)=0.002, p<0.05) no main effect of day 
(F(1,48)=3.435, p=NS) or day by group interaction (F(1,48)=3.656, p=NS). 
There was no significant main effect of group found in the maximum distance the middle of the 
maze (F(1,48)=7.150, p<0.05).  There was a significant main effect of day (F(1,48)=10.534, p<0.01). 
There was no significant group by day interaction (1,48)=2.001, p=NS).  Analysis of the raw scores 
showed no significant main effect of day (F(1,48)=0.74, p=NS) , group (F(1,48)=1.138, p=NS) or day 
by group interaction (F(1,48)=2.425, p=NS). 
 
 
Figure 4.  Maximum distance travelled in each area as a percentage of maximum distance travelled 
in all areas. 
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Table 4. Raw scores of maximum distance 
Area Day  Control Probiotic 
Corner 1 8.53 6.36 
2 7.42 9.24 
Edge 1 13.65 11.48 
2 13.24 15.57 
Middle 1 18.13 13.40 
2 13.72 14.62 
 
 
Velocity 
Velocity in each area of the maze is displayed in Figure 5.  There was no significant main effect of 
group found on velocity in the corners of the maze (F(1,48)=0.245, p=NS).  There was also no 
significant main effect of day (F(1,48)=.553, p=NS) or group by day interaction (F(1,48)=0.172, p=NS).  
Statistical analysis of the raw scores also reflected these results.  There was no significant main 
effect of group (F(1,48)=0.009, p=NS) or day (F(1,48)=5.03, p=NS) or day by group interaction 
(F(1,48)=1.343, p=NS).  Raw scores are provided in table 5. 
There was a significant main effect of group on velocity at the edges of the maze (F(1,48)=9.301, 
p<0.01).  However, there was no significant main effect of day (F(1,38)=1.705, p=NS) or group by day 
interaction (F(1,48)=0.687, p=NS).   Analysis of the raw scores also showed a significant main effect 
of group (F(1,48)=9.297, p<0.01), no main effect of day (F(1,48)=1.705, p=NS) or day by group 
interaction (F(1,48)=0.686, p=NS). 
Statistical analysis showed that there was no main effect of group on velocity in the middle of the 
maze (F(1,48)=1.637, p=NS).  There was also no main effect of day (F(1,48)=0.02, p=NS) or group by 
day interaction (F(1,48)=0.006, p=NS).  These results were also found when raw score were analysed, 
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no main effect of group (F(1,48)=1.642, p=NS), day (F(1,48)=0.02, p=NS) or day by group interaction 
(F(1,48)=0.006, p=NS). 
 
 
Figure 5.  Average velocity in each area. 
 
Table 5.  Raw scores of velocity 
Area Day  Control Probiotic 
Corner 1 6.95 5.57 
2 5.07 4.87 
Edge 1 13.23 14.56 
2 12.56 15.94 
Middle 1 18.32 19.27 
2 17.42 19.55 
 
The results of the open field test indicate that the probiotic group showed preference for the 
corners and edges of the maze.  The control group had a significantly higher frequency of entrances, 
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contrast to the probiotic group who showed significantly greater frequency of entrances into the 
corners of the maze, higher duration and total distance travelled in the corners on the second day.  
Results from the measures taken at the edges of the maze indicated that the control group had 
significantly higher duration.  However the probiotic group showed a higher maximum distance 
travelled and velocity indicating that the control group explored the edges more whilst the probiotic 
group used this area to move from one corner to the other. 
 
 
 
4.4.2. Experiment 2: Elevated Plus Maze 
One-way ANOVA was carried out on the measures recorded in the elevated plus maze.  Statistical 
analysis showed no significant differences between the groups on any of the measures, closed arm 
frequency (F(1,48)=0.912, p= NS), closed arm duration (F(1,48)=0.148, p= NS), closed arm total 
distance travelled (F(1,48)=0.649, p=NS), closed arm maximum distance travelled (F(1, 48)=0.122, 
p=NS) (see Figure 6), closed arm velocity (F(1, 48)=0.004, p=NS) (see Figure 7), open arm frequency 
(F(1,48)=0.912, p= NS), open arm duration (F(1,48)=0.062, p = NS), open arm total distance travelled 
(F(1,48)=0.649, p=NS), open arm maximum distance travelled (F(1,48)=0.122, p=NS) (see Figure 6), 
open arm velocity (F(1,48)=0.42, p= NS) (see Figure 7).  Raw scores from which the rations were 
derived are provided in table 7.  Statistical analysis of the raw scores also found no significant 
difference between and of the groups on any of the measures. 
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Figure 6. Frequency of entrances, maximum distance, total distance and duration in closed and open 
arms of the maze. 
 
 
Figure 7.  Mean velocity in the closed and open arms of the maze. 
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Table 7.  Raw scores for all measures 
Area Measure Control Probiotic 
Open Frequency 5.08 4.70 
Duration 37.16 35.61 
Total Distance 1196.83 1175.92 
Maximum Distance 41.72 32.99 
Velocity 31.43 37.67 
Closed Frequency 14.81 15.30 
Duration 221.44 225.39 
Total Distance 7087.3 7334.26 
Maximum Distance 128.64 94.73 
Velocity 37.80 37.83 
 
Results from the EPM indicated that treatment did not differentially affect any of the behavioural 
measures. 
 
4.4.3. Experiment 3: Locomotor Activity Test 
The mean number of total beam breaks is displayed in Figure 8.  Statistical analysis showed there 
was no significant main effect of group (F(1,43)=1.538, p= NS) or day (F(2,86)=1.871, p=NS).  
However, there was a significant day by group interaction (F(2,86)=14.865, p<0.001).  Analysis of the 
simple effects of this interaction showed the probiotic group had a significantly higher number of 
breaks on the first day (F(1,43)=12.984, p<0.01)  and significantly lower on the third day 
(F(1,43)=4.598, p<0.05) with no significant difference found on the second day (F(1,43)=2.616, 
p=NS). There was also a significant main effect of bin (F(5,215)=45.363, p<0.001). However there was 
no significant group by bin interaction (F(5,215)=0.377, p=NS) or day by bin by group interaction 
(F(10,430)=1.342, p=NS). 
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Figure 8.  Total number of beam breaks achieved by the probiotic treated group and the control 
group. 
The number of consecutive breaks refers to the number of pairs of beam breaks which that occur at 
the same side of the testing chamber, displayed in Figure 9.  Repeated measure ANOVA indicated 
that there was no significant main effect of group (F(1,43)=1.734, p=NS) or day (F(2,86)=2.491, 
p=NS).  There was also no significant bin by group interaction (F(5,215)=0.918, p=NS) or bin by day 
interaction (F(10,430)=1.563, p=NS).  There was however a significant main effect of bin 
(F(2,215)=29.98, p<0.001) and significant day by group interaction (F(2,86)=18.417, p<0.001).  
Analysis of the simple effects of this interaction indicated that the probiotic group had a significantly 
higher number of consecutive breaks on the first (F(1,43)=14.327, p<0.001) and second days 
(F(1,43)=4.329, p<0.05) but a significantly lower number of consecutive breaks on the third day 
(F(1,43)=5.914, p<0.05).  There was also a significant day by bin by group interaction 
(F(10,430)=2.182, p<0.0.05).  The results of the analysis of the simple effects are displayed in table 1.  
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Table1.  F ratios and p values for pairwise comparison of day by bin by group interaction. 
Day Bin F ratio p value 
1 1 7.727 0.008 
2 4.129 0.048 
3 18.141 0.000 
4 7.484 0.009 
5 1.362 0.250 
6 4.249 0.045 
2 1 1.001 0.323 
2 0.213 0.647 
3 0.534 0.469 
4 4.110 0.049 
5 1.352 0.251 
6 3.583 0.065 
3 1 0.123 0.728 
2 0.008 0.931 
3 13.780 0.001 
4 3.482 0.069 
5 6.286 0.016 
6 10.507 0.002 
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Figure 9.  Mean number of consecutive breaks achieved by the probiotic treated group and control 
group. 
The number of runs refers to the number of pairs of beam breaks which were on opposite sides of 
the testing chamber; this is displayed in Figure 10.  Repeated measures ANOVA indicated that there 
was no significant main effect of group on number of runs completed (F(1,43)=0.825, p=NS).  There 
was also no significant bin by group interaction (F(5,215)=0.975, p=NS), day by bin interaction 
(F(10,430)=0.930, p=NS) or day by bin by group interaction (F(10,430)=1.7, p=NS).  However, there 
was a significant main effect of bin (F(5,215)=110.286, p<0.001), a significant main effect of day 
(F(2,86)=10.377, p<0.01) and a significant day by group interaction (F(2,86)=10.377, p<0.001).  
Analysis of the simple effects of this interaction showed that there was no significant difference 
between the groups on the first (F(1,43)=1.837, p=NS) and second days (F(1,43)=0.454, p=NS).  
However the control group had a significantly higher number of runs than the probiotic group on the 
third day (F(1,43)=20.05, p<0.001). 
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Figure  10.  Total number of runs achieved by the probiotic treated group and the control group. 
 
The probiotic group showed a significantly higher number of beam breaks on the first day and a 
significantly lower number on the third day.  This pattern was also reflected in the number of 
consecutive breaks, with the probiotic having a higher number than the control group on the first 
day and significantly lower number on the third day.  Analysis of consecutive breaks by bin showed 
that, on the first day, the probiotic group had a higher number of breaks on all bins except bin 5.  
However on the third day they had significantly lower number of breaks in the third, fifth and sixth 
bins.  The number of runs completed also paralleled the results from the number of breaks and 
consecutive breaks.  There was a significantly lower number of breaks completed by the probiotic 
group on the third day.  
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4.4.4. Experiment 4: Probabilistic Reversal Learning 
Results were analysed by phase on the first day of the PRL task.  All trials up to the first reversal were 
analysed and included in the ‘acquisition phase’ data.  Subsequent trials until a further reversal had 
been reached were analysed and included in ‘reversal phase’ data. 
Acquisition and reversal phase of session 1 
Conditional probabilities during session 1 are presented in Figure 11.  Statistical analysis showed no 
significant main effect of group on win-stay probability (F(1,18)=0.862, p=NS), there was also no 
significant group by phase interaction (F(1,18)=0.665, p=NS).  However there was a significant main 
effect of phase (F(1,18)=21.808, p<0.001).  Analysis of lose-shift probabilities indicated that there 
was no significant main effect of group (F(1,18)=0.162, p=NS) or group by phase interaction 
(F(1,18)=1.048, p=NS).  However there was a significant main effect of phase (F(1,18)=10.071, 
p<0.05). 
 
Figure 11.  Win-stay and lose-shift probability analysed by phase, acquisition and reversal, on the 
first test session. 
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Reversals 
Figure 12 shows the mean number of reversals over the sessions.  Repeated measures ANOVA 
showed no main effect of group on number of reversals (F(1,21)=0.014, p=NS).  There was also no 
group by session interaction (F(4,84)=0.531, p=NS) or main effect of session (F(4,84)=0.887, p=NS). 
 
Figure 12.  Mean number of reversals completed by probiotic and control group over the test 
sessions. 
  
0 
0.5 
1 
1.5 
2 
2.5 
1 2 3 4 5 
R
e
ve
rs
al
s 
Session 
 
Error bars = +/- SEM 
Control 
Probiotic 
Behavioural impact of dietary probiotics Chapter 4 
 
103 
 
Win-stay 
Win-stay probability over the test sessions is displayed in Figure 13.  Statistical analysis showed no 
significant main effect of group on win-stay probability (F(1,21)=0.831, p=NS),  no significant group 
by session interaction (F(4,84)=0.903, p=NS) or main effect of session (F(4,84)=0.501, p=NS). 
 
 
Figure 13.  Win-stay probability of probiotic and control group over the test sessions. 
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Lose-shift 
Lose-shift probability is displayed in Figure 14.  Repeated measures ANOVA showed no significant 
main effect of group on lose-shift probability (F(1,21)=0.015, p=NS), no significant group by session 
interaction (F(4,84)=0.621, p=NS) nor main effect of session (F(4,84)=1.128, p=NS).  
 
Figure 14.  Lose-shift probability of the probiotic and control groups over the test sessions. 
In summary, the results from the probabilistic reversal learning task indicated that probiotic 
administration did not significantly alter sensitivity to positive (win-stay) or negative (lose-shift) 
reinforcement in either acquisition or reversal in the initial day of the task.  Probiotic treatment also 
did not significantly affect the number of reversals completed or sensitivity to positive or negative 
reinforcement over any of the test sessions. 
Repeated measures ANOVA of the perseverative errors indicated that there was no significant main 
effect of group (F(1,21)=1.155, p=NS) or session (F(1,21)=1.004, p=NS).  There was also no significant 
session by group interaction (F(1,21)=1.163, p=NS) (figure 15). 
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Figure 15. Perseverative errors of control and probiotic treated groups. 
Analysis of the trials to criterion showed that there was no significant main effect of group 
(F(1,20)=1.052, p=NS) or session (F(1,20)=0.059, p=NS).  There was also no significant session by 
group interaction (F(1,20)=0.223, p=NS) (figure16). 
 
Figure 16.  Trials to criterion of control and probiotic treated groups. 
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4.4.5. Experiment 5: Watermaze Reversal Task 
Acquisition Phase  
Time spent in the correct quadrant of the watermaze during acquisition sessions is displayed in 
Figure 15.  A repeated measures ANOVA of the time spent in the correct quadrant indicated a 
significant session by group interaction during acquisition (F(5,150)=2.491, p<0.05).  There was also a 
significant main effect of session (F(5,150)=6.81, p<0.001),  however, there was no significant main 
effect of group (F(1,30)=0.695, p=NS).  Pairwise comparisons revealed no significant difference 
between the groups on any sessions.  Session 1 (F(1,30)=1.053, p=NS), session 2 (F(1,30)=1.183, 
p=NS), session 3 (F(1,30)=0.014, p=NS), session 4 (F(1,30)=1.274, p=NS), session 5 (F(1,30)=3.819, 
p=NS), session 6 (F(1,30)=1.906, p=NS). 
 
Figure 15.  Mean time spent in correct quadrant during acquisition sessions.  
Figure 16 displays the time spent in the correct zone during the acquisition session.  Repeated 
measure ANOVA indicated that there no significant main effect of group on time spent in the correct 
zone during the sessions (F(1,30)=1.509, p=NS).  There was also no significant interaction over the 
sessions (F(5,150)=0.349, p=NS). However there was a main effect of session (F(5,150)=6.342, 
p<0.001). 
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Figure 16.  Mean time spent in correct zone during acquisition sessions. 
The mean time to reach the platform during the acquisition phase is presented in Figure 17.  
Repeated measure ANOVA indicated that there was no main effect of group (F(1,30)=1.528, p=NS) or 
session by group interaction (F(5,150)=0.429, p=NS).  However, there was a significant main effect of 
session (F(5,150)=10.175, p<0.001). 
 
Figure 17.  Mean time taken to reach the platform in the acquisition phase. 
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The mean velocity of swimming in the acquisition phase is presented in Figure 18.  Repeated 
measures ANOVA indicated there was no significant main effect of group (F(1,30)=1.009, p=NS) or 
group by session interaction (F(5,150)=2.062, p=NS).  However, there was a significant main effect of 
session (F(1,30)=21.381, p<0.001). 
 
Figure 18. Mean velocity of swimming in the acquisition phase. 
During the probe trial in the last session of the acquisition phase the platform was removed and the 
number of platform crossings during the trial was calculated (Figure 19). One-way ANOVA of the 
number of platform crossings in the probe trial showed no significant difference between the groups 
(F(1,30)=0.339, p=NS).   
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Figure 19.  Mean number of platform crossings in probe trial of acquisition phase session 6. 
Reversal Phase  
The percentage of time spent in the correct quadrant of the maze during the reversal phase is 
presented in Figure 20.  Repeated measures ANOVA indicated there was no significant main effect of 
group (F(1,30)=0.807, p=NS) or interaction across the sessions (F(2,60)=0.280, p=NS).  However, 
there was, a significant main effect of session (F(2,60)=12.561, p<0.001). 
 
Figure 20.  Mean time spent in correct quadrant during reversal sessions. 
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The percentage of time spent in the correct zone is presented in Figure 21.  Repeated measures 
ANOVA indicated that there was no significant main effect of group (F(1,30)=1.464, p=NS).  There 
was also no significant session by group interaction (F(2,60)=0.852, p=NS).  However, there was a 
significant main effect of session (F(2,60)=7.565, p<0.01). 
 
Figure 21.  Mean time spent in correct zone during reversal sessions. 
The mean time to reach the platform in the reversal phase is presented in Figure 22.   Repeated 
measures ANOVA showed there was no significant main effect of group (F(1,30)=0.255, p=NS) or 
group by session interaction (F(2,60)=0.796, p=NS).  There was also no significant main effect of 
session (F(2,60)=1.603, p=NS). 
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Figure 22.  Mean time taken to reach the platfrom in the reversal phase. 
The mean velocity in the reversal phase is presented in Figure 23.  Repeated measures ANOVA 
indicated that there was no significant main effect of group (F(1.30)=2.493, p=NS) and no session by 
group interaction (F(2,60)=0.027, p=NS).  However, here was a significant main effect of session 
(F(2,60)=21.927, p<0.001). 
 
Figure 23.  Mean velocity of swimming in the reversal phase. 
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Figure 24 shows the mean number of platform crossings in the reversal phase.  Repeated measure 
ANOVA indicated a significant session by group interaction (F(1,30)=4.347, p<0.05).  However, there 
was no significant main effect of group (F(1,30)=2.033, p=NS) or main effect of session 
(F(2,60)=2.292, p=NS).  Pairwise comparison of the sessions show the probiotic group had a 
significantly higher number of platform crossings in the third reversal session (F(1,30)=5.232, 
p<0.05), however, there was no significant difference between the groups on the first reversal 
session (F(1,30)=0.260, p=NS) or the second reversal session (F(1,30)=0.108, p=NS).  
 
Figure 24. Mean number of platform crossings in probe trials of reversal sessions. 
The results for the watermaze reversal task indicated that during acquisition the probiotic group 
showed less time spent in the correct quadrant in the first 3 sessions.  However, results showed a 
higher percentage of time spent in the correct quadrant in the last 3 sessions.  This was reflected in 
the probe trial of session 6 where the probiotic group showed a higher number of platform crossings 
compared to the control group.  Time spent in the correct zone, time taken to reach the platform 
and velocity in the acquisition phase did not differ between the groups.  In the reversal phase the 
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probiotic group had a significantly higher number of platform crossings in the third session.  This was 
the only measure that showed differences between the groups in the reversal phase. 
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4.5. Discussion 
The elevated plus maze (EPM) and open field test (OFT) are behavioural tests often used to assess 
the efficacy of pharmacological treatments for anxiety (Ramos et al, 2008).  The results from the 
current study indicate conflicting results with no significant difference found between the groups in 
the EPM.  However, in the OFT the control group showed significantly more entries into the middle 
of the maze, duration of time spent there, total and maximum distance travelled in that area.  The 
probiotic group showed a preference for the corners of the maze demonstrating increased 
frequency of entrances into the corners as well as higher duration and total distance travelled on the 
second day.  The results from the OFT are indicative of greater anxiety-like behaviour displayed by 
the probiotic group.  
 This is the first time this has been found in ‘normal’ probiotic treated animals.  However, of the 
existing evidence of anxiety-like behaviour in ‘normal’ probiotic treated animals, none of the studies 
examined behaviour in the OFT.  Results from a study by Bravo et al (2011) indicated that in the 
EPM, lactobacillus rhamnosus treated mice had significantly greater frequency of entries to the open 
arms of the maze.  Duration of time spent in the open arms did not significantly differ between the 
two groups suggesting that it was a mild effect.  This gives further support to the theory that the 
anxiolytic effects of probiotic administration are more profound in animals that have either been 
exposed to stress, (Desbonnet et al, 2010)  infection (Bercik  et al, 2010) or suffering induced 
depression (Arseneault-Bréard  et al, 2012).  However, this is in contrast to the current results from 
the OFT.  Exploration into the middle potion of the maze was mostly a behaviour exhibited by the 
control group.  However, when examining the differences between the groups on behaviour in the 
corners and edges, some of the differences between the groups were only found on the second day, 
suggesting differential adaptive behaviour between the groups. The probiotic group showed higher 
total distances travelled and duration of time spent in the corners on the second day.  The control 
group demonstrated greater exploration of the middle and edges of the maze.  Of the previous 
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studies showing an anxiolytic effect of probiotics in ‘normal’ animals (Bravo et al, 2011; Messaoudi 
et al, 2011) the rats were treated with probiotics for 28 days and 14 days, respectively.  Neural 
adaptations are evident in pharmacological interventions for anxiety, for example serotonin 
selective reuptake inhibitors (SSRIs) (Muraki et al, 2008; Portella et al¸ 2011; Romero et al, 1996). 
Therefore, it is possible that chronic treatment compared with acute treatment with probiotics may 
induce differential neurochemical changes resulting in contradicting behaviours. 
Desbonnet et al, (2008) demonstrated that probiotics reduced degradation of frontal lobe serotonin 
levels.  Increased serotonin levels with SSRIs are known to cause desensitisation of the 5-HT1a 
autoreceptor in the dentate gyrus (Blier, 2001), and prolonged exposure inducing serotonin 
signalling to the frontal cortex (Kreiss & Lucki, 1994, 1995).  If the impact of probiotic treatment on 
serotonin functioning is limited to the frontal cortex, it may inhibit serotonergic functioning  in the 
dentate gyrus via a negative feedback mechanism thereby reducing activation of serotonergic 
signalling pathways to other areas of the brain, of which may be implicated in anxiety-like behaviour.  
Further inspection of the effect of probiotics on serotonergic receptors in the frontal cortex and the 
dentate gyrus are required before conclusions can be drawn on whether chronic probiotic treatment 
influences adaption in this system. 
The results from the locomotor activity test again showed differential adaptive behaviour between 
the two groups.  On the first day the probiotic group were breaking the same beam repeatedly 
indicating that they did not actively move around in the cage as much as the control group.  On the 
third day this was reversed with fewer consecutive breaks in the probiotic rats.  Further analysis of 
this showed that the differences occurred in the latter bins of the third day indicating that adaption 
to the chamber was different between the groups.  The probiotic group also had fewer breaks of 
beams on opposite ends of the cage on the third day.  When considered collectively this pattern 
indicates that the probiotic increased activity, as represented by the significantly higher number of 
breaks.  On the third day the number of consecutive breaks and runs were lower in the probiotic 
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group indicating that there was a general decline in locomotor activity over the three days.  This 
reduction in activity may account for some of the results from the OFT.  Much of the group 
differences in the OFT were only found to be significant on the second day.  Although the OFT results 
indicate that the probiotic group showed initial preference for the edges and corners of the maze, 
their lack of exploration beyond those areas may be as a result of reduced activity following 
adaption on the second day.   The results from these three tests combined produce a challenging 
pattern of results to interpret.  The OFT and EPM are both used a standard behavioural tests of 
anxiety but have produced contrasting results. The changes in locomotor activity may confound the 
results of the OFT test.  Given that there was a smaller area for exploration in the EPM than the OFT, 
the differences in LMA may account for the lack of between group differences in the EPM.  
Results from the PRL task indicate that probiotic treatment had no effect on probabilistic reversal 
learning, during either acquisition or reversal and no effect on sensitivity to positive or negative 
reinforcement. 
 In the nosepoke training phase of the PRL task, 8 rats failed to complete this stage.  This is a much 
greater proportion of rats unable to complete this stage of the task compared with previous cohorts 
(see Chapter 2 Experiment 1 and 2 and Chapter 3 Experiment 4).  In the current study, the rats were 
24 months old when being tested.  With the previous cohorts the rats were tested from 3 months to 
7 months.  The greater age of the probiotic and control groups could explain the performance in the 
PRL task.  As cognitive abilities diminish with age this may have reduced the margin whereby one 
group could have out-performed the other. 
The probabilistic reversal learning task is a more demanding procedure than classical reversal 
learning paradigms, as the response-reward contingency is less than 100%.  This requires greater 
attention to the reward contingency, as is found to be reliant on the mPFC (see Chapter 2 
Experiment 2).  It is possible that the effects of probiotic administration reported by Desbonnet et al 
(2008) do not impact serotonergic function in areas of the frontal cortex required for probabilistic 
Behavioural impact of dietary probiotics Chapter 4 
 
117 
 
reversal learning, namely, the mPFC. In the watermaze reversal learning paradigm, accurate 
identification of the ‘correct’ response was always rewarded by escape from the water.  In this task 
the 100% rewarded correct response bears similarity with ‘classical’ reversal learning paradigms, 
which is reliant on OFC functioning.  It is possible that the differentiation of the effect of probiotic 
treatment in these two tasks identifies dissociable brain areas as a locus of impact of probiotics.  
However, a comparative study controlling for age differences would be required in order to examine 
this hypothesis. 
Ability to effectively use extramaze cues was fundamental to the watermaze reversal learning task.  
The results indicated that acquisition of the task was significantly different between the groups with 
the probiotic group showing less time spent in the correct quadrant of the pool in the first two 
sessions. This pattern was then reversed in the last three sessions.  This differential adaption to the 
task may be indicative of the same underlying effects responsible for the differential adaption to 
environments found in the OFT and the LMA test.  As the watermaze task is an anxiety inducing 
paradigm it is possible that an increased state of anxiety may have increased sensitivity to the 
probiotic treatment, therefore facilitating faster learning of the platform location.  An index of the 
accuracy of the animals representation of the platform location was provided by the number of 
platform crossings.  During the reversal phase the probiotic group learned the new platform location 
faster than the control group and by the third reversal session this group had a significantly higher 
number of platform crossings than the control group.  Interpretation of this data is difficult as the 
data for platform crossings in the incorrect quadrant was not analysed therefore it cannot be 
concluded as to whether the probiotic treated rats learned the new location of the platform with 
better accuracy than the control group or they showed improved memory for locations in general. 
The watermaze reversal learning paradigm arguably relies to a greater degree on spatial memory 
than the PRL task.  In order to examine the sensitivity of spatial memory to probiotic administration 
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in the absence of an explicit navigation requirement the subsequent chapter will examine the effects 
of probiotic treatment on spatial recognition memory. 
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The effects of probiotic administration on novel object recognition, object-in-
place and object recency and the effect of citalopram on novel object 
recognition. 
5.1. Summary 
This chapter presents a series of experiments that examined the effects of probiotic administration 
on object novelty, object-place associations and object recency memory processes.  The purpose of 
this was to examine the effects of probiotics on memory.  This chapter also presents a series of 
experiments that examined the extent to which altered serotonergic function (citalopram 
administration) paralleled the behavioural effects of probiotic administration on recognition 
memory.  The results from the novel object recognition task indicated that probiotics improved 
memory when a longer delay of one hour occurred between the sample and test phase.  This was 
not found when a shorter delay of 5 minutes was used.  When normal rats were administered with 5 
mg/kg of citalopram an opposing pattern of results were obtained.  Again, no difference with found 
in the novel object recognition task with the shorter delay of 5 mg/kg however, when there was a 
longer delay of one hour been the sample a test phases the citalopram group showed impaired 
memory for the familiar objects.  Spatial recognition memory was assessed using an object in place 
task and found that probiotic treatment improved memory for the spatial arrangement of object.  
An object recency task was employed to examine the effect of probiotics on temporal 
discrimination.  The results from this showed that there was no effect of probiotics on this type of 
memory. 
5.2. Introduction 
Novel object recognition (NOR) is a one-trial test of object memory developed by Ennaceur and 
Delacour in 1988 for use in neurobiological studies (Akkerman et al, 2012).  The assumption that 
underpins NOR is that rodents show an instinctual preference for novel objects over familiar objects. 
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This is expressed as an increase in exploratory behaviour towards the novel versus familiar objects.  
NOR utilises spontaneous behaviour and allows for examination of learning and memory without the 
use of food or water deprivation, rule learning or training of response-reward associations (Dere et 
al, 2007).  
The most commonly used version of the NOR task consists of a sample trial (using sample exposure 
times ranging from 2-10 minutes) during which the rat or mouse is allowed to explore two identical 
copies of the same object spaced a few centimetres apart.  This stage is followed by a delay (in 
which the animal is confined to a holding cage) and then a test phase, during which one of the 
original objects is replaced with an object that the animal has not seen before.  Normal animals 
demonstrate a preference for exploring the novel object exploration during the test phase that is 
typically modified by increasing the delay between the sample and test phases.  In order to examine 
not only encoding of the main features of the object but its spatial location object-in-place tasks are 
used (Ozawa et al, 2014).  This involves switching the location of two familiar objects, while leaving 
two equally familiar objects in the locations they occupied during the sample stage.   A further 
assessment of recognition memory focuses on object recency.  In a task involving a temporal 
discrimination presentation of a pair of objects is followed by a delay after which there is the 
presentation of another pair of objects.  The test phase consists of the presentation of an object 
from each of the pairs.  In this task, recognition of the object from the most recently presented pair 
and greater exploration of the most recent object is found in control animals (Barker, 2007). 
Studies have shown functional dissociations in the brain systems responsible for different aspects of 
recognition memory.  In NOR tasks, lesions to the rhinal (perirhinal and entorhinal) cortices impair 
performance, specifically the deficit exhibited is delay-dependent (Eacott et al, 1994; Meunier et al, 
1993).  Lesions disrupt performance when the task involves longer delays (>60 seconds) but result in 
no deficits at shorter delays (10 seconds) (Eacott et al, 1994; Meunier et al, 1993).  Conversely, 
lesions to the hippocampus and amygdala which leave the rhinal cortices intact produce no deficit in 
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NOR performance (Murray and Mishkin, 1998; Tam et al, 2013). Further studies have shown that 
impairment of the perirhinal cortex produces the most substantial deficits in object novelty 
recognition with impairments of the entorhinal cortex producing only a mild and transient deficit 
(Buffalo et al, 1999; Meunier et al, 1993).  This is supported by findings showing that bilateral lesions 
to the perirhinal cortex induce deficits in object recognition (Barker et al, 2007).  Whilst there exists 
an consensus of opinion that role of the hippocampus in encoding of information about the object in 
the NOR task is limited (Baxter et al, 2001; Prusky et al, 2004), studies have found a double 
dissociation in the role of the hippocampus and the rhinal corticies in spatial recognition memory 
and NOR (Bussey et al, 2000; Ennaceur et al, 1996).  Fornix lesions impair spatial memory but not 
NOR  (Bussey et al, 2000). A study by Winters et al (2004) demonstrated that specific neurotoxic 
lesions of the hippocampus impaired performance in a standard radial maze spatial task but not the 
NOR task, conversely lesions to the perirhinal cortex impaired NOR but not spatial memory tasks 
(Barker et al, 2007; Winters et al, 2004).  NOR tasks using the same objects but in different spatial 
arrangements are impaired following hippocampal lesions although NOR performance is unaffected 
(Barker & Warburton, 2011).  This heterogeneity of function between these brain areas has been 
reported in other studies using immediate-early gene expression (Aggleton & Brown, 2005; Wan et 
al, 1999).  Much of the recent research on the contribution of specific brain areas to recognition 
memory focus on c-fos levels.  There are several benefits to this methodology over lesion studies.  It 
allows for an assessment of the contribution of the targeted brain area as opposed to focussing 
solely on the aberrant behaviour as a consequence of lesions that may produce more widespread 
systems effects.  Due to the difficulty in achieving highly selective lesions without impacting the 
adjacent brain areas, c-fos studies allow for examination of adjacent and subregions of the target 
site (Aggleton et al, 2012).  C-fos studies have consistently reported that the perirhinal cortex is 
fundamental to recognition memory independent of hippocampal and entorhinal cortex function 
(Zhu et al, 1995, 1996, 1997).  Adaptations of recognition memory tests include the bow-tie maze 
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(Albasser, 2010); which is a running recognition procedure.  Perirhinal lesions also produced a deficit 
in novel object discrimination in this task (Albasser, 2010). In addition, increased levels of c-fos in the 
perirhinal cortex are associated with object novelty detection (Aggleton et al, 2012).  Unlike previous 
c-fos and lesion studies, the bow tie maze, as a test of novel object discrimination, also implicated a 
role for the hippocampus in recognition.  Increased levels of c-fos were also reported in the 
hippocampus. However, the authors did not attribute the hippocampal activation to object novelty 
per se rather the behavioural demands of the task, active exploration and navigation through the 
maze utilises object-in-place or object recency learning (Aggleton et al, 2012).  Furthermore, spatial 
rearrangements of familiar objects resulted in significantly higher c-fos levels in the hippocampus 
but not the perirhinal cortex (Jenkins et al, 2004; Wan et al, 1999).  When object-in place recognition 
was tested in the bow-tie maze, precisely the same pattern of c-fos increases were found in 
hippocampal subreqions (Dentate gyrus, CA1 and CA3) as in the object novelty task (Albasser et al, 
2010).  This gives support to the theory that the behavioural demands of the object novelty task in 
the box-tie maze employ hippocampal resources but that these are not fundamental for 
discrimination of novelty specific to the objects. 
The relative contribution of hippocampal resources in recognition memory following preoperative 
exposure was examined by Broadbent et al, (2010).  The results from this study indicated that when 
several tests of NOR, larger groups sizes, larger lesions and shorter delays between exposure phase 
and surgery are used hippocampal lesions produce deficits in NOR.  Furthermore, in NOR tests 
where spatial and contextual cues are limited hippocampal lesions produce a deficit (Broacdbent et 
al, 2004).  When considered with the previous work on IEG expression and the factors required to 
produce a deficit highlighted by Broadbent et al (2004,2010), it is possible that larger hippocampal 
lesions may impair function of adjacent brain areas such as the rhinal corticies thereby explaining 
the mild impairment found with multiple tests of NOR. 
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This research implies that performance on NOR tasks and object-in-place tasks have differential 
dependence on the function of different components of the memory system.  However, due to the 
anatomical interconnectedness of these regions various forms of recognition memory testing have 
varying degrees of dependence on different components of this system.  Temporal order recognition 
memory, where performance is based on the relative recency of objects, is reliant on both the 
perirhinal cortex and hippocampus with lesions to either or contralateral lesions to both areas 
severely impairing performance (Barker et al, 2007; Barker and Warburton, 2011; Fortin et al,  2002; 
Hannesson et al, 2004).  Another structure found to be fundamental for memory for the sequence of 
events is the medial prefrontal cortex (mPFC).  Bilateral lesions to this area impair temporal order 
memory tasks as does contralateral lesions to the mPFC and perirhinal cortex (Barker et al, 2007, 
Baker & Warburton, 2011).  This suggests a functional interdependence of these two brain regions in 
processing sequence information.  A functional interdependence of the hippocampus and mPFC was 
also found in this task with contralateral lesions producing a deficit in memory for temporal order 
(Barker & Warburton, 2011).  This research provides evidence that the hippocampus, perirhinal 
cortex and mPFC form a functional network in order to successfully process sequential information.  
The current literature on recognition memory including lesion studies and IEG expression provide a 
comprehensive framework on which to test the effects of probiotic administration on memory 
function. 
Of particular interest in the current study is the effect of serotonergic manipulations on recognition 
memory.  The reasoning behind this stems from research published by Desbonnet et al (2008) who 
showed that probiotic administration reduced degradation of serotonin (5-HT) in the frontal cortex 
of rats.  The present study used serotonin reuptake inhibitors (SSRIs) to explore the effects of direct 
serotonergic manipulation on NOR.  This experiment provides important baseline data to determine 
if behavioural changes in novel object recognition following probiotic administration may reflect (at 
least in part) changes in serotonergic function.  
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In order to examine the effect that 5-HT manipulation has on NOR the current study used 
citalopram, a SSRI.  This class of antidepressant drugs prevents reuptake of 5-HT from the synaptic 
cleft back into the presynaptic membrane increasing the concentration of 5-HT in the cleft.    Much 
of the research on the role of 5-HT function in NOR has focussed on the expression of the 5-HT1A 
receptor and subsequent effects following agonism and antagonism of this receptor.  Systemic 
application of the 5-HT1A receptor antagonist, WAY100635, was found to improve NOR with a 24-hr 
delay when administered prior to the sample trial (Pitsikas et al, 2003).  Furthermore the 
administration of WAY100635 was also shown to ameliorate deficits induced by the AMPA receptor 
blocker, NBQX (Schiapparelli et al, 2006).  Other studies have focussed on the effect of selective 5-HT 
lesions.  Lesion of the dorsal raphe nucleus with 5,7-DHT impairs NOR with a 1-hour delay (Lieben et 
al, 2006).  Given the results with the perirhinal lesion studies previously discussed, this result implies 
serotonin manipulation in the dorsal raphe nuclei may affect perirhinal cortex function. 
Detrimental effects of serotonergic manipulation on performance in the Morris watermaze, a test of 
spatial memory, have been reported following administration of the serotonergic depletor, p-
chloroamphetamine (PCA) (Santucci et al, 1995) and citalopram (Schaefer et al, 2013). Performance 
in this task has shown to be dependent on hippocampal functioning as with object-in-place tasks.  
Manipulation of 5-HT levels though either 5,7-DHT lesions, tryptophan depletion, 5-HT receptor 
agonism/antagonism or SSRI administration have effects on other neurotransmitter concentrations.  
Some of the behavioural effects found on NOR and spatial memory maybe mediated by the effect of 
5-HT manipulation on other neurotransmitter concentrations.  For example, WAY 100635 
antagonises acetylcholine release in the neocortex and hippocampus, and blockade of cholinergic 
function using scopolamine has been shown to impair NOR (Koyama et al, 1999).  Similarly, agonism 
of the 5-HT6 receptor improves recognition memory via modulation of cholinergic and glutaminergic 
neurotransmission (Kendell et al, 2001). 
Novel object recognition following probiotic and citalopram 
administration Chapter 5 
 
125 
 
The pattern of results summarised above suggests a role for 5-HT function in NOR. This effect may 
occur either directly by altering serotonergic functioning of fundamental brain areas such as the 
perirhinal cortex or indirectly though attenuated function of other neurotransmitters such as 
dopamine or acetylcholine (Koyama et al, 1999; Nelson et al, 2012). 
The current experiment examined the effect of probiotic administration on NOR, object-in-place and 
temporal recognition memory.  The rats in the current study were chronically exposed to probiotics 
from birth in order to examine the effects of probiotics on the brain over an extended period.  
Although there is a lack of data available on probiotic treatment and monoaminergic concentrations, 
it is hypothesised that chronic exposure will lead to more pronounced affects on neurotransmitter 
function similar to those reported by Desbonnet et al (2008).  The effects citalopram on NOR were 
also examined to provide a reference condition involving a direct manipulation of 5HT function to 
establish their effects on NOR with short and long delays .  As acute treatment of citalopram 
treatment has been shown to activate the auto-inhibitory properties of 5-HT1a receptor it is 
expected citalopram will impair NOR.  
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5.3. Methods and Procedure 
 
Subjects 
Probiotic treated group 
The cohort of rats were used in the current experiments as those in Chapter 4, section 4.3.  Twenty 
from this cohort were randomly selected to participant in these experiments.  The rats were 17 
months old when being tested.  Their weights ranged from 400g to 560g.  The rats were housed in 
pairs in a holding room with a 12h light-dark cycle with lights on at 7am.  Testing occurred during 
lights on hours.  The temperature of the room was maintained at 19-23 oC and humidity at 55% ±10.  
Feeding Procedure  
The feeding procedure is identical to that described in Chapter 4, section 4.3. 
Citalopram treated group 
Ten male adult Lister hooded rats (Harlan, UK) weighing 400-550g were used in this experiment.  
This group were housed under the same conditions as the probiotic treated rats and were also 17 
months old when being tested.   
Injection Procedure 
The citalopram treated groups were injected intraperitoneally (i.p) with 5mg/kg of Citalopram 
Hydrobromide (Tocris, Bristol, UK).  Citalopram was dissolved in 0.9% injectable saline at a 
concentration of 1mg/ml and administered 30 minutes prior to testing.  Vehicle treated animals 
were injected with 0.9% injectable saline at a volume of 1ml/kg administered 30 minutes prior to 
testing.  The animals were injected in a separate room and were returned to their holding room for 
30mins before testing. 
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All animals were thoroughly habituated to handling before the study began.  The experiment was 
performed in accordance with Home Office under Animals Scientific Procedures Act 1986. 
Apparatus 
An adaption of the apparatus originally used by Ennaceur and Delacour (1988) was used in this 
study.  A 1m x1m arena with walls 40cm high was used.  Sawdust was placed on the floor of the 
arena at the start of each test session.  Illumination was provided by 70 watt florescent tube lighting 
in the centre of the room.  All phases of the study were recorded by a camera in the ceiling placed 
directly above the centre of the maze.  The visual feed was sent directly to a monitor from where the 
experimenter observed the behaviour and recorded it in real time.  When the objects were placed in 
the arena they were 40cm apart and 25 cm from the walls. 
Procedure 
Habituation 
Habituation was carried out for four days.  During habituation each rat was placed in the arena for 
15 minutes.  Rats were carried from their holding room in a blacked out carrying box to the testing 
room.  They were introduced to the arena facing the wall.  They were given 15 minutes to explore 
the arena after which they were removed and any faecal matter was removed and the walls of the 
maze were cleaned with alcohol wipes to remove any olfactory cues.  They were placed back into 
the carrying box and placed back into their home cages. 
Yolking 
After four days of habituation, during which the animals became familiar with the arena, their 
average exploration time was recorded over two days.  The purpose if this phase was to control for 
contact time with the object between the two groups.  Each rat was introduced to the arena in the 
same way as the habituation phase.  During this phase two identical objects were placed into the 
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arena.  Each rat was given four minutes to explore the objects.  During this time the contact time 
with the objects was recorded.  Contact time was defined as the nose directed towards the object at 
a distance of two centimetres or less.  Climbing or sitting on the object was not considered to be 
object exploration. 
After two days of data collection the average exploration time for each rat was calculated.  From this 
the rats from the group which explored the most were paired with a rat from the group which 
explored the least so that they were matched for exploration time in the next phase of the 
experiment. (The data from the yolking phase is not available) 
 
Experiment 1 (Probiotic) & 5 (Citalopram) – Novel object recognition with 5 minute delay 
Sample Phase 
During this phase the rats were introduced to the arena in the same way as in the habituation phase.  
A pair of identical objects, different from the pair used in the yolking phase, was placed in the arena.  
The rats from the group which explored the least were the first from each pair to take part in this 
phase.  They were given four minutes to explore the objects during which their contact time was 
recorded.  Following this their paired rat in the other group was given four minutes to reach the 
same amount of contact time.  Therefore, each pair of rats had different lengths of contact time to 
other pairs. 
Test Phase 
After the sample phase the rat was removed from the arena and placed into the carrying box for five 
minutes.  During this time one of the objects was replaced with a new, novel object.  Both objects 
were wiped with alcohol wipes to remove any olfactory cues.  The object which was replaced was 
counterbalanced across the groups.  After five minutes the animal was reintroduced to the arena 
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and contact time with the familiar and novel objects was recorded.  At the end of this phase the 
animal was removed from the arena and placed back into their home cages and the arena was 
cleared of faecal matter and the walls cleaned with alcohol wipes.  The test phase lasted for 5 
minutes. 
This experiment was run on two consecutive days with new objects used on the second day. The 
data from the two days was then averaged for analysis. 
 
Experiment 2 (Probtiotic) & 6 (Citalopram) –Novel Object Recognition with 1 hour delay 
The protocol for this experiment follows the same procedure as experiment 1 however instead of a 
five minute delay between the sample and test phase, a one hour delay was given.  During the one 
hour delay the rats were removed from the testing room in the carrying box and placed back into 
their home cages.  This was to minimise anxiety levels during the longer delay.  The experiment was 
run of two consecutive days with new objects used on the second day.  The data from the two days 
was then averaged for analysis. 
 
Experiment 3 – Object in place with five minute delay 
Sample Phase 
The rats had two days free of testing before the second experiment.  The protocol used for this 
experiment followed a similar pattern as experiment 1.  The rats from the group which had lower 
exploration times in the yolking phase were the first from each pair to take part in this phase.  Rats 
were handled and introduced to the arena in the same way as during the habituation phase.  Four 
different objects were placed into the arena 40 cm from each other and 25 cm from the walls.  None 
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of these objects had been previously used in any other phases of the study.  The rats were given four 
minutes to explore all the objects during which their contact time was recorded.  Following this their 
paired rat in the other group was given four minutes to reach the same amount of contact time.  
Therefore, each pair of rats had different lengths of contact time to other pairs. 
 
Test Phase 
After the sample phase the rat was removed from the arena and placed into the carrying box for five 
minutes.  During this time two of the objects which were diagonally opposite each other were 
switched.  The pair of objects that were switched was counterbalanced across the two groups.  After 
five minutes the rat was reintroduced to the arena for four minutes and contact time with each of 
the objects was recorded.  The contact time with the objects which had been switched was complied 
to give a contact time for ‘novel’ exploration, the same was done with the data recorded for the 
‘familiar’ pair of objects.  At the end of this phase the animals were removed from the arena and 
placed back into their home cages and the arena was cleared of faecal matter and the walls cleaned 
with alcohol wipes. 
The experiment was run twice, on two consecutive days, the pairs of objects used on the second day 
had never been used in any phase of this, or any previous experiment.  The data for the two days 
was complied to give one value. 
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Experiment 3 – Object Recency 
Sample Phase 1  
The rats were given a further two days free of testing before the third experiment.  The protocol 
used for this experiment followed a similar patter as experiment one.  The rats from the group which 
had lower exploration times in the yolking phase were the first from each pair to take part in this 
phase.  A pair of objects was placed in the arena.  These objects had not been previously used in any 
experiment.  Rats were introduced to the arena in the same way as in the habituation phase.  They 
were given four minutes to explore all the objects during which their contact time was recorded.  
Following this their paired rat in the other group was given four minutes to reach the same amount 
of contact time.  Therefore, each pair of rats had different lengths of contact time to other pairs. 
After this phase the rat was removed from the arena and returned to its home cage. 
Sample Phase 2 
After one hour the rats were returned to the arena.  A new pair of objects had been placed into the 
arena.  Again, this pair of objects had never been used in any of the previous experiments.  The rats 
were given four minutes to reach the same amount of contact time as they had with the previous 
pair of objects.  After this phase the rats were returned to their home cages for three hours. 
Test Phase 
After three hours the rats were reintroduced to the arena.  In the arena one of each of the pairs of 
objects were placed.  These were counterbalanced between the groups so that the most recent 
object was placed on the right an equal number of times as placed on the left.  The rats were given 
four minutes to explore the objects and their contact time with the ‘primary’ object (object from 
sample phase 1) and ‘recent’ object (object from sample phase 2) were recorded.  At the end of this 
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phase the rats were removed from the arena and placed back into their home cages.  The arena was 
cleared of faecal matter and the walls cleaned with alcohol wipes. 
This experiment was run twice, on two consecutive days, the pairs of objects used on the second day 
had never been used in any phase of this, or any previous experiment.  The data for the two days 
was complied to give one value. 
Statistical Analysis 
The data was analysed using an investigation ratio (IR).  Raw exploration times of each object were 
calculated as a ratio of exploration times of both objects.  The difference in IRs for the familiar and 
novel objects was then used for statistical analysis.  Each of the experiments were run twice, a mean 
was calculated for each rat and the data complied. The data from the probiotic and control groups 
were analysed separately to the citalopram and vehicle treated groups.  One-way ANOVA were 
carried out on the data using SPSS version 20.0. 
The results are expressed as mean ± 1 standard error.  The threshold for significance was p<0.05.  
Where data was non-spherical given the output from Malchly’s Test of Shericity  ,the Greenhouse-
Geisser adjustment was used to give a corrected F ratio.  Where interactions were significant 
pairwise comparisons were used to examine the simple effects of this interaction.   
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5.4. Results  
5.4.1. Experiment 1-4: Probiotic administration 
Figure 1 shows the raw scores of time spent exploring the novel and familiar objects during the test 
phase of novel object discrimination with a 5 minute delay, a one hour delay, object in place 
discrimination and object recency.  Analysis of this data indicated that the probiotic group spent 
significantly longer investigating the novel object in the novel object discrimination tasks with both a 
5-minute delay (t(13)=8.06, p<0.001) and one hour delay (t(13)=7.43, p<0.001) as well as the object 
in place task (t(13)=3.534, p<0.01) and the object recency task (t(12)=2.368, p<0.05) (one animal was 
excluded in the object recency as it did not explore any of the objects in the test phase).  Analysis of 
performance of the control animals indicated that they explored the novel object significantly longer 
than the familiar object in the novel object discrimination task with a 5 minute delay (t(13)=3.576, 
p=NS) and object in place recognition (t(13)=2.702, p<0.05).  However, with 1 hour delay in the novel 
object recognition task (t(13)=1.706, p=NS) and the object in place task the control rats did not 
significantly discriminate between the objects (t(13)=0.754, p=NS). 
 
Figure 1.  Experiment 1-4:  Exploration time of novel and familiar objects (raw scores) by control and 
probiotic groups. 
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Figure 2 shows the investigation ratio (IR) of exploration time in the test phase of novel object 
discrimination with a 5 minute delay, one hour delay, object in place discrimination and object 
recency.  Statistical analysis of the IR of exploration time in novel object discrimination test with a 5 
minute delay showed no significant difference between the groups (F(1,27)=4.545, p=NS).  However, 
a 1 hour delay showed a significantly higher IR in the probiotic group (F(1,27)=7.615, p<0.05).  
Analysis of the data from the test phase of the object in place experiment as showed a significantly 
higher IR in the probiotic group (F(1,27)=6.876, p<0.05).   Analysis of the object recency indicated 
that there was no significant difference between the groups (F(1,27)=0.624, p=NS). 
 
 
Figure 2. Experiment 1-4:  Investigation ratios (IR) of object novelty with a 5 minute delay, a one 
hour delay, object in place discrimination and object recency in probiotic and control groups. 
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5.4.2. Experiment 5 & 6: Citalopram Administration 
Figure 3 shows the raw scores of exploration time of the novel and familiar objects in the test phase 
by the control and citalopram treated groups.  Statistical analysis of the exploration times indicated 
that both the control (t(9)=8.643, p<0.001) and citalopram (t(9)=3.331, p<0.01) treated groups were 
able to discriminate between the two objects with a significantly longer exploration times of the 
novel object in the novel object discrimination task with a 5 minute delay between the sample and 
test phase.  With one hour delay between the two phases, only the control group (t(9)=3.202, 
p<0.05) showed significantly longer exploration times of the novel object. 
 
Figure 3.  Experiment 5 & 6:  Exploration time of novel and familiar objects (raw scores) by control 
and citalopram groups. 
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analysis of the novel object discrimination with a one hour delay showed that the citalopram treated 
group had a significantly lower IR than the vehicle treated group (F(1,19)=8.601, p<0.01). 
 
Figure 4. Experiment 5 and 6:  Investigation ratio (IR) of novel object recognition with a 5 minute day 
and a one hour delay in citalopram and vehicle treated groups. 
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5.5. Discussion 
The beneficial effects of probiotic administration on recognition memory presented here is to my 
knowledge the first demonstration of such an effect. The changes found in frontal lobe serotonergic 
function and hippocampal noradrenalinergic function reported by Desbonnet et al (2008) provided 
the rationale for the present study.  The results from the probiotic study where novel object 
discrimination was examined indicated that following a 5 minute delay between the sample phase 
and the test phase there was no significant effect of treatment type despite the probiotic group 
having higher mean exploration time of the novel object.  However, with a longer delay this effect 
became statistically significant.  The memory for object place associations was significantly improved 
by probiotic treatment following a 5 minute delay between sample and test phase.  Processing of 
sequential information tested in the object recency task was clearly unaffected by probiotic 
administration following a 3 hour delay period.  Of particular interest in the results from analysis of 
the raw scores is that the probiotic group were able to significantly discriminate between the novel 
and familiar objects during the test phase of all the tasks however the control group were unable to 
do this with the longer delay in the object novelty task or the object in place task.  These results 
indicate that the probiotic group had superior recognition ability over the control group.  In contrast 
to probiotic administration, rats given an acute administration of citalopram revealed a deficit in 
object novelty discrimination following a 1 hour delay but no significant difference was found 
following a 5 minute delay.  Analysis of the raw scores indicated that citalopram treatment 
diminished the rats ability to discriminate between the objects following a longer delay. Given the 
functional dissociations found in lesion and IEG studies the results indicate that the locus of action 
for probiotic treatment is the perirhinal cortex (Eacott et al, 1994; Meunier et al, 1993; Zhu et al, 
1995, 1996, 1997), accounting for the improvement in the NOR task, and the hippocampus (Barker & 
Warburton, 2011) indicated by improved performance in the object in place task.  However, both of 
these regions are implicated in temporal order recognition tasks (Barker et al, 2007; Barker and 
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Warburton, 2011; Fortin et al, 2002; Hannesson et al, 2004).  In the current study no improvement is 
temporal order processing was found following probiotic treatment.  The medial prefrontal cortex 
(mPFC) has also been reported to be fundamental to this task (Barker et al, 2007, Baker & 
Warburton, 2011) suggesting a functional interdependence of this brain area and the perirhinal 
cortex.  Implications from this study may indicate anatomical specificity for the action of probiotics 
limited to the perirhinal cortex and the hippocampus.  Furthermore, the contribution of the mPFC 
may prove to be a limiting factor in temporal order processing following probiotic treatment. 
The results from the citalopram study are consistent with those found in previous studies using SSRIs 
in NOR.  Fluoxetine was found to impair novel object discrimination following delays from 15 
minutes to 24 hour between the sample phase and the test phase (Valluzzi & Chan, 2007, Sass & 
Wortwein, 2012).  Both of these studies involved administration of fluoxetine over an extended 
period (14 days and 32 days).  Given the acute dosing procedure used in the present study and the 
selective affinity of citalopram for the 5-HT transporter protein (Friedman et al, 2005), the present 
study indicates that NOR is sensitive to transient alterations in global 5-HT levels.  Acute treatment 
of citalopram has been shown to activate the auto-inhibitory properties of the 5-H1a receptor 
(Ceglia et al, 2004). The results found here are consistent with studies that have shown antagonism 
of this receptor improves NOR performance (Pitsikas et al 2003).  This suggests that the 5-HT1a 
receptor is implicated in NOR.   As the acute dosing regime used in the current study produced 
similar results to the studies using longer dosing periods of SSRIs, it suggests that either fluoxetine 
has a lower affinity for the 5-HT1a receptor, therefore not inducing desensitisation following 
prolonged expose, or the adaptive response of this receptor requires longer exposure to the drug 
than that used in these studies.  The relevance of this information to the current study is that the 
effects of probiotic treatment on NOR could be explained by prolonged activation of 5-HT1a 
receptors causing desensitisation and therefore improving performance.  In order to clarify the 
involvement of the 5-HT1a receptor in the effects of SSRIs on NOR a study using much longer dosing 
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periods is required.   Results by Leiben et al (2006) found that acute tryptophan depletion and 5,7-
DHT lesions to the dorsal raphe nuclei both impaired novel object recognition.  The inhibitory effect 
of 5-HT1a receptor activation in the raphe nuclei on 5-HT stimulation in other areas of the brain by 
acute citalopram treatment further supports the theory that this receptor is implicated in the effect 
of SSRIs on NOR.  Whether the effect of citalopram on NOR is direct by altering 5-HT transmission or 
indirect through 5-HT1a receptor activation altering transmission of other neurochemicals remains 
speculative.  Blockade of cholinergic function through administration of scopolamine has been found 
to impair NOR, furthermore it has been demonstrated that 5-HT1a receptor antagonism has been 
found to attenuate the deficit.  In order to examine the impact of citalopram administration on 
choleringic neurotransmission in NOR a study using co-administration of citalopram and 
scopolamine should be conducted. Given the results of previous studies showing that the perirhinal 
cortex is fundamental for NOR, it suggests that citalopram may compromise the function of this 
region.  Previous studies have demonstrated that lesions of the perirhinal cortex impair NOR 
performance in a delay-dependant manner, similar to the pattern of results shown in the present 
study by citalopram-treated rats. 
In summary, the results from this study indicate that probiotic treatment facilitates specific aspects 
of recognition memory, object novelty detection over long delays and object-place associations. In 
contrast, temporal order memory was not influenced by probiotics. This pattern of results contrasts 
with those following acute administration of citalopram and suggest that alterations in the 5-HT 
neurotransmitter system may not provide the main mechanism by which probiotics influence 
memory (although further work is required to examine the effects of chronic alterations in 5-HT 
activity).  As the perirhinal cortex is fundamental to NOR following delays lasting longer than 10 
minutes the results of the present study suggest that probiotics may influence processes supported 
by this region.  However, the mechanism of action for this effect remains unclear.  The opposite 
effect found with acute citalopram treatment , which may reflect activity at the 5-HT1a receptor, 
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provide an interesting avenue for further research.  Should the action of citalopram on NOR be 
mediated by acute 5-HT1a receptor activation, prolonged exposure to the drug may presumably 
produce an opposing effect, similar to that found with probiotic treatment.  Co-administration of 5-
HT1a receptor agonists and probiotics would provide further insight into this theory.  As with 
citalopram, the effect of probiotics it not limited to one neurotransmitter. Desbonnet et al (2008), 
reported alterations in dopamine metabolite concentrations in the amygdaloidal cortex.  
Furthermore, acetylcholine, GABA, NMDA and AMPA have all been implicated in NOR (Kim et al, 
2014; Rogoz, 2013; Yamaguchi et al, 2013; Zheng et al, 2011).  In order to understand the 
mechanism by which probiotics have a beneficial effect on memory, further research is required to 
understand the putative neurotransmitter systems affected by this dietary manipulation. 
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Nuclear Magnetic Resonance (NMR) identifies alterations in metabolite profile 
in bifidobacterium bifidum (CUL20), bifidobacterium lactis (CUL34) and  
lactobacillus acidophilus (CUL21 & CUL60)  treated rats. 
6.1. Summary 
Nuclear magnetic resonance spectroscopy (NMRS) was used to examine the metabolic profile of the 
frontal cortex and hippocampus of probiotic treated and control rats.  1H nuclear magnetic 
resonance spectral analysis indicated peaks with significantly higher correlation coefficients for 
inosine, alanine, succinate and lactate in the hippocampus of probiotic treated rats and a 
significantly higher correlation coefficient for hypoxanthine in control rats.  In the frontal cortex 
significantly higher correlation coefficients were found for lactate, myo-inositol, GABA and fumarate 
in the probiotic group.  The results from this study indicate that dietary probiotic administration 
alters intracellular metabolism in the neurons of both brain areas.   
6.2. Introduction 
 Nuclear magnetic resonance spectroscopy (NMRS), as used in the present context, falls under the 
heading of metabolomics.  It represents a powerful assessment tool that detects alterations in the 
metabolome, a pool of metabolites that are end products of cellular processes (Fiehn, 2002).  The 
metabolite profile serves as a chemical fingerprint reflecting downstream genomic, transcriptomic 
and proteomic fluctuations and provides insight into cellular processes in the context of health and 
disease (Trushina and Mielke, 2013).  To my knowledge NMRS has never been conducted on animals 
administered probiotics.  It has been used in the current study to examine the effects of probiotic 
treatment on the intracellular metabolism in brain tissue.  As discussed in the previous chapters, 
probiotics modulate the function of several putative signalling pathways between the gut and brain, 
including enteric nerve stimulation, possibly through neurotransmitter production, vagus nerve 
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stimulation, immune system activation and hormonal stimulation of the HPA axis. However, the 
effect of dietary probiotic administration on intracellular metabolism has yet to be explored.  
Interestingly, a recent study used NMRS to examine the neurometabolites of patients with minimal 
hepatic encephalopathy (MHE) (Ziada et al, 2013). This disease results in perturbation in cognitive 
function caused by peripheral ammonia levels accumulating in the brain.   Probiotics were 
administered to a group of patients based on the rational that improving gut flora and composition 
would inhibit urease-producing bacteria, thus resulting in decreased ammonia absorption.  The MRS 
data showed increased brain metabolite ratios of myo-inositol/choline and myo-inositol + 
choline/glutamine and decreased glutamine/creatine (Ziada et al, 2013).  Given that previous NMRS 
studies on MHE patients have indicated significant decreases in myo-inositol and choline and 
increases in glutamine levels as a result of perturbed liver function (Kreis et al, 1991), probiotic 
treatment could potentially be used as therapeutic intervention for this disorder.   
The aim of the current study was to use NMRS to evaluate the potential effects of probiotic 
treatment on the metabolic profile in the hippocampus and frontal cortex.  These two brain areas 
have been implicated in the behavioural studies carried out in the present thesis and in other 
published biochemical studies.  Given the results of the study by Ziada et al (2013) it was expected 
that probiotic administration in rats would produce a change in the metabolic profile.  Although the 
nature and direction of changes is difficult to predict, prior work in humans would suggest potential 
increases in myo-inositol, choline and decreased glutamine/glutamate peak intensities in rats 
administered with probiotics. 
Myo-inositol is a naturally occurring isomer of nine possible inositol isomers (Parthasarathy & 
Eisenberg, 1986).  It comprises 95% of the total free inositols in the human body (Petroff et al, 1988) 
and is a natural dietary component found in a range of food stuffs, fruits beans, grains in nuts 
(Clements & Darnell, 1980).  There are three main sources of myo-inositiol; recycling in the 
phosphate-phosphonositide (PIP) cycle, de novo synthesis from D-glucose-6-phosphate and as 
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previously mentioned, extracelluar dietary sources.  However, only 3% of plasma myo-inositol passes 
the blood-brain barrier (Spector, 1988).  At an intracellular level, myo-inositol is a precursor for the 
inositol PIP cycle, a metabolic cycle that serves as a neuronal second messenger system.  PIP cycle 
turnover is directly related to neurotransmitter functioning.  Incubation of cortical tissue with 
varying concentrations of 5-HT induces accumulation of intracellular myo-inositol.  Treatment with 
resperine, a mono-amine depletor, induced upregulation of the 5-HT2C receptor which in turn 
increased myo-inositol concentrations (Lee and Wei, 2013).  Reduced immobility time in the forced 
swim test following inositol treatment was found to be abolished following co-administration of 
inositol and PCPA, a serotonergic metabolism inhibitor.  This was not the case following co-
administration of inositol and the noradrenergic neurotoxin, DSP-4. This observation suggests a 
common pathway for inositol and serotonergic functioning in influencing behaviour (Einat et al, 
2001).  Products of the PIP cycle have also been coupled with dopaminergic  systems (D1 and D2 
receptors) (Frégeau et al, 2013; Medvedev et al 2013; Lezcano et al, 2000).  Analysis of monoamines 
and their metabolites via high performance liquid chromatography (HPLC) following acute and 
chronic myo-inositol administration indicates that myo-inositol does not directly impact monoamine 
synthesis, metabolism or reuptake (Einat et al, 1999b).  However, coupled with the results of 
receptor studies it is evident that a complex interaction occurs between monoamine function and 
components of the PIP cycle. 
The behavioural effects of myo-inositol treatment in clinical trials have presented this compound as 
a potential treatment for patients with depression, panic disorder and obsessive-compulsive 
disorder (OCD) but not patients with schizophrenia, Alzheimer’s disease, attention-deficit-
hyperactivity disorder (ADHD) or autism (Einat and Belmaker, 2001).  Lower levels of myo-inositol 
have been found in prefrontal and anterior cingulate cortical areas of depressed patients (Coupland 
et al, 2005).  Post-mortem studies of the frontal cortex in bipolar patients and suicide victims have 
also shown lower levels of myo-inositol with no differences in myo-inositol levels in the cerebellum 
or occipital cortex relative to controls (Shimon et al, 1997).  Animal studies of affective disorders 
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have reflected these results.  Chronic myo-inositol treated (2 weeks) rats showed significantly 
reduced immobilisation time and increased struggle time in the forced-swim test (FST) (Einat et al, 
1999), an established pre-clinical model of depression (Porsolt et al, 1978; Borsini and Meli, 1988).  
Genetic models of depression, Flinders Sensitive Line rats (Overstreet, 1986), have demonstrated 
that inositol treatment ameliorates exaggerated immobility in the FST (Einat et al, 2001).  Locomotor 
activity levels has also been reported to be significantly affected by myo-inositol oral administration, 
a 30% increase in ambulation was observed as well as a 60% increase in rearing (Kofman et al, 1998). 
A similar result was reported with i.p. myo-inositol administration, which significantly increased 
vertical activity (rearing) and induced a similar but non-significant trend in horizontal activity 
(Kofman et al, 1993).  Reserpine- induced hypoactivity, used as a model of depression, is also 
sensitive to myo-inositol administration by reducing immobility time in locomotor activity tests 
(Einat et al, 1999a).   Myo-inositol administration is also implicated in anxiety-related behaviours, 
anxiety-like behaviour in the elevated plus maze (EPM) is reduced following myo-inositol treatment 
(Cohen et al, 1997).  An acute dose of 1.25g/kg administered i.p. has been shown to significantly 
increase the number of entries into the open arms of the maze and the duration of time spent in the 
open arms of the EPM relative to control animals (Einat et al, 1998).   
The effects of probiotic treatment on anxiety-like behaviour in the open field test in the current 
thesis were inconclusive.  However, further analyses of the metabolites myo-inositol and choline 
concentrations in these animals may provide an insight into the possible mechanisms responsible for 
the alterations in anxiety-like behaviour found in other animal models treated with probiotics.  The 
improved memory demonstrated by the probiotic group in the spatial memory tasks (Chapter 5 
experiment 3) may be accounted for by increasing in choline levels previously reported as a function 
of probiotic treatment (Ziada et al, 2013). 
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6.3. Method and Procedure 
Subjects 
The rats used in this study were also used in the studies described in chapter 4 & 5.  5 rats from the 
control group and 5 from the probiotic group were used for NMRS analysis. 
Brain dissection for NMRS 
Animals were sacrificed by decapitation.  The brain was removed and extirpated; the hippocampus 
and frontal cortex were snap-frozen immediately in liquid nitrogen.  Samples were stored at -80 oC 
until tissue was processed. 
NMRS method  
Tissue samples were defrosted and extracted with a mixture of water, chloroform and methanol 
(v:v:v, 3:2:1) in a glass test tube. Following centrifugation at 5,000 rpm at 4 oC, the aqueous phase 
was separated into an Eppendorf tube and then dried using a speed vacuum.  The sample was then 
suspended with 600 µl of deuterium oxide (D2O) and sonicated for 10 min. Fifty micro litre of 0.2 M 
phosphate buffer (pH=7.4) containing 100% D2O for the magnetic field lock, 0.01% 3-(trimethylsilyl)-
[2,2,3,3-2H4]-propionc acid sodium salt (TSP) for the spectral calibration and 3mM sodium azide 
(NaN3) to prevent bacterial contamination was added and thoroughly vortex for 15 sec followed by 
spinning at 10,000 g for 5 minutes.  A total of 600 µl of the supernatant was transferred to an NMR 
tube (5mm outer diameter) for 1H NMR spectral acquisition using a Bruker 600MHz spectrometer 
(Bruker; Rheinstetten, Germany).  A 1H frequency of 600.13 MHz was applied to the samples at a 
temperature of 27 oC.  A standard NMR pulse sequence (recycle delay[RD]-90o-t1-90
o-tm-90
o-
acquisition) was applied to acquire 1-dimensional (1-D) 1H NMR spectral data with t1 set to 3 µs and 
tm (mixing time) set to 100 ms.  Using selective irradiation during RD of 2s and tm the water peak 
suppression was achieved.  A total of 128 scans were collected into 64 k data points. 
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Statistical analysis 
Multivariate data analysis was performed based on pre-processed NMRS datasets.  1H NMR spectra 
were phased, referenced and baseline corrected manually in TopSpin 3.0.b.60 software (Bruker). The 
entire spectral data (0-10ppm) were imported into MATLAB R2012a and the water signal region 
(4.75-5.05 ppm) was removed to avoid water suppression-induced baseline distortion. The 
remaining spectral data was normalised using median fold change normalisation method and  
subsequently analysed using principal component analysis (PCA) and orthogonal partial least squares 
discriminant analysis (OPLS-DA).  
Each metabolite may have multiple peaks in the 1H NMR spectra.  A peak, which is least overlapping 
with other signals, was selected and values of correlation (r, Pearson’s correlation coefficient) and 
significant differences in correlations of these variables, calculated using students t-test,  between 
the two group.  
 
 
 
 
 
 
 
The brain tissue was collected and stored at Cardiff University.  NMR analysis was conducted at 
Imperial College London by Dr. Jia Li, Faculty of Medicine, Department of Surgery and Cancer.  
Production of PCA and OPLS-DA score plots and statistical analysis was also conducted by Dr. Jia Li. 
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6.4 Results 
6.4.1. Frontal Cortex 
 
Spectral data of frontal cortex was aligned using recursive segment-wise peak alignment method 
due to the heavy shift of peaks (Veselkov et al, 2009). 
Figure 1 shows an unsupervised multivariate principal component analysis (PCA) score plot for the 
frontal cortex.   The purpose of this was to observe intrinsic trends in metabolites between the 
samples and identify any outliers.  The PCA score plot indicates strong segregation of the two groups 
based on the correlation of their main metabolites.  The R2 value for main metabolites in this in the 
samples is 0.43, i.e. 43% of the variance between the samples is accounted for by the main 
metabolites.  
Figure 2 shows supervised multivariate analysis orthogonal partial least-squares discriminant (OPLS-
DA).  This is a predication regression model which assumes there are two groups and separates the 
samples based on correlation between its main components.  The R2 value in the model was 0.38.  
The Q2 value is indicative of the quality of the model in its prediction ability.  The Q2 value in this 
model was 0.45.  
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Figure 1.  Principal Component Analysis (PCA) score plot of metabolites in the frontal cortex. A = 
Control group, B = Probiotic Group. 
 
 
Figure 2.   OPLS-DA score plots of metabolites in the frontal cortex. A = Control group, B = Probiotic 
group. 
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Table 1 shows the Pearson’s correlation coefficient (r) of the metabolites which produced the largest 
peaks in NMR spectral output and the significant value (p) of theses metabolites between the 
groups.  This was conducted using a student’s t-test.  
Table 1.  Correlation coefficients (r) of the main metabolites in frontal cortex of the probiotic group 
and significance values (p) when compared with control group. 
Front cortex metabolites  Selected chemical shift r p 
lactate  1.34 ppm  0.76  0.01  
myo-inositol  4.06 ppm  0.73  0.015  
GABA  1.89 ppm  0.59  0.02  
fumarate  6.52 ppm  0.79  0.01  
alanine  1.47 ppm  0.60  0.06  
 
6.4.2. Hippocampus 
Figure 3 shows an unsupervised multivariate principal component analysis (PCA) score plot for the 
hippocampus.  The PCA score plot indicates strong segregation of the two groups based on the 
correlation of their main metabolites.  The R2 value for main metabolites in the samples is 0.41, i.e. 
41% of the variance between the samples is accounted for by the main metabolites.  
Figure 4 shows supervised multivariate analysis orthogonal partial least-squares discriminant (OPLS-
DA).  The R2 value in the model was 0.34.  The Q2 value in this model was 0.72.  
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Figure 3. Principal Component Analysis (PCA) score plot of metabolites in the hippocampus. A = 
Control group, B = Probiotic Group. 
 
 
Figure 4.  OPLS-DA score plots of metabolites in the hippocampus. A = Control group, B = Probiotic 
group. 
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Table 2 shows the Pearson’s correlation coefficient (r) of the metabolites which produced the largest 
peaks in NMR spectral output and the significant value (p) of theses metabolites between the 
groups.  This was conducted using a student’s t-test. The NMR spectral output identifies 
hypoxanthine as the only metabolite to produce a higher peak in the control group than the 
probiotic group.  Therefore, the r and p values reported for this metabolite are the correlation 
coefficient in the control group and difference from the probiotic group, respectively.  
Hippocampus metabolites  Selected Chemical shift  r p  
Inosine  6.10 ppm  0.76  0.01  
alanine  1.47 ppm  0.72  0.02  
succinate  2.41 ppm  0.67  0.03  
hypoxanthine  8.19 ppm  0.71  0.02  
lactate  1.34 ppm  0.81  0.005  
 
Table 3.  Correlation coefficients (r) of the main metabolites in hippocampus of the probiotic group 
and significance values (p) when compared with control group, with the exception of hypoxanthine 
(see above).  
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Summary 
The results from the NMRS output, PCA, OPLS-DA score plots and statistical analysis of the 
metabolites in the frontal cortex indicate that the metabolites which produced the main differences 
between the groups were lactate, myo-inositol, GABA, fumarate and alanine.  The concentrations of 
these metabolites were all significantly different between the groups with the exception of alanine 
(p=0.06).  In the hippocampus the main metabolites were inosine, alanine, succinate, hypoxanthine 
and lactate.  The concentrations of these metabolites were all found to significantly differ between 
the groups.  The correlation coefficient of hypoxanthine was found to produce a strong peak in the 
NMR spectral output of the control group which does not occur in the probiotic group.  This 
difference was also found to be significant.  
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6.5. Discussion 
As expected probiotic treatment significantly increased myo-inositol concentrations in the frontal 
lobe however this was not observed in the hippocampus.  The differentiation between the brain 
areas indicate that myo-inositol is regulated differentially in the brain by probiotic administration  
Myo-inositol transport from extracellular sources across the blood-brain barrier is a low-capacity 
saturable system and thus it is unlikely that this is the sole explanation for high peak intensities in 
the probiotic treated group.  Myo-inositol is a precursor for the PIP cycle and is synthesised from D-
glucose-6-phosphate therefore it is reasonable to assume that probiotic treatment is altering this 
process or another process in the PIP cycle resulting in increased recycling.  Either way, it is 
hypothesised that probiotic treatment affects endogenous levels of myo-inositol as opposed to 
facilitating an extracellular source.  Furthermore, studies have shown that levels of myo-inositol, 
when in the environment of probiotic microbiota, are reduced by the bacteria that utilise it in their 
own metabolic pathways (Yebra et al, 2007).  However, the current in vitro study produces 
contrasting results to systemic studies and may fail to identify this as a saturable process.  Other 
studies focussing on the effects of route of administration have found that oral administration of 
myo-inositol is not as effective in altering brain levels of the metabolite as intraperitoneal (i.p.) 
administration (Einat et al, 1999a).  This gives some weight to the hypothesis that gut bacteria also 
utilise this compound.  As regards to the current study, the increase in frontal lobe myo-inositol 
indicated a net increase in myo-inositol production from extracellular processes or more likely, 
altered PIP cycle functioning.  There is need to further examine the metabolite profiles of the blood 
from control and probiotic treated rats in order to determine the extent of the effect of extracellular 
processes on intracellular myo-inositol concentrations.   
Direct oral consumption of myo-inositol has been found to significantly increase cortical and 
hippocampal inositol levels by 36% and 27%, respectively (Kofman et al, 1998).  However, due to the 
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differential alteration in the metabolic profile between the two brain areas in this study, this 
provides support for the hypothesis that probiotic treatment alters intracellular metabolic pathways. 
The differences in peak intensities in GABA, alanine and lactate in the frontal cortex and alanine, 
lactate and succinate in the hippocampus strongly implicate alteration of the GABA/glutamate-
glutamine cycle in the probiotic group.  This is the first time this has been reported in animal models. 
However, it is consistent with the findings of Ziada et al (2013) who reported a significant reduction 
in glutamine ratios following treatment with lactobacillus acidophilus in patients with minimal 
hepatic encephalopathy (MHE).  In the current study, an increased level of GABA, an inhibitory 
neurotransmitter, was found in the frontal cortex.  Production of GABA occurs in a cycle known as 
the GABA/glutamate-glutamine cycle.  Glutamate is a major excitatory neurotransmitter in the brain 
while GABA acts an inhibitory neurotransmitter.  The balance of these two neuroactive substances is 
maintained by the GABA/glutamate- glutamine cycle (Bak et al, 2006).  When glutamate is released 
into the synaptic cleft it activates the receptors on the post-synaptic membrane, this reduces some 
of the glutamate present.  However, some is reabsorbed into the presynaptic neuron while most is 
taken up into astrocytes where it is converted to glutamine by glutamine synthetase using ammonia 
and returned to the neuron where it is converted back to glutamate and the ammonia transported 
back to the astrocyte.  Glutamate may be released in the synaptic cleft or converted to GABA by 
glutamate decarboxylase and released to act as an inhibitory neurotransmitter.  As with glutamate, 
some GABA is taken up post-synaptically, some undergoes reuptake but some is also absorbed by 
astrocytes.  In the astrocyte, GABA is converted to succinate in the tricarboxylic acid (TCA) cycle and 
then into α-ketoglutarate before being converted into glutamate.  From there it undergoes the same 
process as glutamate; directly absorbed by the astrocyte, aminated to glutamine and transported to 
the neuron where it is degenerated back into glutamate and ammonia (Bak et al, 2006).  The role of 
alanine in this system is to balance the pH disturbance caused by the movement of ammonia 
between the neuron and the astrocyte.  When glutamine is transported to the neuron it is converted 
back into glutamate and ammonia.  The ammonia is then used in the lactate-alanine shuttle which 
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converts pyruvate (derived from lactate) into alanine and then exported to the astrocyte where this 
process is reversed (alanine converted back into pyruvate and then lactate) and an ammonium 
cation produced  and used for the amination of glutamate.  Lactate is then exported back to the 
neuron where it is used to produce more alanine.  In the TCA cycle, some succinate is converted into 
fumarate as part of the process to process energy (ATP) from carbohydrates, fats and proteins 
(Krebs & Weitzman, 1987).  In the current study increased concentrations of GABA were found in the 
frontal cortex of probiotic treated rats.  This suggests a shift in the GABA/glutamate-glutamine cycle 
functioning to favour the production of the inhibitory neurotransmitter GABA over the excitatory 
neurotransmitter glutamate. This is consistent with reports by Ziada et al, (2013) were probiotic 
treatment reduced levels of glutamine/glutamate. 
The present study also found no difference in choline levels between the two groups.  The difference 
in choline concentrations reported in the study by Ziada et al (2013), indicated an increase in myo-
inositol + choline: glutamine/glutamate ratios.  The present study has also found an increase in myo-
inositol and GABA concentrations (which may account for lower glutamine/glutamate levels 
previously reported).  Therefore, the previously reported increase in myo-inositol +choline: 
glutamine/glutamate ratio may have primarily driven by changes in myo-inositol and 
glutamine/glutamate levels as opposed to any net change in choline concentrations which would be 
consistent with the current study. 
 In the hippocampus of probiotic treated rats, there was increased inosine and decreased 
hypoxanthine concentrations relative to controls.  The opposing concentrations of these two 
metabolites are unsurprising given that both of these metabolites are part of the purine nucleotide 
cycle (Schultz & Lowenstein, 1978).  A precursor to both of these metabolites is adenosine.  
Adenosine is a potent neuromodulator in the brain and inhibits neurotransmitter release and 
neuronal excitability (Dunwiddie, 1985; Dunwiddie & Masino, 2001).  Adenosine concentrations in 
the hippocampus have been implicated in long-term potentiation (LTP) with increased levels 
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associated with inhibition of LTP via activation of adenosine A1 receptors (A1Rs) (Arai et al, 1990, 
Alzheimer et al, 1991; Forghani & Krnjevic, 1995).  A1R agonist administration was found to impair 
spatial memory acquisition in a watermaze paradigm while antagonists produced no behavioural 
alteration (Von Lubitz et al, 1993).  In a study examining the role of adenosine in impaired 
hippocampal LTP and spatial memory following chronic opiate exposure, it was reported that 
accumulation of adenosine contributed to impaired performance in spatial memory and induced 
inhibition of hippocampal CA1 LTP. Administration of an A1R antagonist was found to reverse the 
deficit in the watermaze.  Furthermore, adenosine deaminase, which converts adenosine into 
inosine, also reversed the impaired CA1 LTP inhibition (Lu et al, 2010).  The results from the study by 
Lu et al (2010) indicated that the presence of inosine acts as a neuroprotective agent and facilitates 
LTP in the hippocampus.  Concentrations of inosine are regulated by conversion to hypoxanthine by 
hypoxanthine-guanine phosphoribosyltransferase (HGPRT) where it is either converted back into 
inosine monophosphate (IMP) which (as well as adenosine) is a precursor to inosine or converted 
into the waste product uric acid.  The higher concentrations of inosine found in the probiotic group 
along with the higher concentration of hypoxanthine found in the control group in the hippocampus 
suggest probiotic treatment impacts this pathway.  As there was no increase in adenosine found in 
the hippocampus and control animals showed higher levels of hypoxanthine it is likely that probiotic 
treatment reduces metabolism of inosine.  This may have been achieved though deactivation of 
nucleoside phosphorylase (NP), the enzyme responsible for converting inosine to hypoxanthine or 
facilitation of HGPRT which converts hypoxanthine to IMP.  These higher concentrations of inosine 
found in the hippocampus of the probiotic group indicate that LTP may be facilitated with dietary 
probiotic administration. 
Of particular concern regarding the methodology of this experiment was the possible presence of 
blood in the brain tissue due to the method of collection.  However given the differences in 
metabolite profiles between the two brains areas, it is evident that some of the alterations in 
metabolite profiles originate in brain tissue as opposed to the blood.  Of the metabolites 
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demonstrated to alter between the groups, lactate is the only one which is consistent between the 
two brain areas.  This is unsurprising given the probiotic group were fed lactic acid producing 
bacteria (Klein et al, 1998).  However lactate also serves as a precursor to alanine, which was found 
to be elevated in the hippocampus of probiotic treated animals.  Therefore, it is possible that 
increases in lactate are a result of both, increased exogenous production (from bacteria) and 
increased intracellular production from alanine.  However, statistical analysis of alanine indicated 
that there was not a significant difference between the concentrations in the frontal cortex of the 
two groups despite there being a significant increase in lactate concentrations in the probiotic 
group.  This implies that much of the increase in lactate concentrations can be attributed to 
exogenous production. 
The results of this study can be used to explain some of the behavioural alterations reported in 
probiotic treated animals and provides a platform on which to continue investigations into how 
metabolism within the CNS is affected by probiotic treatment and how this may affect behaviour 
and cognition. This will be considered further in the General Discussion. 
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General Discussion 
7.1. Summary 
The purpose of the experiments presented in the current thesis was to examine the effects of 
dietary probiotic on central nervous system function.  The basis of the research stems from a study 
by Desonnet et al (2008).  Results from high performance liquid chromatography (HPLC) indicated 
that probiotic treatment altered metabolism of serotonin (5-HT) in the frontal cortex.  Due to these 
effects on 5-HT transmission it has implied that probiotic treatment may be used an adjuvant 
therapy for affective disorders (Desbonnet et al, 2008, 2010).  Therefore, the effects of prolonged 
probiotic treatment on anxiety-like behaviour were examined.  The effects of direct 5-HT 
manipulation in anxiety-like behaviour, were also examined following administration of the 
serotonin selective reuptake inhibitor (SSRI) citalopram.  The current studies also aimed to identify a 
behavioural task which is reliant on serotonergic frontal cortex functioning in order to test the 
effects of probiotic treatment.  The probabilistic reversal learning (PRL) task was reported by Bari et 
al (2010) to be reliant on 5-HT functioning.  In order to establish the role of frontal lobe functioning 
in this task the effects of medial prefrontal (mPFC) lesions were examined.   The effects of probiotics 
in a task known to be dependent on the frontal cortex and hippocampus, namely a watermaze 
reversal learning paradigm, indicated that probiotic treatment improves functioning in this task.  
Identification of brain areas that show improvements following probiotic treatment are explored 
through object recognition tasks that rely differentially on contributions of the hippocampus and 
subregions of the frontal cortex.  In order to decipher whether 5-HT alterations played a role in 
spatial recognition memory, this task was also conducted with citalopram.  The effects of probiotic 
treatment on intracellular processes have never previously been explored.  Nuclear magnetic 
resonance (NMR) was conducted on the frontal cortex and hippocampus to establish whether 
probiotics alters the metabolic profile of these two brain areas. 
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7.2. The role of serotonin in probiotic treatment in the probabilistic reversal learning task 
The purpose of the experiments presented in Chapter two were firstly to establish the pattern of 
performance in an automated probabilistic reversal learning paradigm originally developed by Bari 
et al (2010).  This task differs from classical reversal learning paradigms in that the reward schedule 
for ‘correct’ responses is probabilistic i.e. not rewarded on 100% of occasions.  As such, performance 
requires relies on integrating feedback over a number of trials (Cools et al, 2002).  Therefore, 
discrete rules cannot be adopted to guide behaviour as in classical reversal learning.  Due to the 
probabilistic nature of the PRL task, no discrete rules exist therefore sensitivity to positive and 
negative reinforcement on previous trials is required to guide responding on subsequent trials.  This 
initial task manipulated the task difficulty to determine behavioural sensitivity to changes in stimulus 
reward contingencies.  The results indicated that when task difficulty was altered from an easier to a 
more difficult version of the task sensitivity to positive reinforcement was indicative of the number 
of reversals achieved; however, sensitivity to negative reinforcement did not alter between the 
tasks.  The neuroanatomical specificity of this sensitivity to positive reinforcement was identified in 
the second experiment where lesions to the mPFC induced impairment.  More specifically this was 
found only in the reversal phase while sensitivity to positive reinforcement remained intact during 
initial acquisition.  This implies not only that negative and positive feedback sensitivity are neurally 
dissociable but also that sensitivity to positive reinforcement during initial acquisition of the PRL task 
is not reliant on the mPFC, only after a stimulus-reward contingency has been reversed.  Having 
identified a distinct role for the mPFC in probabilistic reversal learning Chapter 3 examined the 
impact of manipulation in the serotonergic system.   
Citalopram was administered in two doses 5 mg/kg and 10 mg/kg.  The 5 mg/kg dose was found in 
increase the number of reversals on the first test session.  This was not found with the higher dose 
and no further improvements were found in sensitivity to positive or negative reinforcement with 
either dose.  This implies that while responsiveness to feedback is not modulated by the serontergic 
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system, the reversal of a learning stimulus-reward association is in part modulated by this system. 
While there is a convergence of evidence suggesting that 5-HT is strongly implicated in reversal 
learning (Bari et al, 2010; Clarke et al, 2005, 2007), other studies have focused on the 5-HT receptor 
subtypes that are thought to mediate the behaviour.  The 5-HT2a receptor antagonist, M100907 
impaired serial spatial reversal learning.  In contrast, the 5-HT2C receptor antagonist, SB242084 
improved serial spatial reversal learning (Boulougouis et al, 2008). The results from the current study 
would imply that varying doses of citalopram doses differentially impact the 5-HT2a receptor with 
the lower dose optimising performance.  The effects of 5-HT receptor antagonism is not limited to 
the 5-HT system and so implicating other neurotransmitters in reversal learning.  Specifically, 
antagonism of 5-HT2a receptor enhances dopamine (DA) 2 receptor (D2) antagonism (Bonaccorso et 
al, 2002; Liegeois et al ,2002; Olijslagers et al, 2004, 2005).  Numerous studies using systemic D2 
antagonist administration have found impairments in reversal learning.  The results indicate that the 
effects of 5-HT transmission on reversal learning induced by the 5 mg/kg dose of citalopram may be 
mediated by cortico-striatal dompaminergic function.    
The results obtained from study reported here were not consistent with those previously report by 
Bari et al (2010).  Further studies are required to elucidate the role of 5-HT transmission in 
processing on positive and negative reinforcement in reversals of previously learned stimulus-
reward associations (two effects reported by Bari et al (2010)).   
The effects of probiotic treatment on probabilistic reversal learning (Chapter 4, Experiment 4) are 
partially consistent with the results from the citalopram study (Chapter 3, Experiment 3 and 4).  
Desbonnet et al (2008) reported reduced degradation of 5-HT in the frontal cortex of probiotic 
treated rats.   Citalopram induces its effects on the 5-HT system by blocking reuptake into the 
presynaptic cleft therefore producing a similar neurological effect to that reported by Desbonnet et 
al (2008) following probiotic treatment.  Chapter 3 experiment 3 showed that citalopram did not 
significantly impact sensitivity to positive reinforcement as was found following probiotic treatment.  
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Furthermore,  Chapter 2 experiment 2 showed that the mPFC is fundamental in the processing of 
positive reinforcement in probabilistic reversal learning.  However, the improved pharmacological 
effect of probiotic treatment in the frontal cortex reported by Desbonnet et al, (2008) did not 
produce an effect on this task.  This indicates that improvement of 5-HT functioning in the frontal 
cortex of probiotic treated rats does not mediate the processing of positive reinforcement in 
probabilistic reversal learning. 
5 mg/kg citalopram was found to increase the number of reversals achieved in the first test session 
of the test phase without significantly altering sensitivity to positive and negative reinforcement.  
The ability to reverse learned stimulus-response patterns though inhibition of responding is well 
established to be reliant on the orbitofrontal cortex (OFC) (Rudebeck et al, 2013).   Intraperitoneal 
administration of citalopram increases global extracellular 5-HT levels therefore impacting the OFC 
which may have improved inhibition of responding resulting in a higher number of reversals in this 
session.  The vehicle treated group demonstrated an increased the number of reversals across the 
sessions implying that learning was still occurring across the test sessions.  These improvement in 
performance may have been due to the rats deciphering the pattern of behaviour which optimises 
the number of rewards.  This trend was also exhibited by the 10mg/kg treated group however it did 
not reach statistical significance.  The study by Desbonnet et al (2008) did not examine the effects of 
probiotic treatment on 5-HT metabolite concentrations in subregions of the frontal cortex, however, 
when the results from the current research are considered it can be assumed that these alterations 
do not occur in the OFC. 
In summary, the probabilistic reversal learning task is a useful task for identifying mPFC dysfunction.  
Also the processes responsible for sensitivity to positive and negative reinforcement are neurally 
dissociable, with the mPFC implicated in the former.  The increased number of reversals achieved by 
the 5 mg/kg citalopram treated group, independent of altered sensitivity to positive or negative 
reinforcement, indicate that SSRI administration may improve inhibition of responding.  The 
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reduction of 5-HT degradation in the frontal cortex, which may have occurred as a result of probiotic 
treatment, does not reflect the pattern of results found with SSRI administration indicating that 
probiotic treatment does not improve 5-HT transmission in all subregions of the frontal cortex.  
Alternatively, the effects of probiotic treatment on frontal lobe serotonergic functioning reported by 
Desbonnet et al (2008) did not occur in rats used in the current study.  Further research examining 
the role of 5-HT function in subregions of the frontal cortex is essential in order to elucidate the 
potential for probiotics to improve cognitive performance. 
7.3. Effects of probiotics and citalopram on anxiety-like behaviour 
The results from Chapter 3 Experiment 1 and 2 indicate that citalopram treatment did not improve 
behavioural measures of anxiety in both tests.  Citalopram administration at two doses, 10 mg/kg 
and 1 mg/kg produced opposite effects in the elevated plus maze (EPM) but not the open field test 
(OFT).  The effects found in the open field test were limited to frequency and duration in the middle 
of the maze.  They were not found to differ significantly between the groups on either day however 
dose did differentially affect these measures.  This is a contrast to the robust changes found in 
behaviour over several measures in the EPM.  The incongruency between these two tests was also 
reported in Chapter 4 experiment 1 and 2 where probiotic treatment produced an opposing pattern 
of results.  Probiotic treatment did not produce any effect on behaviour in the EPM however these 
rats showed preference for the corners and edges of the arena in OFT.  These results highlight an 
issue in assessing the emotional state of rodents using these behavioural paradigms as they lack 
coherency.  This inconsistency has been previously reported in pharmacological and genetic studies 
of anxiety (Vendruscolo et al, 2003) and supports the opinion that construct differences mean each 
test assesses only one facet of an animals’ emotional profile.   In Chapter 3 it was proposed that 
sequential testing may have attributed to the lack of effect found in the OFT, as it was the second of 
the two tests be administered.  However, these tests were administered in the same order with the 
probiotic group and significant differences were reported in the second of the two tests therefore 
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indicating that familiarity with testing in the OFT and EPM did not impact behaviour in this study.  
Given that these results found an opposing pattern of results in the citalopram study in comparison 
with the probiotic study in can be inferred that the effects of probiotic treatment on behaviour in 
the OFT is not mediated by the serotonergic system.  The confounding variable of locomotor activity 
in the OFT and EPM was assessed separately in probiotic treatment and found to produce a similar 
pattern of activity as the results reported by the OFT.  This implies that the results from the OFT are 
not true indicators of anxiety-like behaviour.  Therefore, whether or not the current probiotic 
intervention impacts anxiety-like behaviour cannot be concluded.  Other studies which have 
reported behavioural changes as a result of probiotic treatment in the EPM found the effect in 
hyperammonemia rats (a disease model for hepatic encephalopathy) (Luo et al, 2014).  These results 
indicated that the physiological alterations induced by probiotics are only apparent in already 
compromised systems.  Alternatively, a test which has been found to be sensitive to the behavioural 
manifestations of probiotic treatment in normal rats is the defensive-burying test (Messaoudi et al, 
2011) indicating that choice of behavioural paradigm can lead to alternative conclusions drawn on 
the effects of probiotics on anxiety-like behaviour.  Of particular relevance to the lack of consistency 
between the reported effects of probiotics on anxiety-like behaviour is the choice of probiotic 
bacteria in preclinical studies.  Lactobacillus and bifidobacterium bacteria are the primary probiotics 
used in preclinical studies.  However, preclinical research has varied in choice of stains of these 
bacteria without detailed examination of potential differential effects.  As previously mentioned, 
potential effects on anxiety-like behaviour may be reliant on initial anxiety state and choice 
behavioural paradigm.  However, choice of bacterial strain may also be influential.  Lactobacillus 
helveticus was found to improve anxiety like behaviour in normal rats (in a defensive-burying task) 
(Messaoudi  et al , 2011).  However, the current study used two strains of lactobacillus acidophilus, 
bifidobacterium bifidum and bifidobacterium lactis in normal rats.  Further research should be 
conducted controlling for bacterial strain in order to identify any potential differential effects of 
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these strains on anxiety-like behaviour.  Another methodological consideration is the duration of 
treatment.  There also exists a lack of consistency between studies on treatment duration. 
7.4. Behavioural effects of metabolite profile alterations following probiotic administration. 
7.4.1. Myo-inositol 
Behavioural effects of intracellular metabolism alterations following probiotic treatment were 
examined in Chapter 6.  The results from the NMR study indicate significant alterations in 
intracellular metabolism as a result of probiotic treatment.  This was found to differentially affect 
the hippocampus and the frontal cortex.  Increased levels of myo-inoistol were found in the frontal 
cortex.  Of particular relevance in the current thesis is the association of myo-inositol and anxiety.  
Previous research has shown that direct administration of myo-inositol significantly reduces 
immobility time in the forced swim test (FST).  The watermaze reversal learning task was an anxiety 
inducing paradigm using the same aversive stimuli as in the FST.  The improved acquisition of the 
platform location in this task, as indicated by an increased number of platform crossings in the final 
session of the acquisition phase, as well as the increased number of platform crossings in the 
reversal phase may be accounted for by reduced anxiety levels therefore facilitating learning.  The 
PRL task failed to produce significant results between the probiotic and control group.  The negative 
reinforcement in this task was not designed to induce anxiety, therefore according to this theory the 
effect of increased myo-inositol levels on anxiety would not have enabled improved performance.  
Results from the locomotor activity (LMA) test indicated the probiotic treatment increased activity 
on the first day of testing.  This is consistent with previous studies where oral myo-inositol 
administration resulted in a 30% increase in ambulation in a LMA test (Kofman et al, 1998).  The 
primary effects of probiotic treatment on anxiety-like behaviour have indicated that the effect is 
more profound in compromised systems with models of anxiety and disease exhibiting behavioural 
alterations following probiotic treatment (Desbonnet et al, 2010; Luo et al, 2014).  The increase in 
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myo-inositol reported here was found in normal rats however the behavioural impact may only 
manifest in anxiety inducing environments, such as the watermaze reversal learning task.  Other 
studies have reported significant reductions in anxiety-like behaviour in other behaviour paradigms 
such as the defensive-burying task following probiotics treatment.  Increased myo-inositol levels 
reported here may account for these effects on anxiety-like behaviour. 
7.4.2. Fumarate 
Fumarate has also been implicated in anxiety-like behaviour.   However, there is limited evidence for 
this in the preclinical arena.  Randomised placebo controlled trials have reported benefits in 
generalised anxiety disorder following quetiapine fumarate (Endicott et al, 2012; Katzman et al, 
2011; Mezhebovsky et al, 2013).  It is possible that increased levels of frontal lobe fumarate may 
contribute to the anxiogenic effects of probiotic treatment found in other studies.  However  given 
the lack of preclinical research this is not conclusive. 
7.4.3. GABA 
Increased levels of GABA were found in the frontal cortex of probiotic treated rats.  GABA is the 
main inhibitory neurotransmitter in the brain.  Direct infusions of Muscimol, a GABAA receptor 
agonist, in the mPFC was found to impair reversal learning without affecting acquisition or retention 
of a discrimination (Shaw et al, 2013).  In the probiotic group reversal learning was not impaired in 
the probabilistic reversal learning task.  Performance in this task was shown to be reliant on mPFC 
functioning therefore it can be concluded that the increases in GABA found in the frontal cortex 
were in subregions other than the mPFC.  GABAergic transmission in the frontal cortex has been 
associated with brain-derived neurotrophic factor (BDNF) protein expression (Sakata et al, 2009).  
Mutant mice with selective disruption in activity-dependent BDNF expression (BDNF-KIV) have been 
shown to exhibit deficits GABA-mediated inhibition in the frontal cortex.  BDNF-KIV mice also 
showed reduced long-term potentiation (LTP) in the CA1 of the hippocampus, which contains 
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projections to the PFC (Sakata et al, 2009).  Analysis of GABAergic synapses in the hippocampus and 
PFC showed that BDNF expression only impacts PFC GABA and induced no alterations in 
hippocampal GABA (Sakata et al, 2013).  This result is consistent with the current NMR study that 
found that GABA did not differ in the hippocampus therefore also implying that BDNF protein 
expression was altered by probiotic treatment.  The behavioural effects of BDNF-KIV mutation on a 
watermaze reversal learning paradigm, similar to that conducted in the current thesis (Chapter 4, 
Experiment 5),  included impairment in reversal of the platform spatial location (Sakata et al, 2009).  
Hippocampal BDNF levels have been found to be elevated in probiotic treated rats (O’Sullivan et al, 
2011).   This is consistent with the current findings where improved performance in the reversal of 
the platform location was a function of probiotic treatment.  In conclusion, probiotic treatment may 
have increased BDNF expression resulting in increased LTP in the hippocampus and elevating frontal 
lobe GABA concentrations. 
Novel object recognition has been shown to be mediated by the perirhinal cortex but not the 
hippocampus (Kim et al, 2014).  Furthermore, oral GABA administration was found to significantly 
improve memory in a novel object recognition task (Thanappreddawat et al, 2013).  This result 
supports the current findings were probiotic treatment improved novel object recognition with a 1hr 
delay (Chapter 5, Experiment 2). 
7.4.4. Inosine and Hypoxanthine 
Hippocampal CA1 LTP has been shown to be impaired following chronic opiate exposure due to an 
accumulation of adenosine  (Lu et al, 2010) causing activation of adenosine A1 receptors (Arai et al, 
1990, Alzheimer et al, 1991; Forghani & Krnjevic, 1995).  This has been shown to impair spatial 
memory.  However, administration of an A1R antagonist was found to reverse the deficit in the 
watermaze.  Furthermore, adenosine deaminase, which converts adenosine into inosine, also 
reversed the impaired CA1 LTP inhibition (Lu et al, 2010).  These results imply that increased levels 
of inosine facilitate LTP in the hippocampus. This is consistent with the improvement in spatial 
General Discussion Chapter 7 
 
167 
 
memory in the watermaze reversal learning paradigm (Chapter 4, Experiment 5) and object in place 
recognition (Chapter 5, Experiment 3) found as a result of probiotic treatment.  Hypoxanthine was 
found to be higher in the control treated group.   Hypoxanthine is a product of inosine metabolism, 
where it is either converted into the waste product uric acid or inosine monophosphate (IMP) which 
(as well as adenosine) is a precursor to inosine.  The higher concentrations of inosine found in the 
probiotic group along with the higher concentration of hypoxanthine found in the control group in 
the hippocampus suggest probiotic treatment impacts this pathway.  Furthermore, as there was no 
increase in adenosine found in the hippocampus and control animals showed higher levels of 
hypoxanthine it is likely that probiotic treatment reduces degradation of inosine. These higher 
concentrations of inosine found in the hippocampus of the probiotic group indicate that LTP may be 
facilitated with dietary probiotic administration improving spatial memory. 
 
The results from the studies presented here demonstrate that dietary administration of probiotic 
treatment impacts upon intercellular metabolism in the frontal cortex and hippocampus.  These 
changes may account for the improvement in recognition memory and reversal learning in tasks 
reliant on spatial memory.  Results from the H1 nuclear magnetic resonance spectroscopy study 
provide a new avenue of research to examine the potential for this intervention to improve affective 
disorders.   
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